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Résumé 
 
Ce mémoire décrit le développement d’une nouvelle méthodologie d’expansion de cycle 
irréversible à partir de N-alkyl-3,4-déhydroprolinols pour former des N-alkyl 
tétrahydropyridines 3-substituées en passant par un intermédiaire aziridinium bicyclique. 
Cette méthode permet l’introduction d’un vaste éventail de substituants à la position 3 et 
tolère bien la présence de groupements aux positions 2 et 6,  donnant accès à des 
pipéridines mono-, di- ou trisubstituées avec un excellent diastéréocontrôle. De plus, il est 
démontré que l’information stéréogénique du 3,4-déhydroprolinol de départ est totalement 
transférée vers le produit tétrahydropyridine. Additionnellement, une méthodologie fut 
dévelopée pour la préparation des produits de départ 3,4-déhydroprolinols en forme 
énantiopure, avec ou sans substituants aux positions 2 et 5, avec un très bon stéréocontrôle. 
Le premier chapitre présente un résumé de la littérature sur le sujet, incluant un bref survol 
des méthodes existantes pour la synthèse de pipéridines 3-substituées, ainsi qu’une vue 
d’ensemble de la chimie des aziridiniums. L’hypothèse originale ainsi que le raisonnement 
pour l’entreprise de ce projet y sont également inclus. 
 
Le second chapitre traite de la synthèse des N-alkyl-3,4-déhydroprolinols utilisés comme 
produits de départ pour l’expansion de cycle vers les tétrahydropyridines 3-substituées, 
incluant deux routes synthétiques différentes pour leur formation. Le premier chemin 
synthétique utilise la L-trans-4-hydroxyproline comme produit de départ, tandis que le 
deuxième est basé sur une modification de la réaction de Petasis-Mannich suivie par une 
métathèse de fermeture de cycle, facilitant l’accès aux précurseurs pour l’expansion de 
cycle. 
 
Le troisième chapitre présente une preuve de concept de la viabilité du projet ainsi que 
l’optimisation des conditions réactionnelles pour l’expansion de cycle. De plus, il y est 
démontré que l’information stéréogénique des produits de départs est transférée vers les 
produits. 
 iv 
Au quatrième chapitre, l’étendue des composés pouvant être synthétisés par cette 
méthodologie est présentée, ainsi qu’une hypothèse mécanistique expliquant les 
stéréochimies relatives observées. Une synthèse énantiosélective efficace et divergente de 
tétrahydropyridines 2,3-disubstituées est également documentée, où les deux substituants 
furent introduits à partir d’un intermédiaire commun en 3 étapes. 
 
Mots-clés : Pipéridine 
 Tétrahydropyridine 
 Aziridinium 
 Synthèse énantiosélective 
 Synthèse diastereoselective 
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Abstract 
This thesis describes the development of a novel methodology of irreversible ring 
expansion from N-alkyl-3,4-dehydroprolinols to N-alkyl-3-substituted tetrahydropyridines 
through a bicyclic aziridinium ion intermediate.  This method allows a wide variety of 
substituents at the 3-position, and also permits substitution at the 2- and 6-positions of the 
tetrahydropyridine giving mono-, di- or tri-substituted piperidines with excellent 
diasterocontrol.  Complete transfer of the stereogenic information of the 3,4-
dehydroprolinol to the tetrahydropyridine product is demonstrated. Also, a methodology 
was developed to prepare the 3,4-dehydroprolinol starting materials in enantiopure form, 
with the possibility of substitution at the 2- and 5-positions with excellent diasterocontrol.  
The first chapter presents the literature background, including a brief summary of 
methodologies for the synthesis of 3-substituted piperidines, and an overview of 
aziridinium ion chemistry.  Also presented is the original hypothesis of the project, and our 
reasoning for undertaking this project. 
The second chapter describes the synthesis of N-alkyl-3,4-dehydroprolinols used as 
precursors for the ring expansion to 3-substituted tetrahydropyridines, including two 
different synthetic routes.  The first route route converts L-trans-4-hydroxyproline to 
enantioenriched N-benzyl-3,4-dehydroprolinol  in 6 steps.  The second synthetic route was 
developed using a variant of the Petasis-Mannich reaction and a ring closing metathesis, 
making the precursors more readily available and simple to synthesize. 
The third chapter presents the proof of concept of the viability of the project and 
optimization studies.  Moreover, the transfer of stereogenic information to the resulting 
product is demonstrated.  
The fourth chapter demonstrates the broad scope of the ring expansion and mechanistic 
insight is given based on the relative configuration of the products. An expedient divergent 
enantioselective synthesis of a 2,3-disubstituted tetrahydropyridine is also shown, with both 
substituents being chosen from a common intermediate in 3 steps.   
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Chapter 1: The Aza-Heterocycles Piperidine and Aziridinium 
Introduction 
1.1 Overview of Piperidines 
Substituted piperidines are widespread in natural products as structural features and are of 
great interest to organic chemists.
1
  The piperidine ring is found in many simple substituted 
alkaloids with significant biological activity with examples such as Coniine (a poisonous 
neurotoxin in Poison Hemlock and the Yellow Pitcher plant)
2
, Pipecoline
3
, Conhydrine 
(poisonous, in Poison Hemlock)
4
, and Sedamine (poisonous, in Wallpepper).
5
  They are 
also present in the more complex bicyclic indolizidines, perhydroquinoline, and 
quinolizidine alkaloids, as well as in many of the more complex polycyclic alkaloids 
(Figure 1).  These nitrogen derivatives occur in plants as defense mechanisms, such as 
feeding deterrents against insects.
6
  They are also common in the animal kingdom as 
chemical weapons.  For example, the fire ant produces a variety of simple alkaloids such as 
Solenopsins for venom
7
, the lady beetle extrudes small droplets of hemolymph which 
contains piperidine alkaloids when it is disturbed as a deterent to predators
8
, and over 150 
piperidine alkaloids such as indolizidines have been isolated from poison dart frog skin 
alone.
9
   
Figure 1: Naturally Occurring Piperidine Containing Alkaloids 
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The piperidine skeletal structure is also common in the pharmaceutical industry as a feature 
in many drugs.  In fact, 23 of the “Top 200 Brand-Name Drugs by Retail Dollars in 2009” 
contain piperidine fragments.
10
  Some examples of bioactive piperidine containing 
compounds are Lysergic acid diethylamide (LSD, hallucinogenic), Remifentanil 
(analgesic), and Paroxetine (anti-depressant), as shown in Figure 2.
11
  Due to the prevalence 
of piperidines as natural products and their importance in the pharmaceutical industry their 
synthesis has garnered much attention, however much of that effort has concentrated on 2- 
and 2,6-substituted piperidines.
12
  The construction of enantiopure 3-substituted and multi-
substituted piperidines still remains a significant synthetic challenge. 
Figure 2: Piperidine Containing Bioactive Compounds 
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1.2 3-Substituted Piperidine synthesis 
1.2.1 Overview of the Methods to Prepare 3-Substituted Piperidines 
Given the value of piperidines as structural components in natural products and for the 
pharmaceutical industry, it is not surprising that an abundance of piperidine methodologies 
have been developed. However, to obtain enantiopure 3-substituted piperidines there are 
still few methods, and those that are available suffer from several key drawbacks such as a 
lack of substrate scope, the reliance on diastereomeric separation, a lack of general 
conditions or catalyst, limited substitution at other positions of the piperidine, and/or they 
do not yield enantiopure products.   
 
3 
One methodology for the synthesis of 3-substituted piperidines is the enolate alkylation of 
oxazolopiperidines.
12m, 13
  Though this method leads to enantiopure 3-alkyl piperidines, it 
requires the diastereomeric separation of the intermediates at two points in the synthesis 
and leads to the destruction of the chiral auxiliary (Scheme 1).  The oxazolopiperidine 
method has the benefit of not requiring analytical equipment to ascertain the enantiomeric 
purity of the piperidine product due to the dependence on a chiral auxiliary to give 
diastereomers.   
Another method towards 3-substituted piperidines, that was recently published, is the 
enantioselective hydrogenation of tetrahydropyridines.
14
  This method was reported to give 
good to excellent enantiomeric excess and yields, though a small scope was reported 
including only alkyl and aryl substituents, also the nitrogen was protected with a tosyl 
which can be difficult to remove.  A key drawback of this approach was the lack of general 
conditions, as the authors used a small family of chiral ligands instead of a general ligand.  
The enantiomeric excess was reported with whichever ligand gave the best result (Scheme 
9). 
Yet another methodology to obtain 3-substituted piperidines is the use of an aziridinium ion 
intermediate to perform a ring expansion from N-alkyl-2-hydroxymethylpyrrolidine 
derivatives (Scheme 10).
15
  This method depends on the piperidine being the 
thermodynamically favoured product, with the hydroxyl of the N-alkyl-2-
hydroxypyrrolidine being converted to a labile group such as a halide or trifluoroacetate.  
This method maintains the enantiomeric excess of the precursor allowing enantiopure 
piperidines to be made if enantiopure precursors are used such as proline.  However, it also 
limits the substitution at the 3-position to be labile groups.   
 
1.2.2 3-Substituted Piperidines via Oxazolopiperidines 
The use of oxazolopiperidines to obtain 3-substituted piperidines was pioneered by the 
group of Meyers and refined by the group of Bosch (Schemes 1 and 2).
12m,13
  It continues to 
be a field of interest to these groups and others.  By generating a bicyclic oxazolopiperidine 
it allows functionalization of the piperidine skeleton by taking advantage of the natural 
 
4 
electrophilic and nucleophilic sites with decent diastereoselectivity.  The 2- and 6-positions 
are electrophilic with the 6-position being the more reactive of the two since it contains an 
aminal.  The 3-position when deprotonated can be alkylated with a variety of electrophiles.  
The chiral auxiliary can be varied to be other 1,2-amino alcohols than phenylglycinol such 
as valinol or serine.
16
  However, typically phenylglycinol is used as an auxiliary since the 
substituted benzyl is simple to remove by hydrogenation.  The total yield of the ring 
forming step is typically good to excellent (Scheme 1, 70-99%).
12m,16
  The ratios between 
the two diastereomers is often low such as 1:1 or 1:2 but can range up to 1:20 with the ratio 
of the diastereomers depending on the substitution about the rings.17  Which diastereomer is 
formed as the major product is dependant on the substituents of the ring, if present, and the 
chiral auxiliary employed.  Therefore, a detailed NMR analysis to determine not only the 
ratio between the two diastereomers but also the newly formed stereocenter configuration 
in relation to the auxiliary stereocenter of the major isomer is required.  Interestingly, a new 
method to prepare the oxazolopiperidine was reported recently, which uses a 
multicomponent rhodium catalyzed cyclization (Scheme 1) from a readily available 
precursor (O-succinyl-3-butenoic acid, 15).
18
 This new method to prepare the 
oxazolopiperidine has moderate diastereoselectivity (50-68% de), and demonstrates the 
continuing relevance of this approach to 3-substituted piperidines. 
Scheme 1: Formation of the Oxazolopiperidine 
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Enolate alkylation of the oxazolopiperidine (Scheme 2) occurs with moderate to good 
diastereoselectivity with reactive electrophiles such as benzyl bromide (4:1), allyl bromide 
(9:1), methyl iodide or ethyl iodide (>99:1).
19
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Scheme 2: Enolate Alkylation of the Oxazolopiperidine 
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Removal of the chiral auxiliary can be accomplished by a two step procedure:  cleavage of 
the bridging C-O bond of the auxiliary and piperidone with a hydride source, followed by 
hydrogenolysis of the auxiliary (Scheme 3).
12m, 13
  The cleavage of the C-O bond can be 
done by reduction with lithium aluminum hydride, or displaced with an organometallic to 
gain substitution at the 6-position of the 2-piperidone (Scheme 4).  However, the 
stereochemical outcome of the new substituent depends on the substituents present, their 
relative stereochemistry, and the nucleophile employed. 
 
Scheme 3: Cleavage of the Chiral Auxiliary 
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Scheme 4: Displacement of the Chiral Auxiliary Followed by Cleavage 
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An obvious drawback of the oxazolopiperidine method is the inability to place aryl 
substituents at the 3-position using enolate alkylation and currently no heteroatom 
electrophiles have been explored with the enolate.  However, this can be overcome to some 
extent using this chemistry by including the substituent in the 1,5-dicarbonyl precursor as 
shown in Scheme 5.
17
  However, a significant potential drawback of using an achiral 
substituted 1,5-dicarbonyl precursor is the increase in the number of products and the 
resulting difficulty of separation (Scheme 5). 
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Scheme 5: Using Substituted 1,5-Dicarbonyls for Oxazolopiperidine Formation 
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One significant advantage of the oxazolopiperidine methodology is the ability to generate 
quaternary centers at the 3-position of the piperidine.  The order of alkylation with 
electrophiles, solvent and counterion do impact the diastereoselectivity, and facial 
selectivity is determined experimentally (Scheme 6).
19
  
 
Scheme 6: Double Alkylation to Generate a Quaternary Center at the 3-Position of 
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1.2.3 3-Substituted Piperidines by an Enantioselective Hydrogenation 
For 3-alkyl or phenyl substituted piperidines, another approach was introduced recently by 
Andersson et al (Scheme 7).
14
  This enantioselective iridium-catalyzed hydrogenation of 
tetrahydropyridines was reported to give good to excellent enantiomeric excess when the 3-
substituent was an alkyl or aryl substituent and good to excellent yields.   
 
Scheme 7: Enantioselective Iridium-Catalyzed Hydrogenation to 3-Substituted Piperidines 
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The synthesis of the tetrahydropyridine was accomplished by tosylation of but-3-en-1-
amine, alkylation of the sulfonamide with an allylbromide, which can be made in 2 steps if 
not commercially available, and a ring closing metathesis (Schemes 8 and 9).  Overall this 
gives a 3 step synthesis to the tetrahydropyridine if the allyl bromide is commercially 
available or a total of 5 linear steps if the allyl bromide must be made from a ketone.
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Scheme 8: Formation of the 3-Substituted Tetrahydropyridine 
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Scheme 9: Formation of the Allyl Bromide for the Tetrahydropyridine Synthesis 
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The key drawback of Andersson’s methodology was the lack of a general ligand.  They 
screened their reaction using a family of P,N-ligands (58-62 of Scheme 7) and reported the 
enantiomeric excess of the piperidine and ligand which  had  the best result for each 
specific example.  Despite the elegance of this transformation this prevents it from being 
widely used to obtain a large variety of 3-substituted piperidines as each would have to be 
screened and optimized with a family of ligands.  Also, it is unlikely that these iridium 
catalysts would be used to generate a specific 3-substituted piperidine in process scale since 
iridium is one of the rarer elements found on earth and is as such prohibitively expensive.
20
 
 
1.2.4 3-Substituted Piperidines by an Aziridinium Ion Ring Expansion Under 
Thermodynamic Control 
An interesting approach to piperidines was pioneered by the group of Cossy
15
 using 
prolinol, a cheap enantiopure precursor available in either enantiomeric form.  They 
developed the use of an aziridinium ion ring expansion under thermodynamic conditions to 
obtain 3-substituted piperidines with labile nucleophiles (Scheme 10).  Activation of the N-
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alkyl-prolinol with trifluoroacetic anhydride or mesyl chloride allows the prolinol 
derivative to exist in equilibrium with the aziridinium ion, that under thermodynamic 
conditions converts to the piperidine.  This ring expansion occurs since the piperidine has a 
secondary leaving group which is less reactive than the primary leaving group of the 
pyrrolidine precursor.  The leaving group typically used for this transformation by Cossy’s 
group is trifluoroacetate, but they also use chloride (through the use of mesyl chloride).  
Their method can give enantiopure N-alkyl-3-hydroxypiperidines by saponification of the 
trifluoroacetate, or the N-alkyl-3-chloropiperidines. Also, the 3-chloropiperidines can be 
reacted through a radical pathway with tin hydrides to obtain the reduced piperidine after 
the ring expansion as demonstrated by their group in a synthesis of Paroxetine (Scheme 
11).   
Scheme 10: Aziridinium Ion Ring Expansion From Prolinol to a Piperidine 
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The ring expansion from prolinols has been limited to labile nucleophiles at the 3-position 
almost exclusively.  There is one interesting exception from Cossy where N-alkylprolinols 
were converted into the N-alkyl-3-fluoropiperidines with DAST.  Here, the bulk of the 
alkyl group on the nitrogen was shown to have a significant impact on the regioselectivity 
of the fluoride ion in opening of the aziridinium ion.  N-trityl substituted substrates gave 
>99:1 regioselectivity to yield the piperidine.  Conversely, other alkyl groups gave little 
selectivity to either isomer.  Interestingly, Cossy demonstrated that the solvent and whether 
DAST or Deoxofluor was used had little impact on the regioselectivity.
21
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Scheme 11: Synthesis of Paroxetine via an Aziridinium Ion Ring Expansion Followed by 
Reduction 
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1.3 Aziridinium Ions in Synthesis 
1.3.1 Overview of Aziridinium Ions 
Aziridines have been used as building blocks in organic synthesis much like their epoxide 
cousins.  However, aziridines have relatively low reactivity often requiring a strong 
electron withdrawing group on the nitrogen atom, which can be problematic to remove 
later, and necessitate Lewis acids to activate them sufficiently to react with nucleophiles.  
Their synthesis and opening have been studied extensively, and the control of regio-
selectivity of their opening provides access to amines.
22
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Currently N,N-dialkyl aziridinium ions such as 79 are less well studied than aziridines.  
Aziridinium ions are rarely used as intermediates in organic synthesis, and when used they 
were often unexpectedly formed.
23
  However, they are stronger electrophiles than aziridines 
so they can be used with a wider variety of nucleophiles and under milder conditions.  In 
synthesis when encountered they are often used as an argument for retention of overall 
configuration during a displacement of a leaving group by neighboring group participation 
though these intermediates are rarely isolated.
24
  Aziridinium ions have been isolated 
previously as tetrafluoroborate salts and they proved to be quite stable as a solid though in 
solution they are typically unstable over several hours even at lower temperatures.
25,26
  
Recently aziridinium ions have been of interest to a few groups investigating various 
aspects such as in the formation, isolation and regioselectivity of opening though much 
work remains to be done.
15a,27,28,29,30
 
Figure 3: Formation of an Aziridinium Ion 
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1.3.2 Formation and Thermodynamic Equilibrium of Aziridinium Ions 
Aziridinium ions are often prepared from N,N-dialkyl-1,2-aminoalcohols by first 
converting the alcohol into a leaving group, and the aziridinium ion formed 
intramolecularily by displacing the leaving group through an SNi mechanism.
23
  Typical 
leaving groups are chloride, bromide, iodide, trifluoracetate, mesylate, tosylate and triflate 
though phosphonates have also been reported.
23,25,31,32,33,34
  Also, the aziridinium ion (84) is 
not commonly isolated before use, instead the amine latent form is used with an -leaving 
group that exists in equilibrium with the aziridinium ion (81 or 83). 
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Scheme 12: Formation of an Aziridinium Ion From N,N-Dialkyl-1,2-aminoalcohols 
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Under Appel reaction conditions with tetrabromomethane the alcohol is converted into 
triphenylphosphonium oxide, and that oxide is replaced by a bromide.
23
  However, the 
oxide is not displaced by the bromide directly, instead the phosphonium undergoes an SNi 
mechanism to form the aziridinium ion and this is followed by aziridinium ion opening by 
the bromide for overall retention of configuration.  For tosylate and mesylate groups the 
same can occur if a chloride ion is in solution to form the leaving group (ie: TsCl or MsCl) 
since it is much more nucleophilic than the sulfonic acids as shown in Scheme 13, and 
Scheme 11 during the synthesis of Paroxetine.  
When the aziridinium salt counterion is a labile nucleophile such as chloride, the 
aziridinium ion and the tertiary amine exist in equilibrium (Scheme 13, 85-87).  This 
favours the leaving group to be in the most hindered and least electronically activated 
position to give the more energetically favoured product (87).  This can cause a 
rearrangement from the original 1,2-amino-leaving group compound (reversible with Nu = 
LG).  The two amines (86 and 87) that exist in equilibrium with the aziridinium ion are 
latent forms of the aziridinium ion and can react with nucleophiles through this 
intermediate.
23
   
A second method, though less common, is to prepare aziridinium ions through the reaction 
of diazomethane with iminium cations (Scheme 14).
35
  Other diazoalkanes have also been 
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demonstrated to react with iminium salts to give aziridinium ions.
36
 The mechanism of 
addition probably involves initial attack by the diazoalkane at the highly electrophilic 
carbimino position of the iminium salt, followed by displacement of the diazo with the 
tertiary amine.  No example of this transformation being done with an asymmetric 
induction to gain a chiral center was found in the literature.  
Scheme 13: Conversion of the Alcohol into a Chloride with Overall Retention of 
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Scheme 14: Conversion of an Iminium Cation to an Aziridinium Ion 
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Yet another method that is used to form aziridinium ions but is less common is the N-
alkylation of aziridines (Scheme 15).
27
  The aziridine can be produced also from 1,2-
aminoalcohols or through [1+2] cyclization with a nitrene and an alkene.
37
  Here, benzyl 
bromide and methyl trifluoromethanesulfonate are common as alkylating agents.
27
  As 
shown in Scheme 15, the aziridine is alkylated to form the aziridinium ion which is then 
ring opened with bromide to yield the 1,2-aminobromide.  The product observed is the 
thermodynamically favoured one since the halide is less reactive as a secondary leaving 
group instead of as a primary leaving group. 
Scheme 15: Aziridinium Ions via Aziridine Alkylation 
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The leaving groups chloride, bromide, iodide, trifluoroacetate, mesylate, and phosphonate 
have all been demonstrated  to not only be leaving groups but also nucleophiles capable of 
opening the aziridinium ion, so that the aziridinium ion exists in equilibrium with the 
tertiary amine with an -leaving group (Scheme 12).23,25,31,32,33,34  Just recently, it was 
demonstrated that mesylate is also a reversible leaving group that gives the thermodynamic 
product.
 33
  By extension then, tosylate would be expected to be a reversible leaving group 
also.  Interestingly, in a recent publication the authors originally claimed they were able to 
form and isolate the aziridinium ion as the salt with bromide as a counterion.
38
  This was 
rather surprising since the bromide ion is a good nucleophile and in all previous 
publications it was cited as a reversible leaving group with the 1,2-aminobromide obtained.  
The paper has since been withdrawn citing that the aziridinium ion was not in fact the 
compound isolated with no further details given.   
The equilibrium from 1,2-aminohalides to the aziridinium ion can be forced through the use 
of Ag
I
 salts with 1,2-aminohalides.
 26, 39
  Through the use of non-nucleophilic counterions 
such as triflate, tetrafluoroborate, tetraphenylborate, and perchlorate the aziridinium can be 
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formed and isolated.  Also, Rayner has demonstrated that aziridinium ions can be prepared 
from a 1,2-amino-epoxide by reaction with trimethylsilyltriflate (Scheme 16).  
Interestingly, if the aziridinium -silyl ether were deprotected the epoxide reforms.40 
Scheme 16: An Aziridinium Ion From a 1,2-Aminoepoxide 
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Scheme 17: Ecopipam Synthesis Using a Latent Aziridinium Ion 
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The aziridinium ion 94 observed through the use of 
1
H NMR by Rayner (Scheme 16) was 
cited as being stable in solution at room temperature for days.
40
  However, during the 
synthesis of Ecopipam the authors noted the aziridinium tetrafluoroborate or triflates were 
unstable over several hours in solution even at -20 °C.
25
  There appears to be no trend for 
substitution patterns to the stability of aziridinium ions, except that in general they appear 
to be unstable in solution over prolonged periods of time.  For this reason, aziridinium ions 
are typically not isolated but used as a latent reactive species from the 1,2-aminohalide.  
For example, the authors of the process scale of Ecopipam synthesis relied on using a 1,2-
aminochloride, which exists in equilibrium with the aziridinium ion, reacting with 
organometallics as their key step in the synthesis.  
1.3.3 Ring Opening of Aziridinium Ions with Irreversible Nucleophiles 
This section covers nucleophiles that are poor leaving groups so as to obtain the kinetic 
product, and not the thermodynamic product resulting from an equilibrium with the 
aziridinium ion.  The reaction of aziridinium ions with irreversible nucleophiles is directed 
by the steric demands, electronic factors such as electron withdrawing groups adjacent to 
the aziridinium ion carbons (-EWG) and the nature of the nucleophile.23  Electron 
withdrawing groups that have been demonstrated in literature to be effective include 
phenyl, the carbonyl of an ester, and an acrylate.  Surprisingly, trifluoromethyl was shown 
to not direct the addition to the aziridinium ion with a number of nucleophiles.
41
  
Nucleophiles in this section are separated by atom grouping as it is helpful to compare 
regioselectivity within the same atom family. 
1.3.3a Hydrogen Nucleophiles 
Hydrides have been reported to attack with complete regioselectivity to the least hindered 
carbon when no -EWG is present.  A variety of reagents including ruthenium hydrides, 
NaBH4, NaCNBH3, LiEt3BH, LiBH4, and LiAlH4 have been studied (Scheme 18).
29,42
  
With a single -EWG, no example in literature was found.  However, there was one 
example where both carbons of the aziridinium ion were benzylic (107 of Scheme 19) that 
yielded the bicyclo [4.4.0] decane 108 with moderate selectivity over the spiro [4.5] azecine 
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109.  The stereochemistry of the tertiary center formed from the alcohols, as well as the 
rearranged product was proposed to be obtained from an aziridinium intermediate.
43
 
Scheme 18: Aziridinium Ion Reacting With Hydrides With No -EWG 
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Scheme 19: Dibenzylic Aziridinium Ion Opening with LAH 
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1.3.3b Carbon Nucleophiles 
Carbananion nucleophiles in the absence of an -EWG regioselectively attack the least 
hindered aziridinium ion carbon.  However, the degree of regioselectivity varies depending 
on the nucleophile, steric demands of the aziridinium ion, and reaction conditions.  For 
example, in the absence of an  activating group adjacent to the aziridinium ion carbon, 
cyanide attacks the least hindered position with high regioselectivity.
44
 With an -EWG 
such as an ester or vinyl ester, the cyanide goes regioselectively to the more activated 
carbon even if it is the more hindered carbon.
29
  Malonates and enolates also gave high 
regioselectivity to the least hindered carbon in the absence of an  activating group to an 
aziridinium ion carbon.  If an activating group was present  to an aziridinium ion carbon, 
then attack occurred to the activated position.
26,41,45 
 A trifluoromethyl  to an aziridinium 
ion carbon has been demonstrated to not be a directing group when malonates and enolates 
were used as nucleophiles to generate 112 and 113 (Scheme 19).
41
  The carbonyl of an ester 
 to an aziridinium ion carbon has been reported to be an effective directing group causing 
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regioselective attack to the activated carbon of the aziridinium ion to occur when malonate 
was employed as a nucleophile for opening of the aziridinium ion 115 (Scheme 20).
46
  
However, enolate has not been reported as a nucleophile to an aziridinium ion with an -
carbonyl.  Likely, with an -carbonyl the acidity of the aziridinium ion is increased so that 
the more basic enolate nucleophile may instead deprotonate the aziridinium ion causing its 
decomposition.   
Scheme 20: Aziridinium Ion Reaction with an Enolate and Malonate 
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Scheme 21: Intramolecular Aziridinium Ion Opening with Pyrrole 
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An interesting example of an intramolecular pyrrole alkylation by an aziridinium ion was 
also found (Scheme 21).  Here, the 6-membered rings 119 and 120 were favoured over the 
5-membered ring, with the pyrrole selectively attacking the least hindered carbon of the 
aziridinium ion.
47
   
There are few examples with organometallic nucleophiles opening aziridiniums.  In the 
absence of an -activating group, alkyl cuprates attack the least hindered site with complete 
regioselectivity whereas aryl cuprates lead to moderate regioselectivity (Scheme 22).
23,44a,48
  
The only -activating group examined with organometallics that has been reported is a 
phenyl during the Ecopipam synthesis, which had a strong effect of directing the attack 
though the two carbons of the aziridinium ion were equally sterically hindered (Scheme 
17).
25
 
Scheme 22: Aziridinium Ion Reaction With Organocuprates 
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The mechanism by which organometallics react with aziridinium ions has not been 
elucidated yet and likely varies depending on which type of organometallic is utilized.  
During the optimization of the synthesis of Ecopipam the authors noted three impurities 
(127, 128, and 129, Figure 4) that could be rationalized as being formed through a single 
electron transfer mechanism (SET) when they used a Grignard reagent (Figure 5).
25
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However, the authors noted that the addition of catalytic amounts of copper limited the 
formation of these impurities and the reaction occurred at an accelerated rate.  Also, in this 
publication aryllithiums and arylzinc reagents were noted as being unreactive towards the 
aziridinium.    
Figure 4: Ecopipam Synthesis Impurities Which Support a SET Mechanism With 
Grignards 
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1.3.3c Nitrogen Nucleophiles 
Nitrogen nucleophiles in the absence of an -EWG attack in general at the least hindered 
position though the degree regioselectivity depends on the nucleophile and steric bulk of 
the aziridinium ion.
23
  For example, Rayner showed a substituted N-bis-allyl aziridinium 
ion system where one carbon of the aziridinium was substituted with a methyl, reacted with 
morpholine to have moderate regioselectivity (Table 1, 130, 68:32).  However, when N-
benzyl-valinol was used as a nucleophile an excellent regioselectivity was observed (132, 
>95:5).  Increasing the steric bulk of the aziridinium ion before reaction with morpholine 
by changing the methyl substituent of the aziridinium ion to a benzyl increased 
regioselectivity (131 88:12 vs 130 68:32).  Also, increasing the size of the N,N-alkyl groups 
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of the aziridinium in this system from allyl to benzyl increased the regioselectivity (131 
88:12 vs 132 95:5).
32
  
Table 1: Steric Bulk Affects Regioselectivity for Nitrogen Nucleophiles   
R2N
R'
OH
Tf2O
Et3N
R2N
R'
TfO
R2N
R'
R'
Nu
NR2Nu
a b
 
Entry Product R R' Nu 
Ratio 
(a:b) 
1 130 allyl CH3 morpholine 68:32 
2 131 allyl Bn morpholine 88:12 
3 132 Bn Bn morpholine 95:5 
4 133 Bn CH3 morpholine 71:29 
5 134 Bn CH3 N-allyl-Valinol >95:5 
 
Uneyama published an example with an -trifluoromethyl as the substituent  to the 
aziridinium ion carbon.
41
  In that case, n-butylamine and n-butylmethylamine reacted to the 
least hindered position thereby demonstrating that it was not effective as a directing group.  
The reaction with azide, or phthalimide displayed good regioselectivity, and led to the 
attack at the least hindered position of an aziridinium ion if no -EWG is present unless the 
reaction is done at a high temperature.
23,29
   
With -EWG’s such as phenyl, the carbonyl of an ester, or an acrylate then amines, 
anilines, azide, phthalimide, and imidazole react at the activated, yet more hindered 
position of the aziridinium ion.
29,46,49
  There are three literature examples where two 
activating groups are present on opposing carbons of the aziridinium ion as  substituents, 
and the regioselectivity of attack for nucleophiles opening the aziridinium ion examined 
(Scheme 23).
33,49,50
  These examples (135, 138, and 141) showed nitrogen nucleophiles 
attack the benzylic aziridinium ion carbon with good selectivity instead of  to the carbonyl 
or phosphate.  This occurs even if it is the more hindered position as can be seen with the 
spiro aziridinium ion  141 where the nitrogen is the bridgehead (Scheme 23).   
 
23 
Scheme 23: Regioselectivity of Nitrogen Nucleophiles Towards Activated Aziridinium Ion 
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1.3.3d Oxygen Nucleophiles 
In general, reactions with oxygen nucleophiles have the same regioselectivity as those with 
nitrogen nucleophiles.  They attack the least hindered carbon selectively in the absence of 
an -EWG, and with an -EWG they attack the activated position even if more 
hindered.
23,29,41,51
  However, a key difference between oxygen and nitrogen nucleophiles is 
that nitrogen nucleophiles are typically added as a neutral species and oxygen nucleophiles 
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as a salt unless it is an alcohol (ie: KOAc).  Neutral oxygen nucleophiles are less reactive 
than neutral nitrogen nucleophiles but under forcing conditions can react with aziridinium 
ions, for example when an alcohol nucleophile is used in large excess or as a solvent.  
Phenols and carboxylic acids are acidic enough that deprotonation of the oxygen 
nucleophile facilitates their reaction with aziridinium ions without the possibility of the 
nucleophile acting as a base towards the aziridinium ion.  Examples in literature of an 
alkoxide reacting with an aziridinium ion are rare, and those few examples have no electron 
deficient groups  to the nitrogen of the aziridinium ion that would increase the acidity of 
the aziridinium ion such as 143 (Scheme 24).
52
  With a trifluoromethyl  to the aziridinium 
ion carbon the authors used water as a nucleophile to obtain the 1,2-aminoalcohol with 
selective attack at the least hindered position.
41
  Another approach for addition of water is 
the use of hydrated silica gel as an equivalent of water.
53
  There, the authors attempted to 
isolate the 1,2-aminochloride by column chromatography and found the chloride had 
instead been displaced by water at the benzylic position. 
Scheme 24: Reaction of an Alkoxide with an Aziridinium Ion 
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N,N-Dimethylformamide, though not considered as a common oxygen nucleophile, has 
been reported to react with a 1,2-aminobromide via an aziridinium ion to yield the 1,2-
aminoformate.  Surprisingly, opposite selectivity of what is normally expected occurred, 
with the DMF attacking at the more hindered aziridinium ion carbon with high 
regioselectivity (Scheme 24).
54
   
With an -EWG group such as an ester (or the vinylanalog), oxygen nucleophiles such as 
acetate, attack the activated and more hindered aziridinium ion carbon selectively over the 
least hindered one.
29
  With the EWG’s phenyl and carbonyl present as substituents on the 
aziridinium carbons, oxygen nucleophiles selectively attacked the activated carbon of the 
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aziridinium ion (Scheme 26).  The latent form of the aziridinium ion, a 1,2-aminoiodide, 
was unreactive to alcohols but treatment of the 1,2-aminoiodide with silver salts allowed 
the reaction to proceed.  When the authors used silver nitrate they found that the nitrate 
could act as a nucleophile towards the aziridinium ion which highlighted how electrophilic 
the aziridinium ion is.
49
  
Scheme 25: Reaction of an Aziridinium Ion with DMF 
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Scheme 26: Regioselectivity of Oxygen Nucleophiles with Activated an Aziridinium Ion 
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1.3.3e Fluoride as a Nucleophile 
Regioselectivity for opening of an aziridinium ion with fluoride appears to depend on the 
conditions for forming the aziridinium ion.  With a pre-formed aziridinium ion, the fluoride  
selectively attacks the least hindered position as expected. This has been demonstrated to 
prepare 161 selectively over 162 using TBAF as the source of fluoride with a latent form of 
the aziridinium ion 159 (Scheme 28).
27
   
Reacting a 1,2-aminoalcohol with DAST or Deoxofluor has been proposed to go through 
an aziridinium ion.  However, these reagents gave different results than TBAF.  The attack 
of DAST and Deoxofluor was observed to give the 1,2-aminofluoride in a 4:1 
regioselectivity to obtain the fluoride at the more hindered carbon (Scheme 27).
23
  Cossy 
showed that increasing the steric bulk of the groups on the nitrogen of the aziridinium ion 
favoured attack at the more hindered carbon when DAST or Deoxofluor was used to 
convert a 1,2-aminoalcohol to the fluorinated analog (Table 2).  For the reaction with 
DAST and Deoxofluor the corresponding rearrangement of the amine had no significant 
impact by changing the solvent ruling out tight ion pair association being the cause of this 
unusual regioselectivity.  The authors instead suggested that the additional substituents 
added to the greater partial positive character of that carbon and increased the C-N bond 
length making it more reactive.
21
  However, if this were the case then the same result would 
be expected no matter how the aziridinium ion was formed which does not appear to be the 
case.   
The carbonyl of an ester  to an aziridinium ion ring carbon has been demonstrated to 
direct opening of an aziridinium ion when fluoride was used a nucleophile.
27
   
Scheme 27: Regioselective Opening with Deoxofluor and a 1,2-Aminoalcohol  
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Scheme 28: Fluoride as a Nucleophile to Aziridinium Ions 
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Table 2: Regioselectivity of DAST with 1,2-Aminoalcohols 
N
Bn
R
OH
N
Bn
R
F
N
Bn
R
F
DAST
163 a b  
Entry Product R 
Ratio 
(a:b) 
Yield 
(%) 
1 164 H 70:30 51:12 
2 165 Ethyl 100:0 64 
3 166 Allyl 100:0 76 
4 167 Phenyl 100:0 76 
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1.3.3f Sulfur as a Nucleophile 
Sulfur nucleophiles (thiols, thiophenols, thiolacetate) appear to have regioselectivity that is 
difficult to predict.  Some cases reported that attack occurs at the more hindered position.  
For example thiocyanate and n-propylthiol attack with complete selectivity to the more 
hindered position.
23
  However, in another publication n-propylthiol is shown as having 
complete regioselectivity with attack to the least hindered carbon.
38
  The regioselectivity of 
sulfur nucleophiles in the presence of an activating group however gives predictable 
regioselectivity with attack at the activated position with the use of a phenyl or carbonyl.
46, 
50,55  
1.3.3g Chloride, Bromide and Iodide Nucleophiles 
As mentioned in the overview of aziridinium ions the halides from the second row and 
down (chloride, bromide, and iodide) are nucleophiles for performing ring-opening 
reactions with aziridinium ions.  However, they are also leaving groups which then through 
a thermodynamic equilibrium can lead to the more energetically favoured product of the 
two possible 1,2-aminohalides.
23,27
  There are a few examples where it appears that the 
product of the aziridinium ion and a halide other than fluoride give the kinetic product.  
This can occur when the nitrogen of the ring opening product is protonated by a strong acid 
to prevent it from reforming the aziridinium ion.  A nice comparison of the kinetic product 
versus a thermodynamic product distribution for bromide was done (169 and 171), as 
shown in Scheme 29.
56
    
Scheme 29: Kinetic Product and Thermodyamic Products with Bromide  
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1.3.3h Phosphorous and Selenium Nucleophiles 
Examples with phosphorous nucleophiles opening aziridinium ions are quite rare in 
literature.
41,57
  The first example of an aziridinium ion used for this purpose was a 
protonated aziridine with diphenylphosphine attacking at the least hindered position to give 
173 (Scheme 30).  The second example showed an N,N-dialkylaziridinium ion reacting 
with triphenylphosphine at the least hindered position selectively to yield 175.  The last 
example shown has a phenyl as an activating group to the aziridinium ion carbon.  Here, 
attack of diphenylphosphorane occurred at the activated and more hindered position to give 
178.  This last example was used as a method to prepare gram quantities of the enantiopure 
P,N-ligand 178 for asymmetric hydrogenation of ketones.
57
 
Scheme 30: Phosphorous Nucleophiles Reacting with Aziridinium Ions 
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For selenium only one example was found in literature.  Phenylselenol attacked the least 
hindered carbon of the aziridinium ion, giving an excellent yield (97%) and the 
enantiomeric excess was maintained.
41
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1.4 Hypothesis of the Project 
Analysis of the selectivity obtained in reactions with nucleophiles that are poor leaving 
groups towards aziridinium ions clearly showed a general trend (though with exceptions) 
the attack occurred at the least hindered position with moderate to excellent selectivity 
unless an appropriate activating group is employed such as a phenyl or a carbonyl.   
Cossy’s ring expansion from prolinols to piperidines is restricted to labile nucleophiles to 
obtain the thermodynamic product since they have not employed an activating group in the 
bicyclic ring system to direct the nucleophile.  We believed that with an appropriate 
activating group the prolinol derivative would ring expand to the piperidine as the kinetic 
product with a large variety of nucleophiles.  Activating groups that have been reported to 
direct the nucleophiles are carbonyl, the carbonyl vinyl analog, and phenyl.   
There are some complications with using a carbonyl in the template to obtain piperidines 
from 3-oxoprolinols such as 179; 1) the nucleophiles used with a carbonyl have been 
mostly limited to heteroatom types, with no organometallics reported. This is likely due to 
the acidity of the aziridinium ion which has been alluded to in literature
46
 2) the carbonyl 
would have to be reduced after the ring expansion to obtain the piperidine increasing the 
length of synthesis after the choice of the nucleophile.   
The vinyl analog 183 does not lend itself to this template readily, and if used would require 
the piperidine product to be substituted at the 5-position by a carbonyl achirally placing a 
significant restraint on the utility of the method  (Scheme 31). 
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Scheme 31: Hypothesis:  Carbonyl in 180 or Vinyl Carbonyl in 184 as a Directing Group 
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Using a phenyl as an activating group for an aziridinium ion such as 187 would not yield 
piperidines, but instead iso-tetrahydroquinolines and, although they are interesting, they 
were not the objective of this project.  However, conceptually if we remove 4 atoms of the 
phenyl ring leaving the carbon-carbon double bond we would obtain the tetrahydropyridine 
192 (Scheme 32).  This could easily be hydrogenated to the desired piperidine while 
simultaneously removing the protecting group from the piperidine nitrogen.  The 
regioselectivity of nucleophiles towards a vinyl aziridinium ion has not been reported but 
was believed to react similarily to vinyl epoxides which has been studied extensively.
58
  
At first glance it appeared that the attack of nucleophiles could not only be at the two 
aziridinium ion carbons of 190 but also -to the aziridinium ion through an SN2’ 
mechanism.  However, when one visualizes the intermediate in three dimensions it is 
apparent that the  system of the alkene and the * of the bridging aziridinium ion carbon-
nitrogen bond should not have significant orbital overlap (Figure 5).  Therefore, SN2’ 
should not occur due to the conformational constraint of the bicyclic system.   
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Scheme 32: Hypothesis:  Phenyl and Alkene as Directing Groups 
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In Figure 5, the alkene carbons are shown as yellow and the aziridinium carbons as orange.  
The * of the bridging aziridinium carbon-nitrogen bond points towards the viewers left 
shoulder, and the alkene  electrons are vertical to demonstrate this lack of orbital overlap.  
For this project we chose to have the N-alkyl group as benzyl, since it can be removed 
easily (hydrogenation) unlike most other alkyl groups. 
Figure 5: Conformation of the N-Benzyl-Aziridinium Ion with an Alkene as a Directing 
Group  
 
We sought to answer whether the alkene was sufficiently strong to direct the nucleophiles 
to obtain 3-substituted piperidines, and second if in fact 3-substituted piperidines were 
obtained that they were gained through an SN2 mechanism.   
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Chapter 2: Synthesis of 3,4-Dehydroprolinols 
2.1 Introduction 
For initial proof of concept, we sought to explore a published concise synthetic route to 
enantiopure N-benzyl-3,4-dehydroprolinols as the precursor to piperidines.  Industrially, 
3,4-dehydroproline is obtained in enantiopure form on large scale through a partial Birch 
reduction of the pyrrole followed by a diastereotopic salt resolution of the acid.
59
  This 
method works quite well with an N-Boc derivative of an unsubstituted substrate, but we 
wished to have a general synthetic route to this family of compounds that allows 
functionalization on the ring diastereoselectively so we did not pursue this avenue.  
Donohoe has published an interesting enantioselective partial Birch reduction of pyrroles 
via protonation with the chiral proton source 196 to obtain 3,4-dehydroproline derivatives 
with moderate enantiomeric excess (Scheme 33).
60
  Though this method is interesting, it 
does not give access to enantiopure materials and has not been shown to give substitution at 
other points of the dihydropyrrole so it was not investigated here.   
A more common and well known synthetic method to prepare 3,4-dehydroproline is from 
the commercially available and inexpensive 4-hydroxyproline.  This is a well established 
method first published in 1982 (Scheme 34).  Though, it is also known to not yield 
enantiopure products as partial epimerization occurs during the synthesis and it has only 
been published with an N-Boc protecting group.
61
  Another key drawback of synthesizing a 
proline derivative from 4-hydroxyproline is the lack of opportunity to substitute the ring of 
dihydropyrrole.   
Scheme 33: Donohoe’s Partial Birch Reduction to 3,4-Dehydroproline 
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Scheme 34: 4-Hydroxyproline as a Precursor for 3,4-Dehydroproline 
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One approach to obtain N-Boc-3,4-dehydroprolinol 207 used a Sharpless epoxidation and 
Payne rearrangement to obtain 203 from 202.  The opening of the epoxide with an amine 
led to 204, which after protection underwent a ring-closing-metathesis, followed by Criegee 
oxidation and in-situ reduction to produce 207 (Scheme 35).
62
  This is a powerful method 
that gave an excellent enantiomeric excess (>99%).  However, preparing the vinyl epoxide 
in enantiopure form through an epoxidation is not trivial even with an alcohol anchor.  A 
disadvantage of this method is that the conditions to obtain the desired epoxide with a 
variety of substituents would likely have to be optimized for each substituent, and they 
would probably not yield enantiopure products.  Also, the opening of the chiral epoxides 
generated could proceed through an SN2’ mechanism potentially complicating the reaction 
mixture for analogs with varying substitution.  One potential advantage would be the ability 
to control whether the 1,2-aminoalcohol was syn or anti, thereby controlling the relative 
stereochemistry of the 2,3-substituents of the piperidine final product. 
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Scheme 35: 3,4-Dehydroprolinol from a Sharpless Epoxidation 
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Another methodology to a 3,4-dehydroprolinol derivative is the interesting use of a variant 
of the Petasis-Mannich reaction (Scheme 36).
63
  The authors used D-Xylose as an -
hydroxyaldehyde equivalent, reacting it with an amine and boronic acid to obtain a 1,2-
amino alcohol.  They then protected the nitrogen, and followed this by a ring-closing-
metathesis.  It has been demonstrated by Petasis that the 1,2-aminoalcohol, when prepared 
from an enantiopure -hydroxyaldehyde, is obtained enantiopure and that it is prepared 
with >99% diastereoselectivity.
64
  Schreiber et al demonstrated for this reaction that when a 
chiral amine was used, the absolute configuration of the amine had no impact on the 
stereochemical outcome or diastereoselectivity of the new chiral center that is formed 
during this reaction (Scheme 37).  An advantage of this method is that it allows 
functionalization at the 2 and 5 positions of the 3,4-dehydroprolinol as a single 
diastereomer in enantiopure form.
65
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Scheme 36: 3,4-Dehydroprolinol from a Petasis-Mannich Condensation 
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The mechanism of the Petasis-Mannich reaction has been studied for the different 
variations and is the subject of a recent review.  The first step of the reaction has been 
proposed to be the formation of imine 216, followed by coordination of the boronic acid or 
ester 217 by the hydroxyl forming boronate 218, transfer of the group of the boronic acid or 
ester to the imine to obtain 219, and hydrolysis of the resulting intermediate to obtain the 
1,2-aminoalcohol 220.  The high diastereoselectivity for this variant has been rationalized 
to occur from the coordination of the hydroxyl with the boronic acid or ester, and 
minimization of the 1,3-allylic strain (218a vs 218b) as seen in Scheme 38.
66
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Scheme 37: Stereochemical Outcome of the Petasis-Mannich Reaction 
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Scheme 38: Proposed Mechanism of the Petasis-Mannich Reaction with -
Hydroxyaldehydes 
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Unfortunately, this elegant variant has been rarely reported in the literature since its 
introduction in 1998.  This is likely due to the -hydroxyaldehyde and its hemiacetal 
equivalent being non-trivial to prepare in large amounts in enantiopure form unless a sugar 
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is employed thereby limiting its usefulness.  However, we decided to pursue this avenue 
since it gives access to enantiopure 3,4-dehydroprolinols with a variety of substituents 
about the ring with high diastereoselectivity. 
2.2 Synthesis of N-Benzyl-3,4-Dehydroprolinol from 4-Hydroxyproline 
For initial proof of concept we required N-benzyl-3,4-dehydroprolinol.  For this we decided 
to prepare it from 3,4-dehydroproline which was made using a modified version of the well 
established method from 4-hydroxyproline.  Initially we followed the original protocol 
using N-Boc as a protecting group, and were successful in preparing the known compound 
N-Boc-3,4-dehydro-methylprolinate 200.
61a
   However, the attempts to deprotect the Boc of 
200 and alkylate the nitrogen with a benzyl caused decomposition (Scheme 39). 
Scheme 39: An Attempt to Prepare N-Benzyl-3,4-Dehydroprolinol   
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The fact that a simple deprotection of 200 and alkylation caused decomposition was 
surprising.  Possibly, it may have been the presence of acid, oxidation of the dihydropyrrole 
to the pyrrole by air, or a combination of the two or other factors that led to decomposition.  
Since the purpose of this experiment was simply to prepare a precursor for proof of concept 
we did not pursue the matter further.  We decided to simply alter the protecting group in the 
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beginning of the synthesis to avoid the complication resulting from Boc cleavage.  We first 
investigated the use of a benzyl as a nitrogen protecting group replacement.  Unfortunately, 
with an N-benzyl protecting group the elimination step did not occur during the 3,4-
dehydroproline synthesis from 4-hydroxyproline despite a number of conditions for 
elimination being attempted such as:  1) conversion of the alcohol to an iodide and 
elimination of that iodide
67
 with base, 2) Burgess reagent, 3) Martin’s sulfurane, 4) the 
Hendrickson reagent which typically with secondary alcohols leads to elimination,
68
 and 5) 
T3P, a cyclic phosphate patented for the purpose of conversion of an alcohol to alkene 
through elimination
69
 (Scheme 40). 
Scheme 40: N-Benzyl-3,4-dehydroprolinol From N-Benzyl-4-hydroxy-methylprolinate 
N
HO
O
OBn
MeI
DEAD/PPh3
THF
rt, 16 h
52%
N
O
OBn
DBU
Toluene
80-90°C
8 h
N
H
HO
O
OH
N
H2
HO
O
O
2 equiv HCl
EtOH
, 16 h
>99%
Cl
BnBr
TEA
DCM
rt, 16 h
67%
N
O
OBn
I
Desired
product not
observed
N
HO
O
OBn
Reagents 227-230
Burgess Reagent
S
O
O
Et3N N
Martin's Sulfurane
O
S
O
Ph
Ph
Ph
Ph
CF3F3C
CF3F3C
Hendrickson Reagent
P O PPh3 Ph3
F3C S
O
O
O2
T3P
O
P
O
P
O
P
O
O O
197 223 224
224 225 226
227 228 229 230
Reagent:
 
Since an N-alkyl protecting group failed to yield the elimination, but an N-carbamate 
facilitated the elimination, it was decided to attempt the synthesis with an N-amide as it 
should give similar results to the carbamate.  The synthesis was repeated using N-benzoyl 
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as the protecting group which could be reduced to the benzyl, in place of Boc as a 
protecting group.  The elimination of the iodide from 232 to the alkene 233 proceeded 
smoothly (Scheme 42).  It was found that the elimination step if done under basic 
conditions led to complete epimerization of the chiral center to give 233a (0% ee) as well 
as 234.  It was also found that if the elimination was done under the essentially neutral 
conditions using phenylselenide that a small amount of epimerization occurred to give 233b 
(94% ee from >99% ee).  Though the partial epimerization was unfortunate since it 
procluded this route as a viable method to an enantiopure precursor, the combination of an 
enantioenriched and the racemic precursor being obtained from the same advanced 
intermediate was in fact incredibly useful for proof of concept studies - see Chapters 3 and 
4. 
Scheme 41: N-Benzoyl-4-iodo-ethylprolinate 
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The reduction of the benzoyl could be accomplished with lithium aluminum hydride which 
had the added benefit of reducing the ester to the desired alcohol simultaneously, thereby 
limiting the number of synthetic steps required to prepare N-benzyl-3,4-dehydroprolinol 
236 (Scheme 43).   
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Scheme 42: Reaction Conditions to Gain Iodine Elimination Causes Epimerization 
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Scheme 43: Synthesis of N-Benzyl-3,4-dehydroprolinol 236 
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2.3 Synthesis of N-Benzyl-3,4-Dehydroprolinols via the Petasis-Mannich Reaction 
Initial proof of concept could be accomplished with the N-benzyl-3,4-dehydroprolinol 233 
available from 4-Hydroxyproline.  However, due to the possibility of an SN2’ mechanism 
the regioselectivity and stereochemistry of the piperidine derivatives prepared through this 
method would have to be determined.  There are few methods to prepare such piperidines, 
and reference compounds were not available for those piperidines prepared for the initial 
proof of concept.  Therefore, we decided to prepare another dihydropyrrole precursor 
containing an additional substituent, so that the regioselectivity and relative stereochemistry 
could be elucidated from products such as 239 and 240, as seen in Scheme 44.  An 
enantiopure and diastereoselective method to prepare the dihydropyrrole was still required.  
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Of the possible routes discussed in section 2.1, the Petasis-Mannich reaction was chosen as 
it is quite general, could give enantiopure materials, and allow substitution at various points 
of the dihydropyrrole with high diastereoselectively (>99% de).   
Scheme 44: Methyl Tag to Demonstrate the Mechanism of Ring Expansion 
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The desired substitution pattern was a 2-methyl-3-substituted piperidine for ease of 
assignment by NMR.  With substituents on adjacent carbons it is a simple matter on a 
cyclic system to assign whether they are syn or anti – and the relative stereochemistry 
between the two substituents being conserved would be important for understanding the 
mechanism.  If the substituents were in a 2,5-relationship to one another as in the SN2’ 
product in Figure 6, their relative stereochemistry would be difficult to ascertain by NMR 
even in this cyclic system.  This is due to a lack of coupling constants between them for 
assignment and an inability to rely on nOe directly as the 2,5-relationship in a 6-membered 
ring has weak nOE interactions due to the conformation of the substituents about the ring. 
Figure 6: Weak nOe Interactions Between the 2- and 5-Substituents on a 6-Membered 
Ring 
N
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Since the mechanism was expected to be SN2, to obtain a 2,3-disubstituted piperidine the 
desired pyrrolidine precursor would be 238a or its enantiomer as shown in Figure 7.  This 
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diastereomer was desired so as to avoid complications of steric repulsion in the aziridinium 
ion between the methyl tag (black) and the bicyclic ring system (238a vs 238b). 
Figure 7: Desired Diastereomer to Avoid Possible Steric Interactions   
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2.4 -Siloxyetheraldehydes as Prescursors for the Petasis-Mannich Reaction 
The Petasis-Mannich reaction was seen as giving the desired (S)-1-((R)-1-benzyl-2,5-
dihydro-1H-pyrrol-2-yl)ethanol diastereomer 242 selectively.  A retrosynthetic analysis of 
the desired diastereomer leads to readily available ethyl lactate which can be obtained in 
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enantiopure form (Scheme 45).  As stated in section 2.1, the Petasis-Mannich reaction has 
been rarely reported due to the difficulty of preparing the -hydroxyaldehyde in 
enantiopure form.  For this reason Petasis and others have used a ketal equivalent of the -
hydroxyaldehyde
64,65,66
.  However, this is also difficult to prepare and suffers from low 
yields.   
Scheme 45: Retrosynthesis of Desired Diastereomer 
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The DIBAL-H reduction of ethyl lactate was done, but we failed to isolate the -
hydroxyaldehyde 247.  The reported yields to prepare the hemiacetal 251 are quite low also 
(16% over 2 steps).
70
  Attempted isolation of the hemiacetal 251 that has been reported to 
work with the Petasis-Mannich reaction through a published protocol
70
, was also 
unsuccessful (Scheme 46). 
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Scheme  46: Attempts to Prepare the -Hydroxyaldehyde or Latent Equivalent  
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As the dehydroprolinol derivative was desired, and this synthetic route was seen as a 
powerful concise method that allowed functionalization of the other points, a solution was 
needed for this apparent drawback of the Petasis-Mannich reaction.  -Siloxy-
etheraldehydes are trivial to prepare in large amounts in enantiopure form from the 
corresponding esters by a reduction with DIBAL-H.  However, they have not been 
previously reported to be a suitable reactant for the Petasis-Mannich reaction.  They lack a 
free hydroxyl for coordination to the boronic acid or ester to facilitate the transfer of the 
boronate group to the imine.  It was hypothesized that an in-situ deprotection of the -
siloxyetheraldehyde would free the hydroxyl and then allow it to coordinate the boronic 
acid or ester.  The -siloxyetheraldehyde 253 was prepared from L-ethyl lactate using a 
known procedure (Scheme 47).
71
  Reaction conditions were tested using the -
siloxyetheraldehyde 253, amine 246 and (E)-styrylboronic acid.  For a silyl protecting 
group, diphenyl-tert-butylsilyl was employed since it is UV visible making the isolation of 
the aldehyde simple.   
It was found that when HF in Pyridine was employed for the in-situ deprotection during the 
Petasis-Mannich reaction that the desired product was not obtained.  However, using 
tetrabutylammonium fluoride (TBAF) for the in-situ deprotection was successful so a quick 
optimization was undertaken (Table 3).  It was found that additional equivalents of reagents 
other than TBAF had no significant impact on the isolated yield (entries 1-3,5-6), however 
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the use of additional TBAF had a dramatic negative impact on the yield (entries 4 and 7).  
Using one equivalent of each reagent was optimal.  Refluxing the reaction mixture was 
tolerated with no apparent effect on the diastereoselectivity, thereby reducing the reaction 
time from 3 days to 16 hours.  In the optimization study, the pinacol ester was used in place 
of the equivalent boronic acid since it is quite simple to prepare from inexpensive reagents.  
With optimal conditions the reaction was repeated using the boronic acid (entry 8) which 
provided a superior yield when compared to the boronic pinacol ester.  Also, it should be 
noted that the optimized conditions of the Petasis-Mannich reaction using an -
siloxyetheraldehyde with an in-situ deprotection gave a comparable yield (entry 8) to the 
original conditions by Petasis when dibenzylamine was used in place of allylbenzylamine 
(entry 9).
64 
 
Scheme 47: Preparation of -Siloxyetheraldehydes 
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Table 3: Optimization for Petasis-Mannich Reaction with -Siloxyetheraldehydes  
CH3
O
O
TBDPS
H
N
Bn
B
Ph O
O
TBAF
N
Ph
Bn OH
H
253 246 254 255  
Entry 
Aldehyde 253 
Equivalents 
Amine 246 
Equivalents 
Boronic ester 254  
Equivalents 
TBAF 
Equivalents 
255 
Isolated Yield  
1 1 1 1 1 64% 
2 1 1.2 1.1 1 62% 
3 2 1.1 1.1 1 59% 
4 2 1 1 2 40% 
5 1 2 1 1 58% 
6 1 1 2 1 61% 
7 1 1 1 5 0% 
8 1 1.1 1.1*                 1.06 83%* 
9 1**            1** 1 0 84%** 
*   :The boronic acid analog was used in place of the boronic ester 
**: Literature value64: HNBn2 was used in place of HN(CH2CH=CH2)Bn and the -hydroxy-
aldehyde was unprotected 
The Petasis-Mannich reaction is known to proceed with >99% diastereoselectivity and to 
maintain the enantiomeric excess of the aldehyde precursor.
64
  Since a modification was 
done to the reaction to make one of the precursors more easily available, the 
diastereoselectivity and enantiomeric excess of the product had to be confirmed.  By 
1
H 
NMR it was apparent both from the reaction mixture and the purified 1,2-aminoalcohol that 
the diastereoselectivity was >99:1.  The scale-up of 255 from the pinacol ester gave a lower 
yield (40%) than the smaller scale reactions, but the undesired diastereomer was isolated in 
only a 0.1% yield confirming the diastereoselectivity of >99%.  When this reaction was 
done with dibenzylamine it gave an equivalent yield and the same diastereomer as that 
prepared by Petasis confirming that the new conditions did not affect the stereochemical 
outcome.  The enantiomeric excess of the 1,2-aminoalcohol 255 was confirmed to be >99%  
as not even a trace of the enantiomer at 8.65 minutes in the SFC chromatogram was visible, 
demonstrating that the new conditions did not provoke epimerization of the chiral center 
(Figure 8). 
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Figure 8: Petasis-Mannich Product SFC Chromatograms Demonstrating the Enantiomeric 
Excess 
 
 
 
 
Racemic 255              Enantiopure 255 
 
2.5 Ring-Closing-Metathesis Optimization to Prepare N-Benzyl-3,4-dehydroprolinols 
A ring-closing-metathesis optimization was undertaken to convert the 1,2-aminoalcohol 
255 to the desired dehydroprolinol 244 (Table 4).  The basic nitrogen was a cause of 
concern as it is well known that such nitrogens can complex the ruthenium of the RCM 
catalyst and deactivate it.  However, it is known that if the nitrogen is properly sterically 
hindered it will be prevented from complexing the metal center of the catalyst, allowing the 
reaction to proceed.  It is also known that the nitrogen can be deactivated by simple 
protonation with a strong acid.
72
  Various commercially available catalysts were 
investigated, as well as reaction conditions.   
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Table 4: Optimization of the Ring-Closing-Metathesis 
N
Bn OH
HN
Bn OH
H
Ph
255 244  
Trial Catalyst 
mol % 
loading 
Concentration 
(M) 
244  
Yield (%) 
(% brsm) 
Solvent, 
Temperature, and 
Time 
           
1 Grubbs 1st Gen 4 0.03 47 (52) DCM reflux, 16h 
2 Grubbs 2nd Gen 1 0.03 70 (79) DCM reflux, 16h 
3 Hoveyda-Grubbs 1st Gen 1 0.03 34 (47) DCM reflux, 16h 
4 Hoveyda-Grubbs 2nd Gen 1 0.03 58 (58) DCM reflux, 16h 
 
     5 Grubbs 2nd Gen 1 0.1 55 (62) DCM reflux, 16h 
6 Grubbs 2nd Gen 1 0.003 67 (72) DCM reflux, 16h 
7 Grubbs 2nd Gen 3 0.003 50 (62) DCM reflux, 16h 
 
Of the commercially available catalysts investigated (Table 4, entries 1-4), Grubbs’ 2nd 
generation catalyst gave superior results to obtain 244 with a low catalyst loading (entry 2).  
When Grubbs’ 2nd generation catalyst was used with a higher concentration the yield of 244 
was adversely affected (entry 5).  Doing the reaction at a lower concentration had no 
significant impact on the yield (entry 6 vs 2).  Increasing the catalyst loading had a negative 
impact on the yield (entry 7).  It was observed during the optimization that when the 
loading of the catalyst was decreased below 1 mol percent, the conversion of 255 to 244 
was incomplete even with prolonged reaction times.  Therefore, 1 mol % of Grubbs 2
nd
 
generation catalyst in refluxing DCM, at 0.03M was seen as the optimal conditions for 
conversion of the Petasis-Mannich product to the desired N-benzyldehydroprolinol 244. 
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2.6.1 (S)-1-((R)-1-Benzyl-2,5-dihydro-1H-pyrrol-2-yl)-2-methylpropan-1-ol via the 
Petasis-Mannich reaction and RCM 
Now that a viable synthetic route to the desired dehydroprolinol was obtained, variations of 
the substitution pattern around the dihydropyrrole ring was desired for three reasons; 1) to 
demonstrate that the synthesis was general, 2) to demonstrate that the other positions could 
be substituted diastereoselectively in piperidine products, and 3) that changing the 
substituents of the dihydropyrrole ring had no impact on the regiochemical and 
stereochemical outcome during the ring expansion.  For these reasons, it was decided to 
prepare analogs where the methyl was replaced by a smaller and larger group - H, and i-Pr 
(Figure 9).  Though N-benzyl-3,4-dehydroprolinol was previously prepared from 4-
hydroxyproline, the Petasis-Mannich reaction was seen as another synthetic route to this 
desired aminoalcohol since it had not been prepared in enantiopure form from 4-
Hydroxyproline.  Also, it was deemed necessary to prepare both diastereomers in which the 
5-position of the dihydropyrrole was substituted with a bulky group for the goals stated 
above. 
Figure 9: Desired Dehydroprolinols  
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Compound 244 had been previously prepared as a single diastereomer and in enantiopure 
form for the optimization of the Petasis-Mannich reaction and ring-closing-metathesis from 
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L-ethyl lactate.  256 was prepared in the same manner but from L-valine instead of from 
ethyl lactate.  The synthesis of the desired -siloxyaldehyde 264 has been previously 
reported from L-valine and the literature procedure was used (Scheme 48).
73
  This was 
accomplished by first undertaking a diazotization reaction of valine to prepare the -
hydroxyacid with retention of configuration.  The retention of configuration is well known 
to occur with amino acids during diazotization, with the mechanism involving the acid in 
an SNi mechanism before opening with the nucleophile (water) to yield the alcohol.
74
  This 
was followed by esterification, protection of the alcohol with a tert-butyldiphenylsilyl, and 
reduction of the ester to the aldehyde by DIBAL-H to obtain the desired -
siloxyetheraldehyde 264.   
 
Scheme 48: Preparation of (S)-2-(tert-Butyldiphenylsilyloxy)-3-methylbutanal   
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From the prepared aldehyde 264, the same conditions as for the methyl analog 244 were 
used to prepare the pyrrolinol, with an in-situ deprotection of the silylether for the Petasis-
Mannich reaction followed by a ring-closing-metathesis (Scheme 49). 
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Scheme 49: Preparation of (S)-1-((R)-1-Benzyl-2,5-dihydro-1H-pyrrol-2-yl)-2-
methylpropan-1-ol 
O
O
TBDPS
H
Ph
B
OH
HO
NH
Bn
N
Bn
Ph
OH
H
N
Bn
OH
H
EtOH
, 16 h
61%
TBAF
Grubb's 2nd Gen
(1 mol %)
DCM
, 16 h
71%
204
246 264
265 266
 
 
2.6.2 Enantiopure N-Benzyl-3,4-dehydroprolinol via the Petasis-Mannich Reaction 
and RCM 
N-Benzyl-3,4-dehydroprolinol 236 had already been prepared from 4-hydroxyproline, 
however using that synthetic protocol did not yield enantiopure material and only one of the 
enantiomers is reasonably priced as a commercial product.  Therefore, it was decided to use 
the Petasis-Mannich and RCM protocol to prepare N-benzyl-3,4-dehydroprolinol 236.  The 
use of glyceraldehyde as a reactant for the Petasis-Mannich reaction was published in the 
original paper by Petasis
64
, and it is commercially available in enantiopure form for either 
enantiomer.  As glyceraldehyde is readily available the silylether modification was not 
necessary for this analog.  Commercially available R-glyceraldehyde was employed as a 
reactant to form Petasis-Mannich 1,2-aminoalcohol 268, followed by a RCM to obtain the 
pyrrolinol 269 (Scheme 50).   
It was also found that the ketal protected glyceraldehyde could be used in place of 
glyceraldehyde if a prior deprotection of the ketal was done in the reaction solution 
(ethanol).  Glyceraldehyde, while commercially available, is an expensive reagent so being 
able to use the ketal was useful since it is quite simple to prepare in either two or three steps 
from inexpensive reagents depending on which enantiomer is desired.
75
  It should be noted 
that the pH of the ethanolic solution after deprotection of the ketal in ethanol was found to 
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be important for the Petasis-Mannich reaction to occur.  To more accurately measure the 
pH, 95% ethanol was used in place of absolute ethanol.  A neutral to slightly basic pH (7.5) 
was found to be acceptable for the reaction and gave similar yields to when commercially 
available glyceraldehyde was used, however even slightly acidic (pH 6) conditions 
prevented the Petasis-Mannich reaction from occurring. 
 
Scheme 50: Preparation of Enantiopure 269 
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From 269, N-benzyl-3,4-dehydroprolinol 236 was prepared by a Criegee oxidation 
followed by reduction in a one-pot procedure (Scheme 51).   
 
Scheme 51: Preparation of Enantiopure N-Benzyl-3,4-dehydroprolinol 236 
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A check of the enantiomeric excess by chiral SFC of the N-benzyl-3,4-dehydroprolinol 236 
prepared by the Petasis-Mannich reaction showed the presence of only one enantiomer.  
Therefore, this synthetic route provided 236 in enantiopure form, which could not be 
accomplished from 4-hydroxyproline.  This sequence was also shorter than that from 4-
hydroxyproline, and allowed the functionalization at the 5-position of the dihydropyrrole 
demonstrating that it is a more powerful method to prepare the desired dehydroprolinols. 
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2.6.3 (S)-1-((S)-1-Benzyl-2,5-dihydro-1H-pyrrol-2-yl)ethanol 
The syn 1,2-aminoalcohol diastereomer 244 and its analogs were also desired to give syn 
2,3-disubstituted piperidines via the aziridinium ion ring expansion.  The high 
diastereoselectivity and ability to obtain enantiopure 1,2-aminoalcohols makes the Petasis-
Mannich reaction quite useful for the synthesis of the desired precursors.  However, the 
Petasis-Mannich reaction yields almost exclusively an anti 1,2-aminoalcohol.  Therefore, in 
order to obtain the syn 1,2-aminoalcohol an inversion of configuration of the alcohol was 
attempted through the use of Mitsunobu conditions.  To prevent the formation of an 
aziridinium ion intermediate that could cause a rearrangement or overall retention of 
configuration of the alcohol, the nitrogen was deactivated by acylating it.  Benzoyl was 
used as an N-protecting group as it could be reduced to a benzyl after the inversion of the 
alcohol.  Using -siloxyetheraldehyde precursor 253, the 1,2-aminoalcohol Petasis-
Mannich product 270 was prepared and then the nitrogen protected as the benzoyl amide to 
yield 271 (Scheme 52).   
Scheme 52: Preparation of 271 
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Alcohol 271 was submitted to Mitsunobu reaction conditions.  This was then followed by a 
reduction of the ester and amide with lithium aluminum hydride to obtain 1,2-aminoalcohol 
255 (Scheme 53).  Comparison of the mitsunobu/reduction product by 
1
H NMR with 255 
and the minor diastereomer isolated from the scale-up of 255 showed that no inversion of 
configuration of the alcohol had occurred.  Likely, the failure to obtain the inverted alcohol 
was due to the carbonyl of the amide participating in an SNi process displacing the 
 
55 
phosphonium oxide followed by attack of the anion of para-nitrobenzoic acid (Scheme 54).  
The desired syn 1,2-aminoalcohol was not prepared and this was not pursued further. 
 
Scheme 53: Mitsunobu Gives Retention of Configuration 
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Scheme 54: Proposed Mitsunobu Mechanism to Have Retention of Configuration 
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2.6.4 Substituting the 5-position of Dihydropyrroles via the Petasis-Mannich and 
RCM Protocol 
As noted in section 2.1 for the Petasis-Mannich reaction Schreiber et al demonstrated that 
chiral amines can be used with this reaction and that the chirality of that amine had no 
impact on the stereochemical outcome of the 1,2-aminoalcohol formed or 
diastereoselectivity of the reaction.
65
  Therefore, by using an enantiopure substituted 
allylamine with an enantiopure -silyletheraldehyde in this methodology, the 5-substituted 
dihydropyrrole would accordingly be produced as an enantiopure single diastereomer.  
There are a variety of methods to prepare chiral allylamines that include: 1) Iridium-
catalyzed asymmetric allylation of amines from allyl carbonates,
76
 2) [3,3]-Sigmatropic 
rearrangement of a chiral allyl cyanate generated from a chiral allylic alcohol (obtained by 
the catalytic asymmetric addition of diorganozinc reagents to substituted acrolein 
derivatives),
77
 3) catalytic asymmetric sigmatropic rearrangement of an allyl alcohol,
78
 4) 
chiron approaches from amino acids to yield enantiopure allylamines,
79
 as well as others.  
An enantiopure allylamine can easily be prepared from an inexpensive amino acid in few 
steps, and therefore phenylalanine was used as a precursor for the synthesis of 
tetrahydropyridine derivatives with a benzyl at the 6-position.  D-Phenylalanine and L-
phenylalanine were esterified, and the nitrogen protected with a trityl group.  The ester was 
then reduced with DIBAL-H to obtain aldehyde 277 which was submitted to a Wittig 
reaction to produce 278.  Deprotection of the trityl was performed to produce the desired 
known allylamine 279 (Scheme 55).
79a
   
When Boc protected amino-aldehydes derived from amino acids are submitted to the basic 
conditions of the Wittig reaction, epimerization of the chiral center is observed.  The trityl 
protecting group was used in place of the more common Boc group since the trityl is 
known to prevent epimerization of the chiral center under the strongly basic reaction 
conditions of the Wittig reaction.  The lack of epimerization is due to the steric hindrance 
of the trityl group, preventing deprotonation of the -carbon by bases.79a   
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Scheme 55: Synthesis of Enantiopure Allylamine 279 
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With the enantiopure substituted allylamine 279 and its enantiomer in hand, we were able 
to synthesize the desired 1,2-aminoalcohols through the Petasis-Mannich reaction.  Petasis-
Mannich product 281 was smoothly obtained using this procedure (Scheme 56).  However, 
the chiral allyl amine must be primary, as N-benzyl analog 282 was unreactive under the 
same reaction conditions. 
Scheme 56: Synthesis of 281 
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Alkylation of the nitrogen of 281 by benzyl bromide required forcing reaction conditions 
that gave unacceptably low yields (9%), and significant decomposition of the reactant 
(Scheme 57).  The amine 281 was also unreactive towards benzaldehyde for a reductive 
amination.  To side-step this problem, a ring-closing-metathesis on 281 was attempted.  
However, no reaction initially occurred.  It was believed that as the basic nitrogen of the 
product dihydropyrrole 284 was not significantly sterically hindered once it was formed, 
and it could therefore complex the catalyst preventing further reaction.  Therefore, one 
equivalent of a strong acid (Tosic acid) was added to quench the basic nitrogens of 281 and 
284, and then 281 was again submitted to RCM conditions.  Gratifyingly, the RCM to 
prepare 284 proceeded smoothly with the nitrogen quenched by an acid.  After the RCM, 
the less sterically hindered nitrogen of the dihydropyrrole of 284 underwent benzylation 
without difficulty with benzyl bromide at room temperature to produce 259 in a 77% yield. 
Scheme 57: Synthesis of 259 
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The diastereomer 285 produced in the Petasis-Mannich from D-Phenylalanine was unstable 
to purification attempts (Scheme 58).  Therefore, the crude mixture from the Petasis-
Mannich reaction was submitted to an RCM in the presence of a strong acid.  The yield of 
the two-step process to 286 without intermediate purification to produce 285 was lower 
than its diastereomer 284 (35% for 286 vs 52% for 284).   Once the dihydropyrrole 286 was 
formed, it was stable to isolation, and alkylation of the nitrogen with benzyl bromide 
occurred readily to produce 258. 
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Scheme 58: Synthesis of 258 
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Figure 10: N-Benzyl-3,4-Dehydroprolinol Derivatives Prepared in This Chapter 
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Chapter 3: Proof of Concept for Ring Expansion and 
Optimization 
3.1 Introduction 
For initial proof of concept we were first interested in the regioselectivity of the reaction of  
nucleophiles towards the aziridinium ions to demonstrate that 3-substituted piperidines 
would be obtained,  and that the enantiomeric excess would be maintained during the ring 
expansion reaction.  Therefore, to study the regioselectivity of such a reaction the 
aziridinium ion would have to be submitted to a representative nucleophile, that would lead 
to a product simple to analyze by NMR.  As we were especially interested in 3-carbon 
substituted piperidines it was decided that a carbon nucleophile should be used for the proof 
of concept.  As discussed in Chapter 1 section 1.3.2b, aziridinium ion ring opening 
reactions with malonates are known to be sensitive to electronic factors for their 
regioselectivity.  With malonate as a nucleophile the isomer formed exclusively or the 
isomer mixture ratio formed could be deduced by 
1
H NMR experiments.  This could be 
done through the use of the methylene of dimethylmalonate as it is deshielded causing it to 
be quite downfield for an alkyl (typically ~ 4 ppm).  This makes it simple to identify, and 
the splitting pattern of the dimethylmalonate methylene would reveal whether 289 or 290 
was obtained (Scheme 59).   
Scheme 59: Dimethylmalonate 
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3.2.1 Choice of Leaving Group 
It was believed that the aziridinium ion 238a should be preformed irreversibly from 291, 
before addition of nucleophiles to avoid the possibility of additional mechanisms that 
would adversely affect the regioselectivity and stereochemical outcome (Scheme 60).  This 
could be accomplished with a leaving group that is an exceptionally poor nucleophile.  Side 
reactions could arise if the aziridinium ion 238a was formed with a counterion that was 
nucleophilic thereby resulting in a thermodynamic equilibrium between dihydropyrrole 291 
and tetrahydropyridine 293.  Tetrahydropyridine 293 could then undergo allylic 
rearrangement to yield intermediate 294, which in turn has similar pathways to react with 
nucleophiles.  Therefore, this ruled out the use of leaving groups that are known to be 
reversible which include chloride, bromide, iodide, and mesylate.
23,25,31,32,33,34 
Scheme 60: Possible Pathways for Reactions and Rearrangements of Aziridinium Ion 238a 
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Ideally, the alcohol of 236 and its analogs could be converted into a leaving group, which 
would then form the aziridinium ion irreversibly, for further reaction with the nucleophile 
in a one-pot procedure.  The remaining typical leaving groups that are not known to be 
reversible for formation of aziridinium ions are tosylate, and triflate.  As mesylate is a 
known reversible leaving group, tosylate by extension is also expected to be, as they are 
quite similar.  Reaction of dehydroprolinol 236 and its analogs with activating agents to 
convert the alcohol to a leaving group generates an acidic proton that would have to be 
quenched with a base to allow the nitrogen of the prolinol to form an aziridinium ion.  
Inspiration was taken from the scale-up optimization of Ecopipam where the authors used 
n-hexyllithium to deprotonate the alcohol prior to reaction with the activating reagent.  
They used the less common n-hexyllithium in place of the n-butyllithium as it was a large 
scale process and they wished to avoid the generation of large amounts of butane gas, a 
potential explosion hazard.
25
  For our purposes, n-butyllithium would suffice as the scale of 
the reaction investigated for proof of concept would be rather small.  To ensure that the 
proper amount of base to obtain 300 was used, a titration with n-butyllithium and 1,10-
phenanthroline as an indicator was performed.  The alkoxide solution was then reacted with 
the activating groups to form species 301 which then could in turn form an aziridinium ion.  
To this solution of 301 was added the sodium salt of dimethylmalonate.  Reaction 
progression from 300 to 302 was determined by quenching an aliquot with methanol and 
analysis by LCMS. 
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Scheme 61: Leaving Group Optimization 
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Of the three activating agents examined, triflic anhydride gave the best yield with a low 
conversion of 34% isolated yield (44% based on recovered starting material) in 30 minutes 
to 3-substituted tetrahydropyridine 302.  We were pleased to find that of the two possible 
isomers (302 and 303) only tetrahydropyridine 302 was observed, albeit in a low yield, 
showing that the ring expansion occurs regioselectively.  This validated our hypothesis that 
the alkene could act as a directing group for nucleophiles, and that the regioselectivity 
should be high.  The reaction with tosylate 301 produced the desired 3-substituted 
tetrahydropyridine 302, albeit only in 12% isolated yield, and also the chloride 302a (11% 
isolated yield), but only after a prolonged reaction time of three days.  The chloride by-
product 302a was obviously from the aziridinium ion formation with the tosylate followed 
by opening with the free chloride ion in solution liberated when tosyl chloride was reacted 
with the alkoxide.  The phosphate was unreactive to form aziridinium 288, even with 
elevated temperatures for prolonged reaction times, as the methanol adduct was not 
observed by LCMS. 
The chloride by-product 302a formed in the tosylate trial would be simple to avoid through 
the use of tosyl anhydride.  However, the use of tosylate as a leaving group required 
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excessively long reaction times which was undesired or elevated temperatures that could 
decrease the regioselectivity of the addition of the nucleophiles towards the aziridinium ion 
which was also undesired.  Of the two leaving groups that produced the desired 
tetrahydropyridine, only triflate was deemed to meet the desired criteria.  The reaction time 
with triflate was quick (<30 minutes), and the reaction could be done at lower temperatures 
increasing the possibility of regioselective attack.  Therefore, triflate was seen as the 
optimal leaving group for conversion of 236 to 302.  Unfortunately, the reaction with 
triflate did not go to completion as a significant quantity of the alcohol precursor 236 was 
recovered.  We next focused on optimizing the reaction conditions to obtain complete 
conversion.   
3.2.2 Base Optimization 
For the initial ring expansion study to find an appropriate leaving group, the alkoxide had 
been formed using a titration with n-butyllithium and 1,10-phenanthroline.  However, this 
was seen as a restrictive factor on the conversion of the alcohol to the tetrahydropyridine as 
the base was then a limiting reagent.  To allow full conversion we wished to be able to 
employ an excess of reagents in relation to the dehydroprolinol.  Therefore, we sought a 
milder, and non-nucleophilic base than an organometallic that could be added to the 
solution to quench the acidic proton generated to allow aziridinium ion formation to occur.  
Alkoxide bases were ruled out as they could potentially react with the triflic anhydride, 
which left tertiary amine bases for the trial.  An inspection of the Bordwell pka table shows 
a variety of amine bases with a large difference in basicity, as seen in Table 5.  For the 
initial tests to find an appropriate leaving group the solvent had been chosen to be freshly 
distilled DME.  This was because it was compatible with forming an alkoxide from the 
alcohol and n-butyllithium, and also DME was compatible with triflic anhydride.  For the 
amine base optimization study we decided to change the solvent to anhydrous DCM in 
place of freshly distilled DME as it is commercially available anhydrous, much less 
expensive than DME, and is also one of the few solvents compatible with triflic anhydride.   
To be certain that yields were consistent, it was deemed necessary to change the 
nucleophile for the optimization study to one that was not a metal salt (sodium 
dimethylmalonate), as metal salts typically have a low solubility in organic solvents which 
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could give variable yields.  N-Methylaniline was chosen for the optimization study as the 
nucleophile since it is UV visible and highly organic soluble making isolation of the 
tetrahydropyridine 304 simple, and by 
1
H NMR the compound 304 is easily identifiable.  
The base optimization study was done in DCM at 0.05 M, 0 °C, using 3.5 equivalents of 
base, 2.0 equivalents of triflic anhydride, with a 5 minute activation period to form the 
aziridinium, followed by 15 minutes with 3.0 equivalents of N-methylaniline (Table 5).  
Aqueous work-up and purification by silica column was done to obtain an isolated yield of 
304. 
The dehydroprolinol 236 was expected to have a pka similar to other tertiary amines such 
as triethylamine.  Logically, the amine base would have to be of approximately equal or 
greater basicity than the dehydroprolinol nitrogen so that the base would scavenge the 
acidic proton thereby allowing the dehydroprolinol nitrogen to form the aziridinium ion.  
Comparison by the bordwell pka scale of the bases was of limited use as the reaction was 
done in DCM and not in DMSO.  The pka of the base and its relative ranking compared to 
other amine bases in different families depends on the solvent environment of which the 
base is dissolved as can be seen in Table 5.
80
  Unfortunately, no pka data of amine bases in 
DCM was available when these experiments were carried out.   
As can be seen in Table 5, the pka of the base had little correlation with the yield and when 
no base was used the desired reaction with N-methylaniline still occurred.  The ring 
expansion occurring in the absence of a base was likely due to the presence of the 
nucleophile, N-methylaniline, acting as a weak base (entry 1). Using pyridine or 
triethylamine as a base did not yield the desired tetrahydropyridine and the alcohol 
precursor was not recovered (entries 2 and 4).  This was likely due to the amine base acting 
as a nucleophile towards the aziridinium ion to form quaternary ammonium salts (see 
Scheme 62 for an example) – though they were not isolated due to their high aqueous 
solubility they were observed by LCMS from the crude reaction mixture.  The sterically 
hindered bases diisopropylethylamine, DBU, and Barton’s base all gave a low to moderate 
yield of the tetrahydropyridine with no alcohol precursor recovered (entries 5-7).  However, 
the quaternary ammonium salt was observed by LCMS showing a loss of intermediate and 
yield due to alkylation of those three bases.   
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Table 5: Base Optimization 
N
OH
H
N
N
N1) 3.5 equiv Base
2.5 equiv Tf2O
2)
3 equiv
N N
Proton Sponge
N N
N
Barton's Base
N
N
DBU
Amine Bases
236 304
 
Entry Base 
304 
Isolated 
Yield (%) 
Bordwell pka 
(DMSO)
80a
 
pka    
(ACN)
80b
 
pka      
(THF)
80c
 
1 None 40 
   
2 Pyridine 0 3.4 12.5 5.5 
3 Proton Sponge 80 7.5 18.6 11.1 
4 Triethylamine 0 9 18.8 12.5 
5 Diisopropylethyamine 42 N/A N/A N/A 
6 DBU 63 12 24.3 16.8 
7 Barton's Base 11 14 ~26 ~18 
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Scheme 62: Triethylamine Alkylation by the Aziridinium Ion 
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Scheme 63: Proton Sponge as a Base 
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Proton sponge gave the best result with an 80% yield and no unreacted alcohol precursor 
was observed (entry 3).  No significant amount of alkylation product of the base was 
observed by LCMS with proton sponge.  Proton sponge is known as a strong amine base 
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with the high basicity being attributed to the relief of strain between the two 
dimethylanilines upon protonation. Proton sponge nitrogens are sterically hindered making 
it a weak nucleophile due to conformational constraint in the molecule which forces the two 
nitrogen lone pairs to be near each other and unavailable sterically to electrophiles larger 
than a proton.  Though by the Bordwell pka values proton sponge would appear less basic 
than desired (i.e. less basic than triethylamine) so as to have the ability to deprotonate the 
dehydroprolinol and allow the formation of the aziridinium ion, the relative basicity of the 
two amines depends on the solvent environment.  Also, as the formation of the aziridinium 
ion would be irreversible the protonated base could be less basic but simply be in 
equilibrium with the protonated dehydroprolinol and still facilitate the formation of the 
aziridinium ion as shown in Scheme 63.  If the pka of protonated proton sponge were lower 
than the pka of the protonated dehydroprolinol it could still allow the formation of the 
aziridinium ion.  As proton sponge is commercially available, gave the highest yield, and 
no alkylation by the aziridinium ion was observed with it, it was seen as the optimal choice 
as a base. 
As the nucleophile had been altered to N-methylaniline the identity of which isomer was 
obtained with complete regioselectivity had to be demonstrated once again.  The identity of 
the isomer could not be determined by COSY experiments or 
1
H NMR coupling.  The 
aniline aryl protons, ortho to the nitrogen, are well separated at 6.8 ppm and they were 
examined for nOe interactions (Figure 11, blue spectra).  They have a strong interaction 
with the N-methyl (2.9 ppm), a peak at 4.6 ppm which integrates to one proton, and the 
meta aryl protons as one would expect for the tetrahydropyridine.  The signal at 4.6 ppm 
has COSY interactions with an alkene proton, and a methylene (not shown).  Therefore, 
nOe experiments combined with the 
1
H NMR chemical shifts and integrations of the peaks, 
COSY interactions of the signal at 4.6 ppm with the alkene and a methylene points to 
tetrahydropyridine 304 as being the isomer obtained.  Had the product obtained been 
dihydropyrrole, the aniline aryl protons would have interactions with the methylene which 
has two protons and not one (Figure 12).  Also, the chemical shifts and integrations of the 
1
H NMR does not match the dihydropyrrole structure but is reasonable for the 
tetrahydropyridine. 
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Figure 11:  nOe of 304  
 
Figure 12: nOe and COSY Interactions of 304 
H
N
CH2
H
N
CH3
H
nOe
H
COSY
COSY
N
N
CH3
H H
H
H
4.6 ppm
nOe
no nOe
COSY
COSY
if 4.6 ppm
The nOe interactions and COSY
clearly point to this isomer as the
product obtained.
Isomer obtained Isomer not obtained
H
H
 
N
N
HD
HC
HCHC
HA
HA
HB
HB
304
 
71 
3.2.3 Reaction Conditions Optimization 
The relative pka’s between the protonated proton sponge and protonated dehydroprolinol 
would depend on the solvent environment as seen in section 2.2.2.  Therefore, it was 
expected that the choice of solvent would have a profound effect on the reaction of 236 
producing 304.  Furthermore, as the reaction proceeds through charged intermediate 288, a 
polar environment that would favor the formation and reaction of such a species would 
likely be beneficial for the conversion of the dehydroprolinol to the tetrahydopyridine.  A 
stock solution of the dehydroprolinol 236 was prepared in anhydrous toluene, as it does not 
readily absorb atmospheric moisture, with a measured amount of 1,3,5-trimethoxybenzene 
which was used as a 
1
H NMR internal standard.  The stock solution was transferred to 
reaction vessels by volumetric pipette to limit the possibility of errors in comparison 
between optimization trial results.  Accordingly, a variety of solvents that are compatible 
with triflic anhydride were investigated for their impact on yield for this transformation as 
seen in Table 6.   
Table 6: Solvent Optimization 
236 288 304
N
Bn
OH
N
Bn
H
TfOProton sponge (3.5 equiv)
Tf2O (1.9 equiv)
solvent (0.05 M)
0 °C, 5 min
N
Bn
N
PhHNMePh (2.6 equiv)
15 min
 
Entry Solvent 304 Yielda 
1 Acetonitrile 9% 
2 Chloroform 9% 
3 1,4-Dioxane 5% 
4 1,2-Dimethoxyethane 20% 
5 Diethyl ether  50% 
6 Dichloromethane 62% 
7 Toluene 63% 
a determined by 1H NMR of the crude reaction mixture by comparison to 1,3,5-
trimethoxybenzene 
Acetonitrile and chloroform gave very poor conversion for the ring expansion at 9% yield 
by 
1
H NMR (Table 6, entries 1-2).  Ethereal solvents such as 1,2-dimethoxyethane, 1,4-
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dioxane, and diethyl ether gave low to moderate yields of the desired tetrahydropyridine 
(entries 3-5, 5-50%).  Of the solvents examined, dichloromethane and toluene gave the best 
result and were within experimental error of one another, with 62% and 63% yields by 
1
H 
NMR respectively (entries 6-7).  Dichloromethane was chosen as the optimal solvent over 
toluene since the dielectric constant is higher (DCM: 8.93 vs Toluene: 2.38).
81
  With a 
higher dielectric constant DCM would be superior in solubolizing polar reagents as 
compared to toluene.   
To determine the optimal temperature at which the ring expansion of 236 producing 304 
should be done, a temperature screen was performed (Table 7).  It was found that above -10 
°C the yields as measured by 
1
H NMR dropped quite dramatically in a direct correlation 
with the increased temperature.  Below -10 °C, the yields remain consistent with each other 
within experimental error.  This was not surprising as the stability of aziridinium ions in 
solution has been noted to be limited even at -20 °C over a period of time.
25
  The 
temperature seen as optimal was -15 °C, which is attained with a simple salt and ice bath, 
thus specialized equipment such as a crysostat would not be necessary.   
Table 7: Temperature Optimization 
236 288 304
N
Bn
OH
N
Bn
H
TfO
N
Bn
N
PhHNMePh (2.6 equiv)
15 min
Proton sponge (3.5 equiv)
Tf2O (1.9 equiv)
DCM (0.05 M)
Temperature
5 min
 
Entry  Bath Temperature (°C) 304 Yielda 
1 -84 82% 
2 -63 76% 
3 -41 81% 
4 -18 79% 
5 -10 80% 
6 0 54% 
7 22 9% 
a determined by 1H NMR of the crude reaction mixture by comparison to 1,3,5-
trimethoxybenzene 
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The minimum amounts of reagents required for the ring expansion of 236 was investigated 
with three trial sets (Table 8).  Firstly, triflic anhydride was examined and it was found that 
only a small excess (1.1 equivalents) was required (entries 1-4).  Secondly, equivalents of 
Proton Sponge was examined and a stoichiometric amount to small excess of the base (1.0-
1.5 equivalents) gave superior results (entries 5-10).  The use of a large excess of proton 
sponge resulted in a decrease in yield (entry 10).  Finally, equivalents of the nucleophile 
were examined (entries 11-16).  Though the yields for the nucleophile equivalents trials 
(entries 11-16) were lower than what would be expected from the previous optimization 
Table 8: Reagent Equivalents Optimization 
236 288 304
N
Bn
OH
N
Bn
H
TfO
N
Bn
N
Ph
Proton sponge (X equiv)
Tf2O (X equiv)
DCM (0.05 M)
-41 °C, 5 min
HNMePh (X equiv)
15 min
 
Entry 
Triflic anhydride 
equivalents 
Proton Sponge 
equivalents 
N-Methylaniline 
equivalents 
304  
Yielda (%) 
1 1 3.5 2.6 76 
2 1.1 3.5 2.6 84 
3 1.5 3.5 2.6 84 
4 2 3.5 2.6 86 
5 1.1 1 2.6 >99 
6 1.1 1.2 2.6 >99 
7 1.1 1.5 2.6 >99 
8 1.1 2 2.6 90 
9 1.1 3.6 2.6 84 
10 1.1 10 2.6 65 
11 1.1 1.2 1 64 
12 1.1 1.2 1.1 73 
13 1.1 1.2 1.2 73 
14 1.1 1.2 1.5 70 
15 1.1 1.2 2 70 
16 1.1 1.2 10.4 65 
a
 determined by 
1
H NMR by comparison to 1,3,5-Trimethyoxybenzene  
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trials (entries 1-10), the trend was consistent within the data set for that day and considered 
reliable from a comparison stand-point.  Utilizing a large excess of the nucleophile, N-
methylaniline, was also deemed not necessary as a small excess (1.1 equivalents) gave an 
equivalent result as using a larger excess. 
It could be deduced from the early proof of concept experiments and the optimization 
experiments that formation of the aziridinium ion 288 was fast with triflate as no 
pyrrolidine isomer by-product was observed.  If it were not fast then the nucleophile could 
react with the alkyl triflate to form the undesired dihydropyrrole in an SN2 fashion (Scheme 
64).  However, in order to verify if the formation of the aziridinium ion was complete, and 
also to discern how stable the intermediate was at this optimal temperature, the timing of 
the nucleophile addition to the aziridinium ion solution was examined (Table 9).   
Scheme 64: Fast Formation of the Aziridinium Ion 
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A quick examination of Table 9 shows that the formation of 288 under these conditions is 
fast and almost complete in one minute (entry 1).  Also, it is apparent that the aziridinium 
ion formed is unstable in solution over several hours at -15 °C (entry 6).  The highest yield 
was obtained when the nucleophile addition was done 5 minutes after triflic anhydride 
addition (entry 2).   
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Table 9: Delay Period Between Triflic Anhydride Addition and Nucleophile Addition 
236 288 304
N
Bn
OH
N
Bn
H
TfO
N
Bn
N
Ph
Proton sponge (1.2 equiv)
Tf2O (1.1 equiv)
DCM (0.05 M)
-15 °C
HNMePh (1.1 equiv)
15 min
 
Entry Activation Time  304 Yielda 
1 60 s 78% 
2 5 min 86% 
3 20 min 83% 
4 1 hour 76% 
5 2 hours 69% 
6 17 hours 42% 
a determined by 1H NMR of the crude reaction mixture by comparison to 1,3,5-
trimethoxybenzene 
We next examined the effect of concentration on the yield of the ring expansion reaction.  
Table 10 shows a clear cut-off in yield as an effect of concentration.  It was observed 
during the optimization trial that solutions with 0.11 M and 0.54 M concentrations were 
thick suspensions where-as the more dilute trials were solutions.  This would explain the 
lower yields, as in a suspension the reactants would not be dissolved sufficiently to obtain 
the optimal yield.  The optimal concentration was deemed to be 0.05 M (entry 3). 
Table 10: Concentration Effect on Yield 
236 288 304
N
Bn
OH
N
Bn
H
TfO
N
Bn
N
PhHNMePh (1.1 equiv)
15 min
Proton sponge (1.2 equiv)
Tf2O (1.1 equiv)
DCM
-15 °C, 5 min
 
Entry Concentration (M) 304 Yielda 
1 0.54 74% 
2 0.11 73% 
3 0.05 100% 
4 0.01 100% 
a determined by 1H NMR of the crude reaction mixture by comparison to 
1,3,5-trimethoxybenzene 
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The optimization study to this point had been carried out with a nucleophile that was 
uncharged and fully soluble in the reaction solution.  However, it was also desireable to 
react nucleophiles that were salts with the aziridinium ion.  The effect of co-solvents and 
solvent modifiers was examined with representative salt nucleophiles (Table 11).  Firstly, 
tetrabutylammonium salts were scrutinized as they are fully soluble in organic solvents.  
Highly variable yields were obtained when a slight excess of tetrabutylammonium cyanide 
was used as a nucleophile (entries 1-3).  This was hypothesized to be due to the cyanide 
being basic enough to be protonated by the ammonium salt irreversibly to form cyanide gas 
consuming the nucleophile in an unproductive pathway.  Therefore, an additional 
equivalent of the cyanide was employed (2.5 equivalents) and yields became quantitative 
and reproducible (entries 4-5).   
The addition of the co-solvent acetonitrile after formation of the aziridinium ion was 
tolerated with no apparent effect on yield to form 308 (entry 5, Table 11).  Acetonitrile had 
previously been shown to give exceptionally poor yields if used as the reaction solvent in 
which an aziridinium ion is formed (Table 6).  Therefore, solvents other than DCM could 
be used for the reaction of the aziridinium ion after its formation without a negative impact 
on the yield.   
As sodium salts are more prevalent commercially than tetrabutylammonium salts, sodium 
cyanide was next used as a representative salt nucleophile (Table 11).  This gave a low 
yield of 48% (entry 6).  A small number of co-solvents with sodium cyanide were 
examined and were found to give no improvement in the yield of 308 (entries 6-9).   When 
DMF was used as a co-solvent the aziridinium ion reacted with DMF instead of the cyanide 
ion (entry 9).  This reactivity of aziridinium ions with DMF has been noted before in 
literature.
23,54
  In the presence of a crown ether, sodium cyanide gave comparable results to 
the tetrabutylammonium salt (entry 10, quantitative yield), showing that the low yield of 
the sodium salt was in fact due to its limited solubility.  Tetrabutylammonium 
hexafluorophosphate was also examined as a potential ion exchange reagent to increase the 
solubility of the sodium salts but it failed to give a significant increase in yields (entry 11).  
Changing the counterion to potassium in place of sodium had a small beneficial effect on 
yield (entry 12: K with 59% vs entry 6: Na with 48%).  Optimal conditions for salt 
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nucleophiles were therefore seen as using tetrabutylammonium salts if commercially 
available, or the sodium salt with the use of the crown ether 15-crown-5. 
Table 11: Co-Solvent and Counterion Effect on Yield for Salt Nucleophiles 
N
Bn
OH
N
Bn
H
TfOProton sponge (1.2 equiv)
Tf2O (1.1 equiv)
DCM (0.05 M)
-15°C, 5 min
N
Bn
CNMCN (1.1 equiv)
1 hour
M = Bu4N, Na, K
236 288 308
 
Trial Nucleophile Equivalents Co-Solvent/Modifier 
308 
Yielda 
1 Bu4N CN 1.2 DCM 61% 
2 Bu4N CN 1.7 DCM 37% 
3 Bu4N CN 1.2 Acetonitrile 43% 
4 Bu4N CN 2.5 DCM 100% 
5 Bu4N CN 2.5 Acetonitrile 100% 
6 NaCN 3 DCM 48% 
7 NaCN 3 Acetonitrile 22% 
8 NaCN 3 1,2-Dimethoxyethane <30% 
9 NaCN 3 DMF 0%b 
10 NaCN 3 DCM/15-Crown-5 (2 equiv) 100% 
11 NaCN 3.5 DCM/Bu4N PF6 (1.1 equiv) 54% 
12 KCN 3.2 DCM 59% 
a determined by 1H NMR of the crude reaction mixture by comparison to 1,3,5-trimethoxybenzene 
b
 apparent by 
1
H NMR of the crude mixture that DMF had reacted with the aziridinium 
 
In summary, the optimal reaction conditions for formation and reaction of aziridinium ion 
288 were found to be:  1.1 equivalents of Triflic anhydride; 1.2 equivalents of Proton 
Sponge; 1.1 equivalents of the nucleophile if neutral or 2.5 equivalents if anionic; 0.05 M 
in DCM; -15 °C; A 5 minute delay period between the triflic anhydride and nucleophile 
additions.  When anionic nucleophiles were employed, the counterion of the nucleophile 
was optimal when it was tetrabutylammonium or sodium complexed with 15-crown-5. 
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Chapter 4: Mechanism of Ring Expansion and Scope 
In the previous chapter, we have established optimal reaction conditions for formation and 
regioselective reaction of aziridinium ion 288 with the nucleophiles malonate, N-
methylaniline and cyanide.  The scope of this reaction will now be studied with various 
aziridinium ions and nucleophiles.  We need also to establish that the enantiomeric excess 
of the precursor would be maintained.  Furthermore, we need to assign the stereochemical 
relationship in between the substituents of the dihydropyridine, which will give us insight 
on the mechanism of this reaction.   
4.1 Enantiomeric Excess Maintained 
We have so far developed optimized reaction conditions for the formation and reaction of 
the bicyclic [3.1.0] aziridinium ion.  Furthermore, synthesis from 4-hydroxyproline to both 
racemic and enantioenriched N-benzyl-3,4-dehydroprolinol 236 was now available (section 
2.2).  The enantiomeric excesses and yields of the ring expansion with three representative 
nucleophiles were then determined.  Nucleophiles were chosen that could be assigned by 
NMR experiments as the tetrahydropyridine isomer over the dihydropyrrole isomer 
unambiguously, such as the dimethylmalonate nucleophile used in chapter 3.  Nucleophiles 
with a carbon (dimethylmalonate), nitrogen (trifluoroacetamide) and an oxygen (phenol) as 
as the reactive atom were used to show that the attack selectively occurred at the bridging 
aziridinium ion carbon to yield tetrahydropiperidines 309, 310, and 311 was general using 
the optimized conditions (Table 12). 
The three nucleophiles examined in Table 12 gave a single isomer, and in all cases no trace 
of dihydropyrrole was observed.  Also, all three of them maintained the enantiomeric 
excess through the ring expansion reaction.  These three examples showed that the ring 
expansion to a tetrahydropyridine occurs selectively, is general and that the enantiomeric 
excess of the dehydroprolinol precursor would be maintained through this process.   
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Table 12: Study of Enantiomeric Excess Retention During the Ring Expansion Reaction 
236
288
N
Bn
OH
N
Bn
TfO
1.2 equiv Proton sponge
1.1 equiv Tf2O
2.5 equiv 15-Crown-5
DCM (0.05 M)
-15 °C, 5 min
N
Bn
RNu
1 h
R = CH(CO2CH3)2,
NHCOCF3
OPh
H
94% ee
 
Entry Compound Nucleophile Structure 
Isolated 
Yield  
(%) 
Enantiomeric 
Excess 
(%) 
1 309 NaCH(CO2CH3)2 
N
Bn
O O
O
O
 
87 94 
2 310 NaNHCOCF3 N
Bn
H
N CF3
O
 
69 94 
3 311 NaOPh 
N
Bn
O
 
97 94 
 
4.2 Mechanism of Ring Expansion and Scope 
In order to assign a mechanism of the ring expansion, the stereochemistry of the products 
had to be verified.  Insight into how the mechanism of nucleophile addition was obtained 
by comparison of the relative position and stereochemistry of the new substituent to a 
methyl tag on the tetrahydropyridine product (Scheme 65).  If an SN2’ mechanism were to 
take place then the 2,5-disubstituted-tetrahydropyridine would be obtained.  If an SN2 
mechanism were to take place as expected, anti-2,3-disubstituted-tetrahydropyridine 312 
would be obtained.  Also, to be certain that additional substituents or steric bulk would not 
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affect the regioselectivity of the nucleophile, the anion of dimethylmalonate was used as a 
representative nucleophile with aziridinium ions containing various substituents. 
 
Scheme 65: Methyl Tagged Dehydroprolinol for Stereochemical Determination 
N
OH
Alk N
Alk
Nu:
N
Alk
SN2'
SN2
N
Alk
SN2' attack
give 2,5-disubstituted
SN2 attack
gives ant i-2,3-disubstituted
Me
Me
Me MeH H
anti-1,2-aminoalcohol
methyl tag
methyl tag methyl tag
238a
237
312
O O
O
O
OO
O
O
Nu = NaCH(CO2CH3)2  
 
As can be seen in Tables 13, 14 and 15, the transformation was quite general with a wide 
scope.  The reaction tolerates a large variety of nucleophiles producing tetrahydropyridines 
in moderate to excellent yields via an SN2 mechanism for all nucleophiles except 
organocuprates.   
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Table 13: Deuterium and Non-Organometallic Carbon Nucleophile Scope of Addition in 
the Ring Expansion Reaction 
N
Bn
R1
OH
H
N
Bn
R1
R4
Tf2O
Proton Sponge
DCM
-15 °C
N
Bn R1
H
TfO
R2
R3 R2
R3
R3
R2
:Nu
SN2
313 314  
Entry Nucleophile Product Structure 
Yield 
(%) 
1 NaBD4 315 
N
D
Bn  
77 
2 Bu4NCN 316 
N
CN
Bn  
79 
3 
O
O
O
O
Na
 
312 
N
Bn
OO
O
O
 
71 
4 
O
O
O
O
Na
 
317 
N
Bn
O
O O
O
 
73 
5 
O
O
O
O
Na
 
318 
N
Bn
OO
O
O
 
81 
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Table 13: Continued 
Entry Nucleophile Product Structure 
Yield 
(%) 
6 
O
O
O
O
Na
 
319 
N
Bn
OO
O
O
 
89 
7 
N
O
ONa
 
320 
N
Bn
NO2
 
0 
8 
ONa
 
321 
N
Bn
O
 
<40 
9 
N
 
321 
N
Bn
O
 
81 
10 
N
 
322 
N
Bn
N
 
<5 
11 NO2Na
 
323 
N
Bn
NO2
 
0 
Sodium borodeuteride was an effective nucleophile to afford the isotopically labeled 
tetrahydropyridine 315 in a 77% yield (Table 13, entry 1).  Carbon nucleophiles such as 
cyanide afforded 316 in a 79% yield, malonate gave 312 in a 71% yield (entries 2-3).   
Variable substitution patterns on the tetrahydropyridine were well tolerated for the ring 
expansion (Table 13, entries: 3-6, compounds 312, 317, 318, and 319) and had no impact 
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on the mechanism of nucleophile addition for the anion of dimethylmalonate.  Unlike 
dimethylmalonate, when deprotonated nitromethane was used as a nucleophile it gave no 
ring expansion product – only decomposition products were observed (entry 7, 320).  
Though while less reactive, similarities between N-methylindole and an enamine exist and 
indoles can be alkylated by strong electrophiles under forcing conditions at the 3-position 
selectively.
82
 Attempts to alkylate N-methylindole with the aziridinium ion were 
unsuccessful at producing significant quantities of the tetrahydropyridine (entry 10).  Only 
a trace of the product was observed by LCMS when the reaction temperature was allowed 
to warm to ambient temperature.  No report was found in literature of an N,N-
dialkylaziridinium ion in an alkylation reaction with an indole.  However, there is one 
report of a protonated aziridine doing so at 70 °C, over a 30 minute period
83
 – well above 
the stable temperature of the aziridinium ion established in the optimization.  The reaction 
of deprotonated p-nitrotoluene as a nucleophile also failed to yield the tetrahydropyridine 
ring expansion product 323 (entry 11).  This was surprising as the pka of this nucleophile is 
somewhat acidic on the Bordwell pKa scale (pka 20.4)
80a
 and it appeared to fit the criteria.  
However, as mentioned earlier the pKa is solvent dependant.
80   
nOe experiments were conducted on the representative compound 312 (Figure 13).  nOe 
confirmed that the methyl at the 2-position and dimethylmalonate at the 3-position were 
anti to one another, as expected if the aziridinium was formed in an SNi process then 
opened in an SN2 process.  By nOe the methyl and malonate were determined to be pseudo-
axial in solution.  This conformation was likely due to gauche interactions between the 
methyl and the benzyl group, as well as the dimethylmalonate.  If the two substituents are 
placed in a pseudo-axial conformation in the tetrahydropyridine then the C2 and C3 
hydrogens are approximately 90
o
 from one another, and therefore they would be expected 
to have a negligible coupling constant
84
 as was observed. 
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Figure 13: nOe of 312 to Confirm the Stereochemistry of the New Substituent 
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Table 14: Heteroatom Nucleophile Scope of Addition in the Ring Expansion Reaction 
N
Bn
R1
OH
H N
Bn
R1
R4Tf2O
Proton Sponge
DCM
-15 °C
N
Bn R1
H
TfO
:Nu
SN2
313 314  
Entry Nucleophile Product Structure 
Yield 
(%) 
1 
NH CF3
O
Na  
324 
N
H
N
Bn
O
F
F
F
 
58 
2 
ONaN
O
 
325 
N
N
Bn
O
O
 
86 
3 NaN
O
O  
326 
N
N
Bn
O
O
 
70 
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Table 14: Continued 
Entry Nucleophile Product Structure 
Yield 
(%) 
4 Bu4N N3 327 
N
N3
Bn  
75 
5 H2N
 
328 
N
H
N
Bn  
80 
6 
N
H  
329 
N
N
Bn  
93 
7 
N
H
N
 
330 
N
N
Bn
N
N
Bn
OH
 
60 
8 H2N  331 
N
H
N
Bn  
89 
9 N
H  
332 
N
N
Bn  
87 
10 
O
O
Na  
333 
N
O
Bn
O
 
65 
11 HO  334 
N
O
Bn  
73 
 
86 
Table 14: Continued 
Entry Nucleophile Product Structure 
Yield 
(%) 
12 NaO
 
335 
N
O
Bn  
85 
13 Bu4NF 336 
N
F
Bn  
57 
14 NaS  337 
N
S
Bn  
45 
15 HS  337 
N
S
Bn  
56 
16 NaS
 
338 
N
S
Bn  
70 
17 HS
 
338 
N
S
Bn  
41 
 
The reaction with heteroatom nucleophiles as shown in Table 14 proceeded through an SN2 
mechanism yielding 2,3-disubstituted tetrahydropyridines.  Nitrogen nucleophiles were 
well accepted and reactions with an amide, carbamate, phthalimide, azide, amines, and 
anilines gave good to excellent yields (Table 14, entries 1-9, compounds 324-332).  The 
reaction with oxygen nucleophiles such as an acetate, phenoxide or alcohol also lead to 
good to excellent yields (entries 10-12, compounds 333-335).  When fluoride was used as a 
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nucleophile, the reaction proceeded in moderate yield (entry 13, 336).  The reaction with 
sulfur nucleophiles gave moderate yields (entries 14-17, compounds 337, 338), with an 
alkyl thiol producing a modestly superior yield to the sodium alkyl thiolate.  Conversely, 
the reaction with sodium thiophenolate provided a superior yield compared to thiophenol.   
The limit of which nucleophile can be used in the ring expansion appears to be highly 
related to the acidity of the aziridinium ion which has been alluded to in literature (Figure 
14).
46
  For example, sodium ethoxide decomposed the aziridinium ion salt but ethanol was 
a suitable nucleophile (Table 14, entry 11).  Likewise, the sodium enolate of acetophenone 
gave poor yields with significant decomposition (Table 13, entry 8), however the enamine 
of acetophenone gave an excellent yield which was the first reported example of such a 
nucleophile reacting with an aziridinium ion (Table 13, entry 9, 321).  Therefore, this limit 
on acidity can be circumvented to some extent since the aziridinium ion is a very strong 
electrophile. 
Figure 14: Aziridinium Ion Acidic Protons 
N
H
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H
H
H
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N
O
O
H
Ph
Ph
H H
H H
288 339  
4.3 Mechanism of Ring Expansion with Organocuprates 
The only nucleophiles that were examined with this system that did not give the 2,3-
disubstituted tetrahydropyridine product solely were organocuprates (Table 15, 340-344).  
They are operating through a different mechanism when reacting with a vinyl aziridinium 
ion, such as 288, than other nucleophiles.  The lack of the 2,3-disubstituted 
tetrahydropyridine as the sole product suggests that the aziridinium ion opening and the    
C-C bond formation occur in separate steps during the ring expansion, instead of in a 
concerted manner as the other nucleophiles had.   
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Table 15: Organocuprate Nucleophile Addition in the Ring Expansion Reaction  
Entry Nucleophile Product Structure 
Yield 
(%) 
1 CuMgBrCN  
340 N
Bn
N
Bn
18 : 1 at -78 °C
1 : 3 at -15 °C
a b  
78 
2 CuMgBrCN 341 
a b
2 : 5 at -15 °CN
Bn
N
Bn
 
95 
3 CuMgBrCN
 
342 
b
11 : 10 at -78 °C
5 : 1 at -15 °C
N
Bn
unidentified isomer+
 
97 
4 CuMgBrCN  
343 N
Bn
N
Bn
20 : 1
a b  
73 
5 CuMgBrCN
 
344 
N
Bn
64% ee,
SM was 94% ee
 
96 
 
The pKa requirement of the aziridinium ion on the nucleophiles procludes that they are 
reacting as simple carbanions as they would be too basic and would simply decompose the 
aziridinium ion much like sodium ethoxide.  There has been evidence presented that 
Grignards can at least partially go through a SET mechanism when reacted with 
aziridinium ions.
25
  However, for cuprates this does not appear to be the case as if it were 
an allyl radical would be formed and one would expect homocoupling products, which 
were not observed.   
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Figure 15: nOe Relationship of Products From an Ethylcuprate and 238a 
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nOe experiments on the compound 340a showed the same anti relationship and 
conformation as compound 312 obtained from a simple carbanion.  However 340b, which 
was the main product formed at higher temperatures, was established as syn by relay nOe 
between the pseudo-axial hydrogen of the methylene at the 6-position of the piperidine and 
the methyl and ethyl groups (Figure 15).  Also, the minor diastereomer 340c (by integration 
<1% by 
1
H NMR) was formed that was assigned to be the anti-2,5-disubstiuted piperidine 
by nOe and COSY experiments of the mixture. 
When using ethyl cuprate as a nucleophile, the ratio of the two main products was 
dependant on temperature.  The anti-2,3-disubstituted tetrahydropyridine 340a was 
favoured at lower temperatures, and the syn-2,5-disubstituted tetrahydropyridine 340b at 
higher temperatures (Table 14, entry 1).  Plausible mechanisms would be as the following 
(Scheme 66):   
Path A would include an oxidative addition of the metal to the aziridinium ion by opening 
the ring, followed by a reductive elimination resulting in C-C bond formation at the  
position to give the 2,3-disubstituted tetrahydropyridine 240 with the two substituents anti 
to one another.   
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Path B diverges from Path A after the oxidative addition to the cuprate by the aziridinium 
ion.  It leads to the enyl[+] copper(III) complex85 followed by reductive elimination 
resulting in C˗C bond formation at the -position to give 239a.  Path B would place the 
ethyl at the 5-position anti to the methyl at the 2-position.   
Path C is where the cuprate is involved in a -complex analogous to the reaction of 
cuprates with enones.
85
  With the greater conformational freedom obtained at higher 
temperatures, and the bond order of the alkene altered by the copper/alkene complex the 
bicyclic could adopt the otherwise unfavourable conformation to open the aziridinium ion 
Scheme 66: Proposed Mechanism for Organocuprate Addition to the Bicyclic Aziridinium 
Ion 
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with an alkene isomerization placing the alkyl copper(III) at the 5-position.  The alkyl 
copper(III) 5-substituted tetrahydropyridine would then undergo a reductive elimination at 
the  position to yield the syn-2,5-disubstituted tetrahydropyridine.  An alkene/copper 
complex as in Path C would likely give the syn-2,5-disubstituted product instead of the anti 
due to steric hindrance of the aziridinium ion blocking one face of the pyrrolidine favouring 
this face (Figure 16).  This pathway would explain the temperature dependence of the 
product distribution of 340a to 340b.   
Figure 16: Organocuprate Complexation of the Alkene to Yield the syn--Substituted 
Product 
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When an allylcuprate was reacted with the methyl tagged aziridinium ion a similar ratio 
was obtained (Table 14, entry 3, 341, 2:5 ratio) as the ethylcuprate (340, 1:3) favouring 2,5-
disubstituted tetrahydropyridine 341b at -15 °C.  A phenylcuprate also favoured 2,5-
disubstituted product 342 (entry 4) at -15°C though had a minor unidentified isomer (1:5 
ratio of 342:unknown isomer at -15 °C) but had lower selectivity than the ethylcuprate at a 
-78°C for 2,3-disubstituted tetrahydropyridine 342a (10:11 for 342 a:b, 18:1 for 340 a:b).   
Ethyl analog 340b relative stereochemistry had been determined by relay nOe interactions 
using the methylene in the ring at the 6-position of the tetrahydropyridine ring.  The two 
hydrogens of the methylene at this 6-position were diastereotopic and clearly 
distinguishable from one another.  For allyl analog 341b and phenyl analog 342b 
unfortunately, the methylene hydrogens of the 6-position were not clearly distinguishable 
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so relay nOe was not feasible and the relative stereochemistry of the substituent to the 
methyl tag could not be assigned.   
We submitted N-benzyl-3,4,-dehydroprolinol 236 obtained from 4-hydroxyproline to the 
ring expansion reaction conditions with two organocuprates (Table 14, entries 4-5, and 
Figure 67).  The reaction of the aziridinium ion with ethylcuprate proceeded with high 
regioselectivity to obtain tetrahydropyridine 343 (20:1 343:349).  Phenylcuprate when used 
as a nucleophile yielded selectively piperidine product 344 with no pyrrole isomer 
observed.  However, the enantiomeric excess was not maintained through the ring 
expansion for either of the two examples.  3-Phenyl piperidine is a known compound, and 
comparison of the optical rotation
86
 of the hydrogenated analog of 344 showed that the 
major enantiomer to be the opposite of what is normally expected if the ring expansion 
would have occurred through an SN2 mechanism.  Chiral SFC showed the enantiomeric 
excess of 344 to be 64% ee while the precursor 236 had 94% ee.  The ethyl analog 343 also 
had a lowered enantiomeric excess (75% ee) from the precursor 236 (94% ee).  
Unfortunately, the optical rotation of the reference for the HCl salt of the hydrogenated 
analog of 327 was too small (3°)
87
 to have confidence in enantiomer assignment by this 
method and was therefore undetermined.  
The opposite enantiomer being obtained for the ring expansion from 236 with 
phenylcuprate to yield 343 is logical if the major reactive pathway for this product to be 
formed was Path B of Scheme 66.  The product ratio for 342 in the ring expansion with the 
methyl tagged analog and a phenylcuprate was likely 5:1 :substitution (minor 
unidentified isomer assumed to be -substitution, though the anti--substitution would also 
give the same result), with the  product relative stereochemistry undetermined.  If the 
relative stereochemistry of the  substitution of 342 were anti to the methyl tag analog, then 
in the absence of a methyl tag it would yield the opposite enantiomer expected and be the 
major product.  With the assumption that the methyl tag had no significant impact on the 
regioselectivity of the new substituent, the ratio of the two possible enantiomers was 
calculated from 94% ee (Scheme 68).  If the  substitution of the product were anti to the 
methyl tag, this yields a value that approximates the enantiomeric excess obtained 
experimentally quite well (theoretical: 63% ee, actual: 64% ee).  This suggests that in the 2- 
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Scheme 67: Ring Expansion from N-Benzyl-3,4-Dehydroprolinol with Organocuprates 
N
OH N
1) Proton Sponge/Tf2O
DCM
-15 oC
2) PhCuMgBrCN
94% ee opposite enantiomer of
what is normally expected
96% (64% ee)
N
OH N
1) Proton Sponge/Tf2O
DCM
-15 oC
2) EtCuMgBrCN
94% ee
75% ee
(undetermined
enantiomer)
total yield: 73%
N20:1
236
236
344
343 349
 
Scheme 68: Approximation of the Enantiomeric Excess of 330 Assuming an anti Product 
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methyl-5-phenyl tetrahydropyridine 342 obtained, the two substituents are anti to one 
another but this would require further experiments to conclusively affirm this as the relative 
stereochemistry. 
Ethyl analog 343 also had a reduction in the enantiomeric excess from its precursor (94% 
ee to 75% ee).  However, 340b was assigned as syn by nOe to the methyl so both pathways 
(-substitution and -substitution) logically should yield the same enantiomer.  If the 
assignment of stereochemistry was incorrect by nOe, and the ratio of the two isomers 
obtained with methyl analog 340 (3:1 :) were translated to analog 343 with no methyl tag 
prepared under the same conditions, then the theoretical enantiomeric excess value would 
still not be in agreement with the experimental enantiomeric excess value.  Therefore, it is 
unlikely that this was the cause of the reduction in enantiomeric excess of 343.  The 
reduction in enantiomeric excess for the ethyl analog 343 could not be explained with the 
data available.  
4.4 Divergent Substitution Using an Aziridinium Ion 
Substitution at the 2-, 3-, and 6-positions of the tetrahydropyridine has been demonstrated 
with excellent diastereocontrol using the aziridinium ion ring expansion and Petasis-
Mannich reaction to prepare the pyrrolinol precursor in the previous chapters.  Also, the 
alkene is a synthetic handle for further derivatization at the 4- and 5-positions or it can be 
potentially substituted earlier in the synthesis.  However, in using this synthetic route the 
substitution at the 2-position (or 6-position) required that the substituent be selected in the 
beginning of the synthesis.  We wished to increase the versatility of this methodology even 
further.  We envisioned using a hydroxymethyl to prepare another aziridinium ion to 
substitute the 2-position at a later stage intermediate (Scheme 69).  Since no activating 
group is present in the bicyclic [4.1.0] aziridinium ion 354 the nucleophiles would 
regioselectively attack the least hindered position.  This would therefore maintain the 
enantiomeric and diastereomeric purity of this approach while also giving the ability to 
functionalize different points of the piperidine from a common precursor.  Fortunately, the 
2-hydroxymethyl tetrahydropyridine 353 and its analogs are readily available in 
enantiopure form from glyceraldehyde.  Potentially, a hydroxymethyl could also be placed 
at the 6-position of the tetrahydropyridine by using a protected chiral 2-amino-but-3-en-1-
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ol as a precursor for the Petasis-Mannich reaction.  Chiral 2-amino-but-3-en-1-ols could be 
made in 2 steps through a catalytic asymmetric method from a racemic vinyloxirane 
through the use of a sigmatropic allylic rearrangement.
88
   
For an example of this divergent approach we selectively protected pyrrolidine diol 269, 
obtained from glyceraldehyde to obtain 350 in three steps from commercially available 
materials (Scheme 69).  350 was ring expanded using sodium phenolate to produce 352 in 
87% yield.  352 was then deprotected using TBAF to obtain 2-hydroxymethyl-3-phenolate 
tetrahydropyridine 353 in a 92% yield.  353 was then converted to an aziridinium ion in-
situ and reacted with an iso-propyl cuprate to produce 355 in an 82% yield.  Therefore, 350 
was converted to the 2,3-disubstituted tetrahydropyridine 355 with the 2- and 3-substituents 
both chosen in 3 steps.  A similar approach could potentially also be used at the 6-position 
though the alkene would have to be converted into a non-activating group before the 
second aziridinium use (e.g.: hydrogenation) so that nucleophiles would be guided by steric 
demands alone for the second substitution. 
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Scheme 69: Using a Hydroxymethyl  to the Piperidine Nitrogen for Substitution 
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Chapter 5:  Conclusions and Future Work 
5.1 Summary and Conclusions 
A method to prepare enantiopure 3-substituted piperidines has been developed that is 
flexible, versatile and concise that also allows substitution at the 2- and 6-positions with 
excellent stereocontrol.  This method demonstrated that the alkene is a sufficiently strong 
activating group so that the aziridinium ion is opened with complete regioselectivity to the 
desired position to obtain a ring expansion with a large number of nucleophiles.     
The aziridinium ion reacted solely with an SN2 mechanism with all nucleophiles examined 
with the exception of organocuprates, which have additional mechanistic pathways allowed 
to them.  The mechanism by which nucleophiles react with the bicyclic aziridinium ion was 
inferred by tagging the template with a methyl group and comparison of the new 
substituent’s relative position and stereochemistry to the methyl tag.  Varying the 
substitution at the 2- or 6-position had no effect on the mechanism of addition of the 
nucleophiles as expected.  Unfortunately, reacting organocuprates with a bicyclic [3.1.0] 
aziridinium ion did not yield a single product as the regioselectivity was affected by a 
number of factors such as temperature and the ligands of the organocuprate, which limits 
their usefulness.  However, alkyl organocuprates are promising as the regioselectivity was 
Scheme 70: Ring Expansion of Pyrrolinols to Piperidines  
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quite high at low temperatures (340:  -78 °C, 18:1 for a:b).  The regioselectivity for other 
alkyl, alkene, and aryl cuprates requires more study.   
Two synthetic routes to N-benzyl-3,4-dehydroprolinol 236 were developed, using 4-
hydroxyproline or glyceraldehyde as the chiral precursor.  The use of 4-hydroxyproline as a 
precursor to prepare the dehydroprolinol for the ring expansion was not optimal giving 
enantio-enriched (94% ee) N-benzyl-3,4-dehydroprolinol 236, in 5 steps with an overall 
yield of 32%.  The synthesis of N-Benzyl-3,4-dehydroprolinol 236 from glyceraldehyde 
was accomplished with >99% ee in 3 steps from commercial materials in a 35% overall 
yield.  
Scheme 71: N-Benzoyl-3,4-Dehydroprolinate 233 from 4-Hydroxyproline 
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Scheme 72: N-Benzyl-3,4-Dehydroprolinol 236 from 233b 
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The Petasis-Mannich reaction was quite powerful, versatile and concise to prepare the 
desired 1,2-aminoalcohols which were subsequently converted to dehydroprolinols by an 
RCM reaction.  The protecting group modification of the Petasis-Mannich reaction with an 
in-situ deprotection had no impact on the diastereoselectivity, enantiopurity or yield of the 
reaction but had the advantage of making the precursor synthesis and isolation trivial.  The 
use of the modified version of the Petasis-Mannich reaction added strongly to the versatility 
of this method of ring expansion, as it allowed diastereoselective synthesis of the 
substituted pyrrolinol precursors.  The enantiomeric purity, length of synthesis, and 
diastereoselectivity clearly point to the Petasis-Mannich and RCM method as being 
superior over using 4-hydroxyproline as a precursor for the synthesis of desired pyrrolinols. 
Scheme 73: Petasis-Mannich Silyl Protecting Group Modification  
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Scheme 74: RCM of the Petasis-Mannich Product to Obtain Pyrrolinols 
N
Bn OH
R2
HN
Bn OH
R2
H
Ph
R1 R
1
* *
364 365  
The use of 2-diol-pyrrolidine 352 prepared from glyceraldehyde in three steps, as a 
precursor to the ring expansion allowed us to choose the substituents at both the 2- and 3-
positions of the tetrahydropyridine from an advanced intermediate (Scheme 75).  The 3-
substituent was chosen during the ring expansion, and the 2-substituent after the ring 
expansion through an unactivated aziridinium ion.  This demonstrated the ability to 
substitute various positions on the enantiopure piperidine skeleton with excellent 
stereocontrol quite well. 
Scheme 75: Choosing the 2- and 3-substituents of the Piperidine from a Common 
Intermediate 
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5.2 Future Work 
The alkene of the tetrahydropyridine is a potentially useful synthetic handle for further 
derivatization or substitution.  Thus, all 5 carbon sites of the piperidine skeleton could in 
principle be accessed for substitution by this ring expansion method.  For example, 
epoxidation of the 3,4-tetrahydropyridine has been done with excellent diastereoselectivity 
on a similar substrate, as shown in Scheme 76.
89
  Epoxides such as 367 have been shown to 
be opened regioselectively by a number of nucleophiles such as hydrides, cuprates, 
cyanide, amines and acids to gain substitution at the 3- or 4-position of the piperidine.
90
   
The conditions for some nucleophiles to obtain epoxide opening at the 3-position or 4-
position regioselectively with the same nucleophile has been studied as shown in Scheme 
77.  This regioselectivity between the two epoxide carbons was due to electrostatic 
replusion of the amine and epoxide oxygen, or through chelation of the additive by the 
amine and oxygen depending on whether an additive was employed or not.  This allowed 
the authors to selectively attack each carbon of the epoxide.
 90c
 
Scheme 76: Epoxidation of an N-Benzyl-Tetrahydropyridine and Opening of Such an 
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Scheme 77: Regioselective Opening of the Epoxide  
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Scheme 78: Proposed Synthesis of Moranoline 
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There are a number of natural products that are potential synthetic targets of this 
methodology such as the aza-sugars Miglitol, Fagomine, Isofagomine, Castanospermine, 
Moranoline, and many others.
91
  Previously Moranoline has been prepared in racemic form 
in 10 steps.
89,Error! Bookmark not defined.
  Moranoline could potentially be prepared in 
enantiopure form in 8 steps from glyceraldehyde using the ring expansion methodology put 
forward here as shown in Scheme 78.   
A -allyl cation has been demonstrated to not form from this system with a large number of 
nucleophiles and this is due to the bridged C-N * of the aziridinium ion being orthogonal 
to the -system electrons.  Therefore, the tagged bicyclic [3.1.0] aziridinium ion gives a 
unique way to study how cuprates react with allyl leaving groups, separating the various 
mechanistic pathways that could occur by comparing the regioselectivity and relative 
stereochemistry of the new substituent to a tag.  As discussed in section 4.3 the mechanism 
of organocuprate addition can be elucidated from the relative stereochemistry of the SN2 
and SN2’ products to a tag.  This would require two tags, at the 2- and 6-positions of the 
tetrahydropyridine to be done quickly.  Two tags would be necessary so that all possible 
products made could have the stereochemistry of the new substituent from the cuprate 
determined and therefore its mechanism of formation elucidated.  Alternatively, the 
products could have the substituent stereochemistry determined by X-ray crystallography.  
However, X-ray determination of each analog would be quite laborious and as seen in 
earlier chapters placing substitution at the 2- and 6-positions is simple. 
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Scheme 79: Aryl or Heteroaryl as a Directing Group for Ring Expansion 
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A variety of activating groups with aziridinium ions have not yet been studied.  For 
example, 1-hydroxymethylisoindolines being ring expanded to tetrahydroisoquinolines or 
homoanalogs for larger rings or heteroaryls with an example shown in Scheme 79.  These 
could be of interest to the pharmaceutical industry, as one could envision producing 
analogs of Plavix, which was the number 2 selling drug in the world in terms of sales in 
2009 (>9$ billion US),
92
 quite easily enantiopure with high diastereoselectivity (>99%).  
The Petasis-Mannich reaction would be incredibly useful in such an endeavor as it could be 
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used twice.  Once for the formation of the phenylglycinol derivative 380, and then again to 
form the second 1,2-aminoalcohol 382. 
The preparation of 3-substituted-4-piperidones could be accomplished from the 3-
pyrrolidone, as shown in Scheme 80.  The precursors are available from the chiral pool 
such as 3-hydroxyproline 391, or possibly through an asymmetric method using aldol 
chemistry.  Enolate formation selectivity between the 2 reactive sites of 3-oxo-pyrrolidine 
has been studied previously, and it is possible to obtain the 3-oxo-prolinol derivative 392 
from the -ketoester 393 though no asymmetric examples have been in found in literature 
for this template.
93
   
Scheme 80: 4-Piperidone Synthesis via Ring Expansion 
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Acyclic vinyl aziridiniums such as 395 or alkynyl aziridiniums such as 399 could be 
explored to see if the SN2’ product was favoured, and if the stereochemical information was 
maintained during the rearrangement.  Surprisingly, this has not been reported to date 
despite the similarity of the aziridinium ion to an epoxide. 
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Scheme 81: Vinyl Aziridinium Ion or Alkynyl Aziridinium Ion Opening 
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There are a few reports of allyl acetates in a tetrahydropyridine template reacting with 
carbon nucleophiles such as cuprates
94
 (Scheme 82), malonates
95
, and nitromethane
96
 
though this has not yet been reported as a general synthetic method to obtain chiral 3-
substituted piperidines.   
Scheme 82: 3-Substituted Piperidines by an Allylic Sigmatropic Rearrangment  
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We have demonstrated that 340 can be prepared in enantiopure form easily using the 
method developed herein.  Potentially this product could be used for a sigmatropic allylic 
rearrangement to prepare 3-substituted piperidines such as 409 (Scheme 83).  The methyl 
tag at the 2-position would be useful for determination of regioselectivity and 
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stereochemistry of the new substituent, or could be omitted to obtain potentially a simple 
chiral 3-substituted piperidine.   
Scheme 83: Proposed Method to Prepare 3-Substituted Piperidines  
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Chapter 6:  Experimental 
6.1 General information 
All non-aqueous reactions were run under an inert atmosphere of argon with rigid exclusion 
of moisture from reagents and glassware using standard techniques for manipulating air-
sensitive compounds.
97
 All glassware was stored in the oven and/or was flame-dried prior 
to use under an inert atmosphere of gas. Analytical thin-layer chromatography (TLC) was 
performed on precoated, glass-backed silica gel (Merck 60 F254). Visualization of the 
developed chromatogram was performed by natural fluorescence or fluorescence quenching 
at 254 nm UV light and/or aqueous cerium molybdate, or aqueous potassium 
permanganate. Flash column chromatography was performed using 230-400 mesh silica 
(EM Science or Silicycle) and the indicated solvent system according to standard 
technique. Melting points were obtained on a Büchi melting point apparatus and are 
uncorrected. Infrared spectra were taken on a Perkin Elmer Spectrum One FTIR and are 
reported in reciprocal centimeters (cm
-1
). Nuclear magnetic resonance spectra (
1
H, 
13
C, 
DEPT 135, COSY, HMQC) were recorded either on a Bruker AV 300, AMX 300, AV 400, 
ARX 400, or DMX 700 spectrometer. Chemical shifts for 
1
H NMR spectra are recorded in 
parts per million from tetramethylsilane with the solvent resonance as the internal standard 
(chloroform, δ 7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, m = multiplet, mc = centered multiplet and br = broad), 
coupling constant in Hz, integration, and assignment.  Chemical shifts for 
13
C NMR spectra 
are recorded in parts per million from tetramethylsilane using the central peak of 
deuterochloroform (δ 77.00 ppm) as the internal standard. All spectra were obtained with 
complete proton decoupling. When ambiguous, proton and carbon assignments were 
established using COSY, HMQC and DEPT 135 experiments.  
 
Where inseparable and/or interconvertible mixtures of diastereomers were obtained, the 
spectra are reported as observed; where chemical shifts are coincidental, they are reported 
with an integration of 1 H (assignment X-H); where diastereomers display separate 
chemical shifts, integrations (and assignments) are reported as 1 H
d1 
(assignment X-H
d1
) 
 
and 1 H
d2 
(assignment X-H
d2
) for the first and second diastereomer, respectively. The two 
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diastereomers were arbitrarily assigned as d1 and d2 with the following relationship to 
their chemical shifts: 
 
d1 = more deshielded diastereomer 
d2 = less deshielded diastereomer 
 
Diastereotopic protons with separate chemical shifts are reported as Ha and Hb; 
diastereotopic carbons with separate chemical shifts are reported as Ca and Cb.  
Quaternary carbons identified by DEPT 135 experiments are reported as Cquat. 
 
Optical rotations were determined with a Perkin-Elmer 341 polarimeter at 589 nm and 
20 °C. Data are reported as follows: [α]λ
temp
, concentration (c in g/100 mL), and solvent. 
High resolution mass spectra were performed by the Centre régional de spectroscopie de 
masse de l'Université de Montréal. Analytical supercritical fluid chromatography (SFC) 
was performed on a Thar Technologies SD-AMDS SFC system equipped with a diode 
array UV detector recording at 210 nm. Data are reported as follows: (column type, eluent, 
flow rate, pressure, column temperature: retention time (tr)). 
 
6.2 Reagents 
Unless otherwise stated, commercial reagents were obtained from commercial sources 
(Sigma-Aldrich, Alfa Aesar or Strem) and used without purification. Anhydrous solvents 
were obtained either by filtration through drying columns (THF, diethyl ether, CH2Cl2, 
benzene, toluene, hexane) on a GlassContour system (Irvine, CA) or by distillation over 
calcium hydride (Et3N, pyridine, diisopropylamine). Molecular sieves were dried at 120 °C 
for 16 hours and stored in a dessicator.  
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6.3 Synthesis of 236 from L-trans-4-Hydroxyproline 
N
H
HO
O
O
Cl
223
N
H
HO
O
OH
L-4-Hydroxyproline  
(2S,4R)-ethyl 4-hydroxypyrrolidine-2-carboxylate Hydrochloride (223) 
L-trans-4-Hydroxyproline (5.05 g, 38.7 mmol) was suspended in anhydrous ethanol 
(100mL), and concentrated HCl was added (1.3 mL, 48% by wt, in water, 49 mmol).  The 
suspension was refluxed for 16 hours, becoming a light yellow clear solution.  Solvent was 
removed under reduced pressure yielding a white solid.  The white solid was resuspended 
in diethyl ether (200 mL), stirred vigorously until a fine suspension, then filtered through a 
sintered glass filter and the filter cake was washed with a minimum of diethyl ether.  
Solvent was removed under reduced pressure to obtain 223 as a fine white powder (7.55 g, 
99%).  mp = 150 °C.  []20D = -33 (c = 0.725, MeOH).  IR (film)/cm
-1 
3360br, 2921, 2848, 
1738, 1633, 1244, 1023.  
1
H NMR (300 MHz, CD3OD):  4.55-4.63 (m, 2H), 4.32 (q, J = 
7.1 Hz, 2H), 3.46 (dd, J = 13.7 Hz, 3.5 Hz, 1H), 3.29-3.35 (m, 1H), 2.43 (dd, J = 13.7, 7.8 
Hz, 1H), 2.20 (ddd, J = 13.7, 10.7, 4.11 Hz, 1H), 1.34 (t, J = 7.1 Hz, 3H).  
13
C NMR (75 
MHz, CD3OD):  169.7, 70.1, 63.4, 58.9, 54.4, 38.1, 13.8.  HRMS Calcd for C7H13NO3 [M 
+ H]
+
: 160.09682; Found: 160.09666.  
 
N
HO
O
O
N
H
HO
O
O
Cl
OPh
223 231  
(2S,4R)-ethyl 1-benzoyl-4-hydroxypyrrolidine-2-carboxylate (231) 
To a stirred suspension of 223 (7.10 g, 36.3 mmol) in anhydrous DCM (100 mL) was added 
triethylamine (15 mL, 108 mmol), followed by dropwise addition of benzoyl chloride (4.25 
mL, 36.6 mmol).  The suspension was stirred for 16 hours.  The mixture was diluted with 
ethyl acetate (300 mL), then washed with 1M HCl (3 x 100 mL), saturated NaHCO3 (3 x 
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100 mL), brine (100 mL), and dried (Na2SO4), filtered and solvent removed under reduced 
pressure.  Purification by flash chromatography (50-100% ethyl acetate/hexane) afforded 
231 as a white solid (8.88 g, 93%).  Rf = 0.52 (EtOAc).  mp = 69 °C.  []20D = -123 (c = 2.2, 
CHCl3).  IR (film)/cm
-1 
 3384br, 2983, 1738, 1612, 1574, 1423, 1275, 1192, 1083, 1029, 
862.  
1
H NMR (300 MHz, CD3OD): 7.57-7.60 (m, 2H), 7.44-7.52 (m, 3H), 4.73 (t, J = 
8.9 Hz, 2H), 4.42 (bs, 1H), 4.24 (q, J = 7.1 Hz, 2H), 3.83 (dd, J = 11.5, 4.2 Hz, 1H), 3.44 
(d, J = 11.4 Hz, 1H), 2.33-2.40 (m, 1H), 2.11 (ddd, J = 13.3, 9.5, 4.2 Hz, 1H), 1.31 (t, J = 
7.1 Hz, 3H).  
13
C NMR (75 MHz, CD3OD):  173.3, 171.8, 136.4, 131.3, 129.0, 127.8, 
127.5, 70.4, 61.9, 59.0, 38.0, 13.9.  HRMS Calcd for C14H17NO4 [M + H]
+
: 264.12303; 
Found: 264.12312. 
N
HO
O
O
N
O
O
I
OPh OPh
231 232  
(S)-ethyl 1-benzoyl-4-iodopyrrolidine-2-carboxylate (232) 
To a stirred solution of 231 (3.30 g, 13.5 mmol) in anhydrous THF (40 mL) was added 
triphenylphosphine (4.20 g, 16.0 mmol), the mixture was chilled with an ice bath, and then 
diethyldiazodicarboxylate (2.60 mL, 16.5 mmol) was added followed by iodomethane (1.00 
mL, 16.0 mmol).  The ice bath was removed and the solution stirred for 16 hours at ambient 
temperature.  Solvent was removed under reduced pressure to yield a yellow oil.  
Purification by flash chromatography (50% diethyl ether/hexane) with TLC visualization 
by UV afforded 232 as an inseparable mixture of diastereomers as a light yellow oil (7.30 
g, 83%).  Rf = 0.22 (50% diethyl ether/hexane).  
1
H NMR (300 MHz, CDCl3):  7.54-7.59 
(m, 1.7H), 7.37-7.48 (m, 3.51H), 4.86 (t, J = 7.3 Hz, 0.57H), 4.69 (t, J = 8.7 Hz, 0.29H), 
4.54 (t, J = 6.3 Hz, 0.16H), 4.44 (t, J = 4.8 Hz, 0.76H), 4.26 (q, J = 7.0 Hz, 1.75H), 4.08 
(dd, J = 11.9, 5.1 Hz, 0.68H), 3.92-3.99 (m, 0.1.18H), 3.73-3.83 (m, 1.46H), 2.95-3.03 (m, 
0.29H), 2.69 (ddd, J = 14.3, 7.9, 5.1 Hz, 0.70H), 2.31-2.51 (m, 1H), 1.84-1.87 (m, 0.92H), 
1.32 (t, J = 7.1 Hz, 2.92H), 1.07 (t, J = 6.9 Hz, 0.45H).  
13
C NMR (75 MHz, CDCl3):  
172.3, 171.4, 170.5, 169.6, 136.2, 136.0, 131.7, 131.4, 131.0, 129.3, 128.4, 128.1, 127.7, 
68.8, 62.4, 61.3, 60.5, 59.8, 59.6, 42.3, 42.0, 26.4, 18.2, 15.0, 12.6.  HRMS Calcd for 
C14H16INO3 [M + H]
+
:  374.02476; Found: 374.02541. 
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Ethyl 1-benzoyl-2,5-dihydro-1H-pyrrole-2-carboxylate and Ethyl 1-benzoyl-2,3-
dihydro-1H-pyrrole-2-carboxylate (233a and 234) 
232 (3.30 g, 8.84 mmol) was dissolved in Toluene (100 mL), and 1,8-
diazabicyclo[5.4.0]undec-7-ene (1.32 mL, 8.83 mmol) was added to the stirred solution.  
The mixture was refluxed for 16 hours, then cooled to ambient temperature and filtered 
washing the filter cake with a minimum of toluene.  The filtrate solvent was removed under 
reduced pressure to obtain an oil.  Purification by flash chromatography (20-100% ethyl 
acetate/hexane) with TLC visualization by UV afforded 233a and 234 as yellow oils (233a: 
1.01 g, 47%; 234: 900 mg, 42%).  Rf = 233a: 0.17 (20% ethyl acetate/hexane); 234: 0.12 
(20% ethyl acetate/hexane).   
 
233a:  The enantiomeric excess of 233a was verified by optical rotation and SFC analysis 
(see 233b, left SFC trace).  []20D = 0.0 (c = 0.34, CHCl3).  IR (film)/cm
-1 
 2981, 2868, 
1742, 1638, 1404, 1335, 1256, 1404, 1029.  233a was a mixture of rotamers:  
1
H NMR 
(300 MHz, CDCl3):  7.58-7.61 (m, 2H), 7.38-7.47 (m, 3H), 6.12 (bs, 0.38H), 5.90-5.97 
(m, 1.84H), 5.75 (bs, 0.37H), 5.47 (bs, 0.87H), 5.12 (bs, 0.33H), 4.58 (bs, 0.70H), 4.43-
4.49 (m, 1.01H), 4.20-4.26 (m, 2.89H), 3.90-4.04 (m, 0.79H), 1.33 (t, J = 7.1 Hz, 3.00H), 
1.08 (t, J = 7.1 Hz, 1.12H).  
13
C NMR (75 MHz, CDCl3):  170.6, 170.5, 136.8, 131.0, 
130.8, 130.1, 129.4, 129.3, 127.8, 127.5, 125.9, 125.5, 69.1, 67.4, 62.3, 56.8, 54.8, 15.0, 
14.8.  HRMS Calcd for C14H15NO3 [M + H]
+
:  246.11247; Found: 246.11267. 
 
234:  []20D = -140 (c = 0.725 CHCl3).  IR (film)/cm
-1 
 2980, 1742, 1640, 1616, 1402, 1290, 
1191, 1107, 1032, 1017, 943, 840.  
1
H NMR (300 MHz, CDCl3):  7.58 (d, J = 6.7 Hz, 2H), 
7.42-7.51 (m, 3H), 6.54 (bs, 2H), 5.13 (bs, 1H), 5.03 (dd, J = 11.5, 5.0 Hz, 1H), 4.29 (q, J = 
7.1 Hz, 2H), 3.07-3.17 (m, 1H), 2.70-2.78 (m, 1H), 1.33 (t, J = 7.1 Hz, 3H).  
13
C NMR (75 
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MHz, CDCl3):  171.8, 167.9, 135.8, 131.7, 131.5, 129.3, 128.7, 109.7, 62.3, 59.3, 34.6, 
15.0.  HRMS Calcd for C14H15NO3 [M + H]
+
:  246.11247; Found: 246.11261. 
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(S)-ethyl 1-benzoyl-2,5-dihydro-1H-pyrrole-2-carboxylate (233b) 
To a solution of Diphenyldiselenide (3.34 g, 10.7 mmol) in methanol (100 mL) that was 
chilled with an ice bath was added sodium borohydride (832 mg, 22.0 mmol).  5 minutes 
later 232 (7.10, 19.0 mmol) was added to the stirred solution, and the solution was refluxed 
for 16 hours.  The solution was allowed to cool to ambient temperature and then was 
chilled with an ice bath.  Hydrogen peroxide (30% by weight in water, 20 mL) was added 
dropwise to the stirred cold solution, delayed initiation occurred and an exotherm resulted 
raising the temperature of the mixture to 40 °C.  After 90 minutes the mixture was diluted 
with ethyl acetate (400 mL) and washed with water (3x100 mL), brine (100mL), and dried 
(Na2SO4).  Purification by flash chromatography (20% ethyl acetate/hexane) with TLC 
visualization by UV afforded 233b as a yellow oil (2.53 g, 54%).  The enantiomeric excess 
was determined by SFC analysis on a chiral stationary phase (Chiralpak AD-H 25 cm, 5% 
MeOH, 3mL/min, 40°C, 150bar, 210 nm, t
r 
(minor) 8.2 min, t
r 
(major) 9.3 min. Rf = 233b: 
0.17 (20% ethyl acetate/hexane).  IR, 
1
H NMR and 
13
C NMR was identical to 233a. 
 
 
       233a            233b 
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(S)-(1-benzyl-2,5-dihydro-1H-pyrrol-2-yl)methanol (236 from 233b, 94% ee) 
Anhydrous THF (100 mL) was brought to reflux, and then lithium aluminum hydride (920 
mg, 24.2 mmol) was added (effervescence!) portionwise forming a grey suspension.  The 
suspension was refluxed for 5 minutes, then a solution of 233b (1.80 g, 7.34 mmol) in a 
minimum of anhydrous THF was added dropwise.  The mixture was refluxed for 1 hour, 
then quenched by adding Na2SO4●10H2O portionwise until effervescence ceased.  The hot 
solution was allowed to cool to ambient temperature, filtered through Celite over a cotton 
washing the filter cake with ethyl acetate.  The filtrate solvent was removed under reduced 
pressure.  Purification by flash chromatography (0-5% methanol/DCM) with TLC 
visualization by KMnO4 afforded 236 as a yellow oil (1.20 g, 86%).  Rf = 0.26 (5% 
MeOH/DCM).  IR (film)/cm
-1 
 3385br, 3064, 3027, 2867, 2791, 1494, 1453, 1376, 1347, 
1112, 1077, 1028, 910, 734.  
1
H NMR (300 MHz, CDCl3):  7.26-7.38 (m, 5H), 5.84 (m, 
1H), 5.68 (m, 1H), 4.04 (d, J = 13.2 Hz, 1H), 3.82 (m, 1H), 3.73 (m, 1H), 3.65 (d, J = 13.2 
Hz, 1H), 3.57 (d, J = 2.5 Hz, 2H), 3.28-3.38 (m, 1H), 2.79 (bs, 1H).  
13
C NMR (75 MHz, 
CDCl3):  140.2, 130.1, 129.5, 129.3, 129.3, 128.0, 72.3, 62.2, 61.2, 59.2.  HRMS Calcd 
for C12H16NO [M + H]
+
:  190.12264; Found: 190.12242. 
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6.4 Synthesis of the 1,2-Aminoalcohols by the Petasis-Mannich Reaction  
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(2S,3R,E)-3-(allyl(benzyl)amino)-5-phenylpent-4-en-2-ol (255) from the Boronic Acid 
(204) 
(S)-2-(tert-butyldiphenylsilyloxy)propanal 233 (103 mg, 0.330 mmol) was dissolved in 
anhydrous ethanol (1.4 mL) and a tetrabutylammonium fluoride solution (1.0 M in THF, 
350 µL, 0.350 mmol) was added.  The mixture was stirred for 5 minutes, then N-
benzylprop-2-en-1-amine 246 (53.6 mg, 0.364 mmol) and (E)-styrylboronic acid 204 (52.2 
mg, 0.353 mmol) were added and the mixture refluxed for 16 hours.  Solvent was removed 
under reduced pressure, the resulting orange oil was dissolved in diethyl ether (20 mL) and 
washed with water (3x10 mL), brine (10mL) then extracted with 1M HCl (3x20 mL).  The 
combined acid extracts had the pH adjusted to 8 using NaHCO3, and then the aqueous 
solution was extracted with DCM (3x20 mL).  The combined DCM extracts were dried 
(Na2SO4), and solvent removed under reduced pressure.  Purification by flash 
chromatography (0-10% diethyl ether/hexanes) to obtain 255 as a yellow oil (85 mg, 83%).  
Identical by NMR to that made from the pinacol ester of the boronic acid shown below. 
CH3
O
O
TBDPS
H
N
Bn
B
Ph O
O
TBAF
N
Ph
Bn OH
H
253 246 254 255  
 
(2S,3R,E)-3-(allyl(benzyl)amino)-5-phenylpent-4-en-2-ol (255) from the Pinacol 
Boronic Ester (254) 
(S)-2-(tert-butyldiphenylsilyloxy)propanal 253 (13.75 g, 44.0 mmol) was dissolved in 
anhydrous ethanol (220 mL) and a tetrabutylammonium fluoride solution (1.0 M in THF, 
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44.0 mL, 44.0 mmol) was added.  The mixture was stirred for 5 minutes, then N-
benzylprop-2-en-1-amine 246 (7.90 g, 53.7 mmol) and (E)-4,4,5,5-tetramethyl-2-styryl-
1,3,2-dioxaborolane 254 (11.59 g, 50.4 mmol) were added and the mixture refluxed for 5 
hours.  Solvent was removed under reduced pressure, then the resulting oil dissolved in 
diethyl ether (200 mL) and washed with water (3x100 mL), brine (50 mL) and dried 
(Na2SO4).  Purification by flash chromatography (0-10% diethyl ether/hexanes) to yield 
255 as a yellow oil (8.37 g, 62%, >99% ee) and its diastereomer was isolated (20 mg, 
0.1%). 
 
255 : The enantiomeric excess was determined by SFC analysis on a chiral stationary phase 
(Chiralpak AD-H 25 cm, 10% i-PrOH, 3mL/min, 40°C, 150bar, 210 nm, t
r 
(major) 6.9 min, 
t
r 
(minor) 8.7 min.  Rf = 0.15 (10% diethyl ether/hexanes). []20D = -146 (c = 0.892 CHCl3).  
IR (film)/cm
-1 
 3438, 3025, 2972, 2928, 2808, 1494, 1449, 1366, 1099, 1071, 971, 912.  
1
H 
NMR (300 MHz, CDCl3):  7.26-7.44 (m, 11H), 6.54 (d, J = 15.9 Hz, 1H), 6.25 (dd, J = 
15.9, 9.6 Hz, 1H), 5.82-5.96 (m, 1H), 5.20 (m, 1H), 4.05 (m, 1H), 3.92 (d, J = 14.1 Hz, 
1H), 3.53 (d, J = 14.0 Hz, 1H), 3.34 (dd, J = 14.5, 5.2 Hz, 1H), 3.13 (d, J = 8.9 Hz, 1H), 
3.09 (t, J = 7.2 Hz, 1H), 2.36 (s, 1H), 1.25 (d, J = 6.2 Hz, 3H).  
13
C NMR (75 MHz, 
CDCl3):  140.7, 137.4, 136.7, 136.7, 129.5, 129.5, 129.2, 128.7, 127.8, 127.3, 126.1, 
118.5, 69.8, 68.0, 55.8, 54.5, 20.8.  HRMS Calcd for C21H25NO [M + H]
+
:  308.20089; 
Found: 308.20110. 
 
 
Racemic 255     Enantiopure 255 
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Diastereomer of 255 : Rf = 0.16 (10% diethyl ether/hexanes). 
1
H NMR (400 MHz, 
CDCl3):  7.27-7.47 (m, 10H), 6.54 (d, J = 15.9 Hz, 1H), 6.11 (dd, J = 15.9, 9.8 Hz, 1H), 
5.81-5.91 (m, 1H), 5.21-5.28 (m, 2H), 4.02 (d, J = 13.4 Hz, 1H), 3.85-3.91 (m, 1H), 3.42-
3.49 (m, 1H), 3.36 (d, J = 13.4 Hz, 1H), 3.03 (t, J = 9.7 Hz, 1H), 2.99 (dd, J = 13.9, 8.6 Hz, 
1H), 1.14 (d, J = 6.0 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.3, 136.9, 136.7, 129.3, 
129.1, 129.0, 129.0, 128.4, 127.7, 126.9, 123.8, 118.4, 69.1, 65.5, 54.3, 53.2, 20.1 
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(3S,4R,E)-4-(allyl(benzyl)amino)-2-methyl-6-phenylhex-5-en-3-ol (265) 
Aldehyde preparation (known synthesis)
74
: To a solution of (S)-methyl 2-(tert-
butyldiphenylsilyloxy)-3-methylbutanoate (1.03 g, 2.78 mmol) in anhydrous DCM (30 mL) 
that was chilled with a dry ice/acetone bath (-78 °C) was added a solution of DIBAL-H in 
Toluene (1M, 5.50 mL, 5.50 mmol) dropwise.  After the reaction was stirred for 1 hour, the 
reaction was quenched by adding MeOH (1mL) and the mixture was allowed to warm to rt.  
A saturated Rochelle salt solution (30 mL) was added, and the mixture stirred at rt until 
clear (aprox. 1 hour).  The solution was extracted with DCM (30 mL), and the organic 
extract was washed with water (30 mL), brine (30 mL), and dried (Na2SO4).  Purification 
by flash chromatography (5% ethyl acetate/hexane) to yield 264 as a colourless oil (70%).  
Rf = 0.2 (5% ethyl acetate/hexanes).  []20D = -35 (c = 0.2 CHCl3).  
1
H NMR (300 MHz, 
CDCl3):  9.55-9.56 (m, 1H), 7.65-7.68 (m, 4H), 7.37-7.48 (m, 6H), 3.87-3.89 (m, 1H), 
1.98-2.07 (m, 1H), 1.15 (s, 9H), 0.97 (ddd, J = 6.9, 5.8, 1.3 Hz, 6H). 
13
C NMR (75 MHz, 
CDCl3):  205.4, 136.7, 136.7, 134.1, 133.9, 130.8, 130.8, 128.6, 128.6, 83.1, 33.4, 27.9, 
20.4, 19.2, 17.9. 
 
Petasis-Mannich Reaction:  264 (663 mg, 1.95 mmol) was dissolved in anhydrous ethanol 
(10 mL) and a tetrabutylammonium fluoride solution (1.0 M in THF, 1.95 mL, 1.95 mmol) 
was added.  The mixture was stirred for 16 hours, then N-benzylprop-2-en-1-amine (315 
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mg, 2.15 mmol) 246 and (E)-4,4,5,5-tetramethyl-2-styryl-1,3,2-dioxaborolane 254 (289 
mg, 1.95 mmol) were added and the mixture stirred at rt for 40 hours.  Solvent was 
removed under reduced pressure, then the resulting oil dissolved in diethyl ether (50 mL) 
and washed with sat. NaHCO3 (3x30 mL), brine (50 mL) and dried (Na2SO4).  Purification 
by flash chromatography (Benzene) to yield 265 as a yellow oil (396 mg, 61%).  Rf = 0.31 
(10% ethyl acetate/hexane).  []20D = -114 (c = 1.19 CHCl3).  IR (film)/cm
-1 
 3444, 3026, 
2958, 2870, 1494, 1449, 1365, 1107, 1071, 1051, 1028, 972, 912, 738, 696.  
1
H NMR (300 
MHz, CDCl3):  7.24-7.42 (m, 10H), 6.57 (d, J = 16.0 Hz, 1H), 6.25 (dd, J = 16.6, 6.8 Hz, 
1H), 5.86-5.96 (m, 1H), 5.15-5.21 (m, 2H), 3.87 (d, J = 13.9 Hz, 1H), 3.57-3.63 (m, 2H), 
3.28-3.35 (m, 2H), 3.16 (dd, J = 14.8, 6.8 Hz, 1H), 2.66 (bs, 1H), 1.87-1.96 (m, 1H), 0.93 
(d, J = 4.0 Hz, 3H), 0.91 (d, J = 4.1 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  140.6, 137.5, 
136.2, 135.8, 129.6, 129.4, 129.2, 128.6, 127.7, 127.3, 126.6, 118.8, 76.4, 66.6, 55.5, 54.2, 
30.4, 19.7, 18.4.  HRMS Calcd for C23H30NO [M + H]
+
:  336.23219; Found: 336.23256. 
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(2S,3S,E)-3-(allyl(benzyl)amino)-5-phenylpent-4-ene-1,2-diol (268) from (R)-2,2-
dimethyl-1,3-dioxolane-4-carbaldehyde  
(R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde (187 mg, 1.43 mmol) was dissolved in 
95% ethanol (30 mL) and with stirring 0.5 M H2SO4 (3 mL) was added.  After 10 minutes 
at rt, a check by TLC showed the reaction was complete (10% MeOH/DCM; Rf of 
acetonide = 0.60; Rf of deprotected diol = 0.19).  The pH of the solution was adjusted to 8 
using ethanolic NaOH (Note: pH is important, too basic or acidic and the yields suffer, pH 
6 no reaction occurs therefore it is important to use wet EtOH to more accurately measure 
the pH).  N-Benzylprop-2-en-1-amine 246 (210 mg, 1.43 mmol) and (E)-styrylboronic acid 
204 (210 mg, 1.42 mmol) were added and the mixture refluxed for 16 hours.  Solvent was 
removed under reduced pressure, purification by flash chromatography (0-50% ethyl 
acetate/hexane) to yield 268 as light yellow oil (122 mg, 77%).  Rf = 0.43 (50% ethyl 
acetate/hexanes).  []20D = +158 (c = 1.28 CHCl3).  IR (film)/cm
-1 
 3346, 3026, 2922, 2812, 
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1494, 1449, 1071,970, 910.  
1
H NMR (300 MHz, CDCl3):  7.46 (d, J = 7.3 Hz, 2H), 7.29-
7.40 (m, 8H), 6.59 (d, J = 15.8 Hz, 1H), 6.27 (dd, J = 15.8, 9.6 Hz, 1H), 5.82-5.95 (m, 1H), 
5.22-5.31 (m, 2H), 3.92-3.99 (m, 2H), 3.77 (dd, J = 11.1, 5.3 Hz, 1H), 3.67 (dd, J = 11.0, 
5.8 Hz, 1H), 3.41-3.47 (m, 1H), 3.39 (d, J = 13.4 Hz, 1H), 3.32 (t, J = 9.1 Hz, 1H), 3.01 
(dd, J = 13.9, 8.3 Hz, 1H).  
13
C NMR (75 MHz, CDCl3):  139.5, 138.2, 137.0, 136.4, 
129.8, 129.6, 129.5, 129.0, 128.2, 127.4, 124.1, 119.3, 70.9, 67.0, 66.9, 55.8, 54.5.  HRMS 
Calcd for C21H26NO2 [M + H]
+
:  324.19581; Found:  324.19588. 
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(2S,3S,E)-3-(allyl(benzyl)amino)-5-phenylpent-4-ene-1,2-diol (268) from R-
Glyceraldehyde   
A solution of (R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde 267 in water (80%, 450mg, 
4.00 mmol) was dissolved in absolute ethanol (50 mL), followed by the addition of N-
Benzylprop-2-en-1-amine 246 (600 mg, 4.08 mmol) and (E)-styrylboronic acid 204 (600 
mg, 4.05 mmol) were added and the mixture stirred at ambient temperature for 40 hours.  
Solvent was removed under reduced pressure to yield an oily residue. Purification by flash 
chromatography (0-20% Acetone/DCM) to yield 268 as a light yellow oil (1.00 g, 77%).  
[]20D = +157 (c = 1.01 CHCl3).  Spectral data were identical to 268 prepared from the 
acetonide protected glyceraldehyde above. 
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(2S,3R,E)-3-(Allylamino)-5-phenylpent-4-en-2-ol (270) 
(S)-2-(tert-butyldiphenylsilyloxy)propanal 253 (1.26 g, 4.03 mmol) was dissolved in 
anhydrous ethanol (20 mL) and a tetrabutylammonium fluoride solution (1.0 M in THF, 4.0 
mL, 4.0 mmol) was added.  The mixture was stirred for 5 minutes, then allylamine 203 
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(300 L, 4.00 mmol) and (E)-4,4,5,5-tetramethyl-2-styryl-1,3,2-dioxaborolane 254 (614 
mg, 4.15 mmol) were added and the mixture stirred at rt for 40 hours.  Solvent was 
removed under reduced pressure, then the resulting oil dissolved in diethyl ether (200 mL) 
and washed with water (3x100 mL), brine (50 mL) and dried (Na2SO4).  Purification by 
flash chromatography (100% benzene, then flush with EtOAc) to yield 270 as a yellow 
solid (720 mg, 83%).  []20D = -56 (c = 0.0059 CHCl3).  IR (film)/cm
-1 
 3271, 3075, 3026, 
2973, 2932, 1641, 1493, 1448, 1416, 1372, 1320, 1073, 967, 911, 743.  
1
H NMR (400 
MHz, CDCl3):  7.23-7.42 (m, 5H), 6.54 (d, J = 16.0 Hz, 1H), 6.12 (dd, J = 16.0, 8.7 Hz, 
1H), 5.85-5.98 (m, 1H), 5.20 (dd, J = 17.2, 1.2 Hz, 1H), 5.13 (dd, J = 10.2, 0.9 Hz, 1H), 
3.87-3.95 (m, 1H), 3.36 (dd, J = 14.1, 5.9 Hz, 1H), 3.12-3.26 (m, 2H), 1.16 (d, J = 6.4 Hz, 
3H).  
13
C NMR (75 MHz, CDCl3):  137.5, 134.5, 129.4, 128.5, 128.4, 127.2, 117.0, 69.2, 
66.4, 50.6, 19.5. 
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(2S,3R,E)-3-(Allylamino)-5-phenylpent-4-en-2-ol (271) 
270 (580 mg, 2.67 mmol) was dissolved in anhydrous dichloromethane (20 mL).  N,N-
diisopropylethylamine (1.4 mL, 8.0 mmol), and DMAP (31.5 mg, 0.258 mmol) were added 
to the stirred solution.  The solution was placed in an ice bath under positive pressure of 
Argon, and then benzoyl chloride (310 L, 2.67 mmol) was added dropwise.  The reaction 
mixture was allowed to stir for 16 hours during which time it warmed to ambient 
temperature.  The reaction mixture was diluted with ethyl acetate (50 mL) and hexanes (50 
mL) and washed with 1M HCl (3x30 mL), a saturated NaHCO3 solution (30 mL), and brine 
(30 mL).  The organic layer was dried using Na2SO4, filtered and solvent was removed 
under reduced pressure.  The residue was purified by flash chromatography (0-50% ethyl 
acetate in hexanes) to yield 271 was a yellow oil (609 mg, 71%).  []20D = -53 (c = 0.57 
CHCl3).  
1
H NMR (400 MHz, CDCl3):  7.31-7.57 (m, 10H), 6.75-6.90 (m, 1H), 6.57 (d, J 
= 17.1 Hz, 1H), 5.77-5.92 (m, 1H), 5.26-5.26 (m, 2H), 4.95-5.15 (m, 1H), 4.43 (s, 1H), 3.98 
(d, J = 16.4 Hz, 1H), 3.86 (d, J = 14.3 Hz, 1H), 3.78 (s, 1H), 1.20-2.31 (m, 3H). 
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(2S,3R,E)-5-phenyl-3-((S)-1-phenylbut-3-en-2-ylamino)pent-4-en-2-ol (281) 
(S)-2-(tert-butyldiphenylsilyloxy)propanal 253 (778 mg, 2.49 mmol) was dissolved in 
anhydrous ethanol (12 mL) and a tetrabutylammonium fluoride solution (1.0 M in THF, 
2.40 mL, 2.40 mmol) was added.  The mixture was stirred for 5 minutes, then (S)-1-
phenylbut-3-en-2-amine 280 (347 mg, 2.36 mmol) and (E)-styrylboronic acid 204 (360 mg, 
2.43 mmol) were added and the mixture refluxed for 24 hours.  Solvent was removed under 
reduced pressure, purification by flash chromatography (0-100% ethyl acetate/hexane) to 
yield 281 as a yellow oil (550 mg, 76%).  Rf = 0.04 (ethyl acetate).  []20D = -40 (c = 0.41 
CHCl3).  IR (film)/cm
-1 
 3060, 3026, 2970, 2926, 1601, 1494, 1453, 1075, 970, 912, 735, 
695.  
1
H NMR (300 MHz, CDCl3):  7.21-7.35 (m, 10H), 6.20 (d, J = 16.1 Hz, 1H), 5.79 
(dd, J = 16.0, 8.2 Hz, 1H), 5.68 (ddd, J = 18.4, 10.3, 8.1 Hz, 1H), 5.11-5.19 (m, 2H), 3.77-
3.83 (m, 1H), 3.43 (td, J = 8.6, 5.3 Hz, 1H), 3.29 (dd, J = 8.1, 3.3 Hz, 1H), 2.88 (dd, J = 
13.6, 5.2 Hz, 1H), 2.71 (dd, J = 13.5, 8.8 Hz, 1H), 1.06 (d, J = 6.4 Hz, 3H).  
13
C NMR (75 
MHz, CDCl3):  141.8, 139.2, 137.5, 133.4, 130.2, 129.4, 129.3, 128.7, 128.4, 127.4, 
127.1, 117.2, 70.1, 63.4, 60.4, 43.6, 19.4.  HRMS Calcd for C21H26NO [M + H]
+
:  
308.20089; Found: 308.20113. 
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6.5 Synthesis of the 3,4-Dehydroprolinols  
 
N
Bn OH
HN
Bn OH
H
Ph
255 244  
 
(S)-1-((R)-1-benzyl-2,5-dihydro-1H-pyrrol-2-yl)ethanol (244) 
To a refluxing solution of 255 (3.40 g, 11.1 mmol) in anhydrous DCM (350 mL) under 
positive pressure of Argon was added Grubb’s 2nd generation catalyst (85 mg, 0.10 mmol) 
and the mixture refluxed for 16 hours.  Added a second portion of Grubb’s 2nd generation 
catalyst (23.1mg, 0.0272 mmol) and continued to reflux for 24 additional hours.  The 
reaction was allowed to cool to ambient temperature, and quenched with ethyl vinyl ether 
(1.0 mL).  Solvent was removed under reduced pressure, redissolved in diethyl ether (50 
mL) and extracted with 1M HCl (3x20 mL).  The combined acid extracts had the pH 
adjusted to 8 using NaHCO3, then extracted with DCM (3x20 mL) and dried (Na2SO4).  
Purification by flash chromatography (10-100% ethyl acetate/hexanes) to obtain 244 as 
yellow oil (1.57 g, 70%, 79%brsm) along with unreacted 255 (410 mg, 1.33 mmol).  Rf = 
0.31 (50% ethyl acetate/hexanes).  []20D = +174 (c = 0.883 CHCl3).  IR (film)/cm
-1 
 3439. 
2972, 2871, 2791, 1495, 1453, 1364, 1276, 1053, 874.  
1
H NMR (300 MHz, CDCl3):  
7.26-7.38 (m, 5H), 5.87 (d, J = 6.1 Hz, 1H), 5.75 (d, J = 6.1 Hz, 1H), 4.09 (d, J = 13.1 Hz, 
1H), 3.60-3.88 (m, 4H), 3.25-3.32 (m, 2H), 1.25 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, 
CDCl3):  140.2, 130.0, 129.3, 129.3, 128.0, 126.7, 76.6, 66.3, 61.2, 59.1, 19.1.  HRMS 
Calcd for C13H18NO [M + H]
+
:  204.13829; Found: 204.12839. 
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N
Bn
Ph
OH
H
N
Bn
OH
H
265 266  
 
 
(S)-1-((R)-1-benzyl-2,5-dihydro-1H-pyrrol-2-yl)-2-methylpropan-1-ol  (266) 
To a refluxing solution of 265 (322 mg, 0.960 mmol) in anhydrous DCM (50 mL) under 
positive pressure of Argon was added Grubb’s 2nd generation catalyst (10.1 mg, 0.0119 
mmol) and the mixture refluxed for 16 hours.  The reaction was allowed to cool to ambient 
temperature, and quenched with ethyl vinyl ether (1.0 mL).  Solvent was removed under 
reduced pressure, purification by flash chromatography (20% ethyl acetate/hexanes) to 
obtain 266 as yellow oil (157mg, 71%).  Rf = 0.09 (20% ethyl acetate/hexane).  []20D = 
+160 (c = 0.570 CHCl3).  IR (film)/cm
-1 
 3429, 3064, 3028, 2957, 2871, 2800, 1495, 1470, 
1453, 1407, 1378, 1360, 1324, 1290, 1275, 1155, 1114, 1072, 1030, 979, 910, 864, 734, 
699.  
1
H NMR (300 MHz, CDCl3):  7.25-7.37 (m, 5H), 5.86 (dd, J = 6.5, 1.7 Hz, 1H), 
5.72-5.74 (m, 1H), 4.08 (d, J = 13.1 Hz, 1H), 3.80-3.88 (m, 2H), 3.66-3.73 (m, 1H), 3.59 
(d, J = 13.1 Hz, 1H), 3.22-3.30 (m, 1H), 3.17 (dd, J = 9.5, 3.1 Hz, 1H), 1.66-1.78 (m, 1H), 
1.13 (d, J = 6.5 Hz, 3H), 0.94 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  140.0, 
130.1, 129.4, 129.3, 128.0, 126.9, 75.7, 73.6, 60.8, 58.8, 32.2, 21.7, 18.9.  HRMS Calcd for 
C15H22NO [M + H]
+
:  232.16959; Found: 232.16954. 
 
N
Bn
Ph
OH
H
OH N
Bn
OH
H
OH
268
269  
 
(S)-1-((S)-1-benzyl-2,5-dihydro-1H-pyrrol-2-yl)ethane-1,2-diol (269) 
To a refluxing solution of 268 (630 mg, 1.95 mmol) in anhydrous DCM (100 mL) was 
added Grubb’s 2nd generation catalyst (23.3 mg, 0.0274 mmol) and the mixture was 
refluxed for 16 hours.  The catalyst was quenched with ethyl vinyl ether (0.5 mL), cooled to 
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rt and solvent was removed under reduced pressure.  Purification by flash chromatography 
(0-100% acetone/benzene) to yield 269 as an amber oil (300 mg, 70%, 81% brsm) along 
with unreacted 3c (86 mg, 0.266 mmol).  Rf 269 = 0.46 (50% acetone/benzene).  Rf 268 = 
0.83 (50% acetone/benzene).  IR (film)/cm
-1 
 3374, 3063, 3027, 2925, 2802, 1495, 1453, 
1376, 1074, 1028, 910, 734.  
1
H NMR (300 MHz, CDCl3):  7.27-7.37 (m, 5H), 5.86 (dd, J 
= 6.1, 1.6 Hz, 1H), 5.70 (dd, J = 6.0, 1.7 Hz, 1H), 4.19 (d, J = 13.1 Hz, 1H), 3.93 (s, 1H), 
3.82 (dd, J = 12.0, 5.4 Hz, 1H), 3.72-3.76 (m, 3H), 3.63 (d, J = 13.1 Hz, 1H), 3.20-3.29 (m, 
3H).  
13
C NMR (75 MHz, CDCl3):  139.7, 129.8, 129.4, 129.4, 128.1, 127.8, 75.1, 71.9, 
64.9, 61.1, 60.8.  HRMS Calcd for C13H18NO2 [M + H]
+
:  220.13321; Found:  220.13344. 
 
N
Bn
OH
H
OH
N
Bn
OH
269 236  
 
(S)-(1-benzyl-2,5-dihydro-1H-pyrrol-2-yl)methanol (236 from 269, >99% ee) 
To a solution of 269 (100 mg, 0.456 mmol) in ethanol/water (80/20, 5 mL) chilled with an 
ice bath was added Sodium metaperiodate (99.7 mg, 0.466 mmol) and the reaction 
progression monitored by TLC (20% acetone/DCM).  After 15 minutes the ice bath was 
removed and the mixture allowed to warm to ambient temperature.  After an additional 30 
minutes the reaction was complete by TLC, so the mixture was again chilled with an ice 
bath, and Sodium borohydride (29.5 mg, 0.780 mmol) was added to the stirred cold 
mixture.  The mixture was stirred for 16 hours slowly warming to ambient temperature, 
then diluted with ethyl acetate and washed with Sat. NaHCO3, Brine and dried (Na2SO4). 
Purification by column chromatography (0-25% acetone/hexanes) to obtain 236 as a light 
yellow oil (61 mg, 71%, >99% ee). The enantiomeric excess was determined by SFC 
analysis on a chiral stationary phase (Chiralpak OD-H 25 cm, 4% MeOH, 4mL/min, 45°C, 
150bar, 210 nm, t
r 
(major) 3.3 min, t
r 
(minor) 3.9 min.  Rf = 0.25 (25% acetone/hexanes).  
Spectra were identical to that made from L-trans-4-Hydroxyproline (section 6.3). 
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N
H
Ph
OH
H
Ph
N
Ph
OH
H
Ph Bn
283281  
((2S,3R,E)-3-(benzyl((S)-1-phenylbut-3-en-2-yl)amino)-5-phenylpent-4-en-2-ol (283) 
281 (280 mg, 0.911 mmol) was dissolved in acetonitrile (20 mL), then N,N-
diisopropylethylamine (0.5 mL, 2.87 mmol) and benzyl bromide (210 L, 1.77 mmol) were 
added.  After stirring at ambient temperature for 16 hours no reaction occurred.  
Tetrabutylammonium iodide (70.9 mg, 0.192 mmol) was added and the mixture refluxed 
for 16 hours – no reaction occurred.  The solvent was removed under reduced pressure and 
the oily residue dissolved in N,N-dimethylformamide (20 mL).  This solution was heated at 
100°C for 48 hours.  The reaction was incomplete, allowed to cool to ambient temperature.  
The mixture was diluted with diethyl ether (300 mL) and washed with a Sat. NaHCO3 
solution (3x50 mL) and brine (50 mL).  The organic layer was dried using Na2SO4, filtered 
and solvent removed under reduced pressure.  Purification by flash chromatography (0-
100% ethyl acetate/hexanes) to obtain 283 as a yellow oil (36 mg, 9%) along with 
unreacted 281 (165 mg).  
1
H NMR (400 MHz, CDCl3):  7.14-7.45 (m, 15H), 6.48 (d, J = 
16.0 Hz, 1H), 6.31 (dd, J = 16.0, 9.5 Hz, 1H), 6.00 (ddd, J = 17.3, 10.2, 8.0 Hz, 1H), 5.16 
(d, J = 10.5 Hz, 1H), 4.99 (d, J = 17.2 Hz, 1H), 4.06 (d, J = 14.5 Hz, 1H), 3.87 (t, J = 6.2 
Hz, 1H), 3.67-3.78 (m, 2H), 3.24 (dd, J = 9.4, 6.0 Hz, 1H), 3.04 (dd, J = 13.7, 6.9 Hz, 1H), 
2.89 (dd, J = 13.8, 7.7 Hz, 1H), 1.06 (d, J = 6.3 Hz, 3H).   
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N
H
OH
H
Ph
284
N
H
Ph
OH
H
Ph
281  
(S)-1-((2R,5S)-5-benzyl-2,5-dihydro-1H-pyrrol-2-yl)ethanol (284) 
To a refluxing solution of 281 (89.0 mg, 0.289 mmol) in anhydrous DCM (50 mL) was 
added Tosic acid monohydrate (56.3 mg, 0.296 mmol), and 15 minutes later Grubb’s 2nd 
generation catalyst (12.1 mg, 0.0143 mmol) was added.  The red mixture was refluxed for 
16 hours.  The catalyst was quenched by adding ethyl vinyl ether (1.0 mL), and solvent was 
removed under reduced pressure.  Purification by flash chromatography (0-100% ethyl 
acetate/hexane then 0-10% methanol/ethyl acetate) to yield 284 as an off-white solid (40 
mg, 68%).  Rf = 0.10 (ethyl acetate).  mp = 99-110 °C.  []20D = +326 (c = 0.050 CHCl3).  
IR (film)/cm
-1 
 3272, 3084, 2847, 1676, 1495, 1454, 1367, 1202, 1140, 1071, 911, 789, 735, 
699.  
1
H NMR (300 MHz, CDCl3):  7.19-7.34 (m, 5H), 5.90 (d, J = 5.9 Hz, 1H), 5.77 (d, J 
= 5.9 Hz, 1H), 4.29 (q, J = 6.5 Hz, 1H), 4.11 (s, 1H), 3.62-3.70 (m, 1H), 2.79 (qd, J = 13.5, 
6.8 Hz, 2H), 2.55 (bs, 2H), 1.16 (d, J = 6.4 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.2, 
134.8, 130.0, 129.4, 127.7, 127.3, 70.2, 69.5, 67.4, 44.1, 19.3.  HRMS Calcd for C13H18NO 
[M + H]
+
:  204.13829; Found:  204.13823. 
 
 
N
OH
H
Ph
Bn
N
H
OH
H
Ph
284 259  
(S)-1-((2R,5S)-1,5-dibenzyl-2,5-dihydro-1H-pyrrol-2-yl)ethanol (259) 
To a stirred solution of acetone (10 mL) was added 284 (40 mg, 0.197 mmol), K2CO3 (83 
mg, 0.600 mmol), and benzyl bromide (125 µL, 1.05 mmol).  The mixture was stirred at rt 
for 16 hours, filtered and solvent removed under reduced pressure.  Purification by flash 
chromatography (10% ethyl acetate/hexane) to yield 259 as a white solid (45 mg, 77%).  Rf 
= 0.10 (10% ethyl acetate/hexanes).  []20D = +240 (c = 0.395 CHCl3).  IR (film)/cm
-1 
 
3026, 2868, 1494, 1453, 1378, 1289, 1127, 1075, 1053, 909, 734, 700.  
1
H NMR (300 
MHz, CDCl3):  7.31-7.49 (m, 5H), 7.13-7.24 (m, 3H), 6.92 (d, J = 7.2 Hz, 2H), 5.75-5.81 
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(m, 2H), 3.99-4.14 (m, 3H), 3.91 (q, J = 6.6 Hz, 1H), 3.79 (s, 1H), 3.09-3.16 (m, 2H), 2.39 
(t, J = 11.4 Hz, 1H), 1.25 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  140.3, 139.6, 
135.6, 129.9, 129.4, 129.1, 128.9, 127.9, 126.8, 126.5, 74.1, 68.5, 65.1, 51.2, 38.6, 19.4.  
HRMS Calcd for C20H24NO [M + H]
+
:  294.18524; Found:  294.18535. 
 
NH2
Ph
O
O
H
Ph
B
OH
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N
H
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OH
H
N
H
OH
H
TBDPS
Ph
Ph
not isolated
TBAF
279
204
253
285
286
 
(S)-1-((2R,5R)-5-benzyl-2,5-dihydro-1H-pyrrol-2-yl)ethanol (286) 
(S)-2-(tert-butyldiphenylsilyloxy)-propanal 253 (556 mg, 1.78 mmol) was dissolved in 
anhydrous ethanol (20 mL) and a tetrabutylammonium fluoride solution (1.0 M in THF, 
1.76 mL, 1.76 mmol) was added.  The mixture was stirred for 5 minutes, then (R)-1-
phenylbut-3-en-2-amine 279 (290 mg, 1.97 mmol) and (E)-styrylboronic acid 204 (261 mg, 
1.76 mmol) were added and the mixture refluxed for 16 hours.  Solvent was removed under 
reduced pressure, and the oily residue was redissolved in anhydrous DCM (100 mL).  To 
the stirred mixture was added Tosic acid monohydrate (710mg, 3.73 mmol).  The mixture 
was refluxed for 30 minutes, then to the refluxing mixture was added Grubb’s 2nd 
generation catalyst (90 mg, 0.106 mmol) and the mixture refluxed for another 16 hours.  
The reaction was allowed to cool to rt, quenched with ethyl vinyl ether (1.0 mL) and 
solvent removed under reduced pressure.  Purification by flash chromatography (0-20% 
THF/hexane) to yield 286 as an off-white solid (122 mg, 35%).  Rf = 0.08 (20% 
THF/hexanes).  mp = 87 °C.  []20D = +101 (c = 0.717 CHCl3).  IR (film)/cm
-1 
 3286, 3059, 
3024, 2974, 2919, 2853, 2810, 1602, 1543, 1495, 1453, 1400, 1374, 1246, 1152, 1088, 996, 
951, 909, 734, 701.  
1
H NMR (300 MHz, CDCl3):  7.21-7.34 (m, 5H), 5.85 (d, J = 5.8 Hz, 
1H), 5.73-5.75 (m, 1H), 4.34-4.38 (m, 1H), 4.09 (s, 1H), 3.53-3.60 (m, 1H), 2.80 (qd, J = 
13.1 Hz, 6.0 Hz, 2H), 2.49 (bs, 2H), 1.18 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): 
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 140.0, 134.6, 130.3, 129.1, 127.6, 127.0, 70.9, 68.5, 66.7, 45.2, 19.1.  HRMS Calcd for 
C13H18NO [M + H]
+
:  204.13829; Found:  204.13831. 
N
H
OH
H
Ph
N
OH
H
Ph
Bn
286 258  
 
(S)-1-((2R,5R)-1,5-dibenzyl-2,5-dihydro-1H-pyrrol-2-yl)ethanol (258) 
To a stirred solution of acetone (10 mL) was added 286 (60 mg, 0.295 mmol), K2CO3 
(103.5 mg, 0.750 mmol), and benzyl bromide (125 µL, 1.05 mmol).  The mixture was 
stirred at rt for 16 hours, filtered and solvent removed under reduced pressure.  Purification 
by flash chromatography (10% ethyl acetate/hexane) to yield 258 as a yellow oil (40 mg, 
69%).  Rf = 0.11 (10% ethyl acetate/hexanes).  []20D = +14 (c = 0.559 CHCl3).  IR 
(film)/cm
-1 
 3456, 3062, 3026, 2972, 2924, 2808, 1602, 1494, 1453, 1325, 1260, 1124, 
1076, 1051, 910.  
1
H NMR (300 MHz, CDCl3):  7.18-7.39 (m, 8H), 7.09 (d, J = 7.2 Hz, 
2H), 5.74 (d, J = 6.3 Hz, 1H), 5.64 (d, J = 6.2 Hz, 1H), 4.01-4.06 (m, 1H), 3.90 (s, 2H), 
3.69-3.73 (m, 1H), 3.34 (qd, J = 6.4, 2.6 Hz, 1H), 2.79 (bs, 1H), 2.75 (dd, J = 13.3, 4.5 Hz, 
1H), 2.55 (dd, J = 13.2, 7.9 Hz, 1H), 1.09 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): 
 139.7, 139.2, 133.1, 130.5, 130.1, 129.4, 129.1, 128.2, 127.1, 126.1, 73.7, 66.4, 59.0, 
43.5, 25.7, 18.8.  HRMS Calcd for C20H24NO [M + H]
+
:  294.18524; Found:  294.18544. 
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6.6 General Ring Expansion Protocol  
A flask containing the pyrrolinol (1.0 equiv) and proton sponge (1.2 equiv) dissolved in 
anhydrous DCM under positive pressure of Argon was chilled with a cryostat bath (˗15 °C).  
To this solution was added triflic anhydride (1.1 equiv) via syringe causing the yellow 
solution to become orange.  5 minutes later the solution containing the nucleophile was 
cannulated to the aziridinium solution or added as a solid.  The mixture was stirred for 1 
hour, then allowed to warm to ambient temperature.  The solution was diluted with water 
(20 mL) and extracted with DCM (2x20 mL) and the combined extracts dried (Na2SO4).  
Purification by flash chromatography.  
 
Note: when 236 is referenced as a starting material in this section it was prepared from L-4-
trans-Hydroxproline, and is 94% ee. 
 
(R)-1-benzyl-N-methyl-N-phenyl-1,2,3,6-tetrahydropyridin-3-amine 
(304) 
Following the general protocol with 236 and N-Methylaniline (1.2 equiv) 
added in one portion via syringe.  Analyzed by 
1
H NMR by comparison 
to 1,3,5-Trimethoxybenzene for yield  (>99%).  Rf = 0.06 (chloroform).  IR (film)/cm
-1 
 
3027, 2928, 2802, 1598, 1503, 1453, 1397, 1358, 1311, 1289, 1219, 1106, 1029, 990, 910, 
734, 697.  
1
H NMR (300 MHz, CDCl3):  7.21-7.34 (m, 7H), 6.79 (d, J = 8.1 Hz, 2H), 6.71 
(t, J = 7.2 Hz, 1H), 5.90-5.98 (m, 1H), 5.76 (d, J = 10.0 Hz, 1H), 4.63 (s, 1H), 3.61 (s, 2H), 
2.89-3.05 (m, 6H), 2.50 (dd, J = 11.1, 7.1 Hz, 1H).  
13
C NMR (75 MHz, CDCl3):  150.4, 
138.8, 130.1, 129.8, 129.4, 129.1, 128.2, 128.0, 117.3, 113.4, 63.6, 54.9, 53.6, 53.0, 34.0.  
HRMS Calcd for C19H22N2 [M + H]
+
:  279.18558; Found: 279.18558. 
 
 
(S)-dimethyl 2-(1-benzyl-1,2,3,6-tetrahydropyridin-3-yl)malonate-
dimethyl (309) 
Following the general protocol with 236 and the sodium malonate 
solution prepared by: NaH (2.6 equiv) was dissolved in anhydrous THF, 
the solution chilled with a cryostat bath (˗15 °C) under positive pressure of argon.  Then 
N
OO
O
O
Bn
N
Bn
N
 
130 
dimethylmalonate (3.5 equiv) was added dropwise to the stirred solution (effervescence).  
Purified by flash chromatography (CHCl3) to obtain 309 as a yellow oil (87%, 94% ee).  
The enantiomeric excess was determined by SFC analysis on a chiral stationary phase  and 
found to be the same as that of the precursor 236 (Chiralpak AD-H 25 cm, 7% MeOH, 
5mL/min, 45°C, 150bar, 210 nm, t
r 
(major) 3.3 min, t
r 
(minor) 4.2 min.  Rf = 0.09 
(chloroform).  IR (film)/cm
-1 
 3031, 2951, 2805, 1752, 1735, 1435, 1335, 1246, 1152, 1027.  
1
H NMR (300 MHz, CDCl3):  7.23-7.32 (m, 5H), 5.79 (d, J = 10.1 Hz, 1H), 5.63-5.67 (m, 
1H), 3.74 (s, 3H), 3.68 (d, J = 10.1 Hz, 1H), 3.58-3.61 (m, 4H), 3.45 (d, J = 13.0 Hz, 1H), 
3.12 (dt, J = 16.6, 1.6 Hz, 1H), 2.94-2.97 (m, 1H), 2.86 (dq, J = 16.6, 2.2 Hz, 1H), 2.50 (d, J 
= 3.9 Hz, 2H).  
13
C NMR (75 MHz, CDCl3):  169.8, 169.7, 139.1, 129.9, 129.2, 129.0, 
127.8, 126.2, 63.2, 56.0, 54.0, 53.3, 53.2, 53.1, 37.9.  HRMS Calcd for C17H22NO4 [M + 
H]
+
:  304.15433; Found: 304.15462. 
 
 
 
 
 
(R)-N-(1-benzyl-1,2,3,6-tetrahydropyridin-3-yl)-2,2,2-
trifluoroacetamide (310) 
Following the general protocol with 236 and the sodium amide solution 
prepared by: NaH (2.7 equiv) was dissolved in anhydrous THF, the solution chilled with a 
cryostat bath (˗15 °C) under positive pressure of argon.  Then Trifluoroacetamide (3.9 
equiv) was added dropwise to the stirred solution (effervescence).  Purified by flash 
chromatography (CHCl3), then once more (20% ethyl acetate/hexane) to obtain 310 as a 
colourless oil (69%, 94% ee).  The enantiomeric excess was determined by SFC analysis on 
a chiral stationary phase to be the same as the precursor 236 (Chiralpak AD-H 25 cm, 7% 
N
H
N CF3
O
Bn
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MeOH, 5mL/min, 45°C, 150bar, 210 nm, t
r 
(major) 2.3 min, t
r 
(minor) 2.7 min.  Rf = 0.11 
(chloroform).  IR (film)/cm
-1 
 3301, 3032, 2922, 2806, 1707, 1526, 1455, 1360, 1276, 1159, 
1063, 1028, 871, 737, 699.  
1
H NMR (300 MHz, CDCl3):  7.27-7.37 (m, 5H), 6.78 (bs, 
1H), 5.97 (ddd, J = 10.0, 4.1, 1.7 Hz, 1H), 5.77-5.82 (m, 1H), 4.47 (bs, 1H), 3.72 (d, J = 
13.1 Hz, 1H), 3.52 (d, J = 13.0 Hz, 1H), 3.27 (dd, J = 17.2, 3.7 Hz, 1H), 2.89 (dq, J = 
17.0,1.7 Hz, 1H), 2.73 (d, J = 11.7 Hz, 1H), 2.49 (dd, J = 11.7, 2.9 Hz, 1H).  
13
C NMR (75 
MHz, CDCl3):  157.1, 138.4, 131.8, 129.6, 128.4, 124.3, 118.6, 62.7, 59.3, 54.8, 53.7, 
45.7.  HRMS Calcd for C14H16F3N2O [M + H]
+
:  285.12092; Found: 285.12112. 
 
 
 
(R)-1-benzyl-3-phenoxy-1,2,3,6-tetrahydropyridine (311)  
Following the general protocol with 236 and the phenoxide solution 
prepared by dissolving sodium phenoxide (3.2 equiv) in anhydrous DME 
(5 mL), the solution chilled with a cryostat bath (˗15 °C) under positive pressure of argon.  
Then the phenoxide solution was added by cannula to the aziridinium solution.  Purified by 
flash chromatography (CHCl3) to obtain 311 as a colourless oil (97%, 94% ee).  The 
enantiomeric excess was determined by SFC analysis on a chiral stationary phase to be the 
same as the precursor 236 (Chiralpak AD-H 25 cm, 7% MeOH, 5mL/min, 45°C, 150bar, 
210 nm, t
r 
(minor) 8.3 min, t
r 
(major) 10.0 min.  Rf = 0.16 (chloroform).  IR (film)/cm
-1 
 
3709, 3680, 2922, 2865, 2821, 1597, 1585, 1492, 1454, 1398, 1289, 1238, 1173, 1053, 
1033, 1017, 752, 735, 691.  
1
H NMR (300 MHz, CDCl3):  7.25-7.38 (m, 7H), 6.91-6.97 
(m, 3H), 5.93-6.01 (m, 2H), 4.92 (s, 1H), 3.71 (d, J = 13.2 Hz, 1H), 3.64 (d, J = 13.2 Hz, 
1H), 3.07 (s, 2H), 2.95 (dd, J = 11.4, 4.8 Hz, 1H), 2.70 (dd, J = 11.3, 6.1 Hz, 1H).  
13
C 
NMR (75 MHz, CDCl3):  158.5, 138.5, 130.7, 130.4, 129.9, 129.1, 128.0, 125.8, 121.7, 
N
Bn
O
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116.6, 71.5, 63.1, 54.9, 53.3.  HRMS Calcd for C18H20NO [M + H]
+
:  266.15394; Found: 
266.15392. 
 
 
 
 
anti-dimethyl 2-(-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridin-3-
yl)malonate (312) 
Following the general protocol with 244 and the sodium malonate 
solution prepared by: NaH (2.6 equiv) was dissolved in anhydrous THF, 
the solution chilled with a cryostat bath (˗15 °C) under positive pressure 
of argon.  Then dimethylmalonate (3.5 equiv) was added dropwise to the stirred solution 
(effervescence).  Purified by flash chromatography (CHCl3) to obtain 312 as a yellow oil 
(71%).  Rf = 0.11 (chloroform).  IR (film)/cm
-1 
 2952, 1732, 1660, 1434, 1261, 1237, 1194, 
1148, 1028, 1007, 732, 700.  
1
H NMR (300 MHz, CDCl3):  7.23-7.33 (m, 5H), 5.78 (d, J = 
10.2 Hz, 1H), 5.53-5.59 (m, 1H), 3.85 (d, J = 10.6 Hz, 1H), 3.73 (s, 3H), 3.57 (s, 3H), 3.56 
(d, J = 10.6 Hz, 2H), 3.13 (d, J = 17.5 Hz, 1H), 2.89 (dq, J = 17.5, 2.2 Hz, 1H), 2.73 (q, J = 
6.4 Hz, 1H), 2.62-2.68 (m, 1H), 0.98 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  
169.1, 139.0, 128.9, 128.2, 128.1, 126.9, 123.1, 58.9, 56.1, 52.3, 52.3, 52.3, 52.0, 47.4, 
41.9, 8.7.  HRMS Calcd for C14H16N2 [M + H]
+
:  318.16998; Found: 318.17018. 
 
anti-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridine-3-deuteride (315) 
Following the general protocol with 244; NaBD4 (2.5 equiv), and 15-Crown-5 
(2.5 equiv), added as a solid and via syringe respectively as the nucleophile.  
Purified by flash chromatography (5% methanol/CHCl3) to obtain 315 as a yellow oil 
(77%).  Rf = 0.59 (5% methanol/chloroform).  IR (film)/cm
-1 
 3028, 2962, 2922, 2791, 
N
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O O
O
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1659, 1493, 1453, 1368, 1329, 1259, 1145, 1071, 1027, 996, 722, 696, 636.  
1
H NMR (300 
MHz, CDCl3):  7.22-7.38 (m, 5H), 5.69-5.75 (m, 1H), 5.60-5.65 (m, 1H), 3.82 (d, J = 13.2 
Hz, 1H), 3.48 (d, J = 13.1 Hz, 1H), 2.99 (qq, J = 14.4, 2.5 Hz, 2H), 2.91 (t, J = 6.0 Hz, 1H), 
1.88 (s, 1H), 1.11 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.4, 128.9, 128.2, 
126.8, 125.0, 124.0, 70.7, 57.9, 51.0, 48.9, 32.3 (t, J = 19.4 Hz, 1C), 14.5.  HRMS Calcd for 
C13H16DN [M + H]
+
:  189.14965; Found: 189.14959. 
 
 
anti-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridine-3-carbonitrile (316) 
Following the general protocol with 244 and Bu4NCN (2.5 equiv), added as a 
solid.  Purified by flash chromatography (CHCl3) to obtain 316 as a yellow oil 
(79%).  Rf = 0.26 (chloroform).  IR (film)/cm
-1 
 3029, 2973, 2928, 2805, 2235, 1494, 1453, 
1373, 1361, 1261, 1199, 1147, 1135, 1071, 1002, 770, 733, 698.  
1
H NMR (300 MHz, 
CDCl3):  7.25-7.43 (m, 5H), 5.91-5.96 (m, 1H), 5.65-5.71 (m, 1H), 3.76 (d, J = 13.3 Hz, 
1H), 3.62 (d, J = 13.3 Hz, 1H), 3.25-3.33 (m, 1H), 3.13-3.21 (m, 1H), 2.96-3.03 (m, 2H), 
1.13 (d, J = 6.6 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  138.2, 129.9, 128.6, 128.4, 127.2, 
120.4, 117.7, 57.4, 53.4, 47.5, 33.7, 11.3.  HRMS Calcd for C14H16N2 [M + H]
+
:  
213.13862; Found: 213.13860. 
 
 
anti-Dimethyl 2-(1-benzyl-2-isopropyl-1,2,3,6-tetrahydropyridin-3-
yl)malonate (317) 
Following the general protocol with 244 and the sodium malonate 
solution prepared by: NaH (2.6 equiv) was dissolved in anhydrous THF, 
the solution chilled with a cryostat bath (˗15 °C) under positive pressure 
of argon.  Then dimethylmalonate (3.5 equiv) was added dropwise to the stirred solution 
(effervescence). Purified by flash chromatography (CHCl3), then once more (10% ethyl 
acetate/hexane) to obtain 317 as a colourless oil (73%).  Rf = 0.24 (10% ethyl 
acetate/hexane).  IR (film)/cm
-1 
 2953, 1752, 1733, 1453, 1434, 1254, 1193, 1155, 1026, 
914.  
1
H NMR (400 MHz, CDCl3):  7.31-7.36 (m, 4H), 7.23-7.27 (m, 1H), 5.76 (ddd, J = 
10.2, 3.4, 2.0 Hz, 1H), 5.60-5.66 (m, 1H), 3.91 (d, J = 10.8 Hz, 1H), 3.86 (d, J = 5.1 Hz, 
1H), 3.78 (s, 1H), 3.76 (s, 3H), 3.68 (s, 3H), 3.21 (dq, J = 17.7, 2.2 Hz, 1H), 3.11 (d, J = 
N
Bn
O
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17.6 Hz, 1H), 2.97 (ddd, J = 9.4, 5.4, 1.2 Hz, 1H), 2.36 (d, J = 7.3 Hz, 1H), 2.09-2.17 (m, 
1H), 1.05 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 6.7 Hz, 3H).  
13
C NMR (100 MHz, CDCl3):  
170.1, 170.0, 140.9, 129.6, 129.5, 129.1, 127.7, 124.9, 65.6, 61.7, 57.7, 53.2, 53.2, 47.5, 
38.5, 28.8, 23.5, 22.3.  HRMS Calcd for C20H28NO4 [M + H]
+
:  346.20128; Found: 
346.20157. 
 
Dimethyl 2-((2R,3R,6S)-1,6-dibenzyl-2-methyl-1,2,3,6-
tetrahydropyridin-3-yl)malonate (318) 
Following the general protocol with 259 and the sodium 
malonate solution prepared by: NaH (2.6 equiv) was dissolved 
in anhydrous THF, the solution chilled with a cryostat bath 
(˗15 °C) under positive pressure of argon.  Then dimethylmalonate (3.5 equiv) was added 
dropwise to the stirred solution (effervescence).  Purified by flash chromatography (CHCl3) 
to obtain 318 as a colourless oil (89%).  Rf = 0.19 (chloroform).  []20D = 92.6 (c = 1.50, 
CHCl3).  IR (film)/cm
-1 
 3026, 2952, 1732, 1601, 1494, 1452, 1433, 1262, 1235, 1192, 
1150, 1074, 1024, 994, 973, 913, 727, 699.  
1
H NMR (300 MHz, CDCl3):  7.34-7.41 (m, 
5H), 7.23-7.26 (m, 2H), 7.15-7.19 (m, 1H), 7.00 (d, J = 8.8 Hz, 2H), 5.66 (dd, J = 10.2, 3.3 
Hz, 1H), 5.52-5.58 (m, 1H), 4.05 (d, J = 13.3 Hz, 1H), 3.84 (d, J = 13.2 Hz, 1H), 3.71 (s, 
3H), 3.68 (d, J = 10.9 Hz, 1H), 3.55 (s, 3H), 3.52 (bs, 1H), 3.29 (dd, J = 12.7, 3.5 Hz, 1H), 
2.83 (q, J = 6.7 Hz, 1H), 2.71 (dd, J = 10.6, 5.7 Hz, 1H), 2.45 (t, J = 12.0 Hz, 1H), 1.20 (d, 
J = 6.6 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  169.9, 141.0, 140.1, 131.8, 130.0, 129.9, 
129.2, 129.1, 127.8, 126.7, 122.8, 59.9, 56.8, 56.5, 53.2, 53.1, 52.6, 41.9, 38.4, 17.2.  
HRMS Calcd for C25H30NO4 [M + H]
+
:  408.21693; Found: 408.21723. 
 
 
Dimethyl 2-((2R,3R,6R)-1,6-dibenzyl-2-methyl-1,2,3,6-
tetrahydropyridin-3-yl)malonate (319)  
Following the general protocol with 258 and the sodium 
malonate solution prepared by: NaH (2.6 equiv) was dissolved 
in anhydrous THF, the solution chilled with a cryostat bath 
(˗15 °C) under positive pressure of argon.  Then dimethylmalonate (3.5 equiv) was added 
dropwise to the stirred solution (effervescence).  Purified by flash chromatography (CHCl3) 
N
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to obtain 319 as a yellow oil (81%).  Rf = 0.25 (chloroform).  []20D = -46.7 (c = 2.25, 
CHCl3).  IR (film)/cm
-1 
 3027, 2950, 2848, 1751, 1735, 1494, 1453, 1434, 1324, 1295, 
1265, 1238, 1151, 1027, 910, 733, 700.  
1
H NMR (300 MHz, CDCl3):  7.22-7.37 (m, 
10H), 5.69 (dd, J = 10.1, 1.9 Hz, 1H), 5.59 (dd, J = 9.8, 5.4 Hz, 1H), 4.14 (d, J = 13.7 Hz, 
1H), 3.74 (s, 3H), 3.64 (d, J = 10.6 Hz, 1H), 3.46 (d, J = 13.7 Hz, 1H), 3.44 (s, 3H), 3.28-
3.31 (m, 1H), 3.19 (dd, J = 13.6, 3.6 Hz, 1H), 2.70 (dd, J = 13.7, 8.8 Hz, 1H), 2.58-2.70 (m, 
2H), 1.02 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  169.8, 169.8, 140.4, 139.6, 
132.8, 130.6, 129.5, 129.0, 128.9, 127.5, 127.0, 123.9, 58.7, 56.2, 54.4, 53.2, 53.1, 50.7, 
41.9, 41.0, 10.9.  HRMS Calcd for C25H30NO4 [M + H]
+
:  408.21693; Found: 408.21817. 
 
anti-2-(-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridin-3-yl)-1-
phenylethanone (321) 
Following the general protocol with 244 and the 1-(1-
phenylvinyl)pyrrolidine solution prepared by a previously published 
method
98
 was added in one portion.  Purified by flash chromatography (CHCl3) to obtain 
321 as a yellow oil (81%).  Rf = 0.22 (chloroform).  IR (film)/cm
-1 
 3027, 2964, 2873, 2751, 
1682, 1597, 1580, 1493, 1448, 1358, 1268, 1204, 1132, 1000, 909, 729, 690.  
1
H NMR 
(300 MHz, CDCl3):  7.96-8.00 (m, 2H), 7.54-7.60 (m, 1H), 7.44-7.49 (m, 2H), 7.29-7.33 
(m, 2H), 7.13-7.22 (m, 3H), 5.66-5.76 (m, 2H), 3.59 (s, 2H), 3.44 (dd, J = 17.3, 8.2 Hz, 
1H), 3.07-3.14 (m, 1H), 3.07 (dd, J = 17.3, 5.1 Hz, 1H), 2.92 (d, J = 17.3 Hz, 1H), 2.78 (q, 
J = 6.6 Hz, 1H), 2.59-2.66 (m, 1H), 1.02 (d, J = 6.6 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): 
 200.6, 139.8, 137.8, 133.2, 128.9, 128.8, 128.5, 128.4, 127.4, 127.1, 125.9, 59.3, 54.6, 
47.6, 43.9, 38.5, 9.8.  HRMS Calcd for C21H24NO [M + H]
+
:  306.18524; Found: 
306.18534. 
 
324a, 324b, 324c 
Following the general protocol with 236 and 
the cuprate solution prepared as follows: a 
suspension of CuCN (15.3 mg, 0.171 mmol) 
in anhydrous THF (3 mL) chilled with a dry ice/acetone bath was added an 
Isopropylmagnesium chloride solution in THF (1.40M, 125 µL, 0.175 mmol).  The 
suspension was allowed to warm to rt, becoming an opaque black suspension, then chilled 
N
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with a cryostat bath (-15 °C). The aziridinium solution was cannulated to the cuprate 
solution since the cuprate solution was too thick to cannulate.  Purification by flash 
chromatography (CHCl3, a second with 10% THF/hexanes was done to separate 324a from 
324b and 324c but they did not fully separate) to yield a mixture of 324a, 324b, 324c as a 
light yellow oil (78% total yield, 30:90:1 ratio of 324a:324b:324c).  Note: when repeated at 
˗78 °C a ratio of 18:1 324a:324b was obtained.  Rf = 0.15 (CHCl3), 324a, 324b, and 324c 
co-elute.   
324a: IR (film)/cm
-1 
 3027, 2959, 2929, 2871, 2800, 2750, 1493, 1454, 1368, 1151, 1123, 
1072, 1028, 998, 909, 728, 698.  
1
H NMR (700 MHz, CDCl3):  7.41-7.47 (m, 2H), 7.34-
7.38 (m, 2H), 7.27-7.30 (m, 1H), 5.75-5.77 (m, 1H), 5.65-5.75 (m, 1H), 3.71 (d, J = 13.3 
Hz, 1H), 3.63 (d, J = 13.3 Hz, 1H), 3.08 (d, J = 17.2 Hz, 1H), 2.94 (dq, J = 17.1, 2.2 Hz, 
1H), 2.81 (qd, J = 6.5, 2.0 Hz, 1H), 1.74 (bs, 1H), 1.55-1.66 (m, 2H), 1.02 (d, J = 6.6 Hz, 
3H), 0.92 (t, J = 7.4 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  140.2, 129.0, 128.5, 128.4, 
127.0, 124.6, 58.9, 54.1, 48.2, 44.7, 27.9, 12.3, 11.0.  HRMS Calcd for C15H21N [M + H]
+
:  
216.17468; Found:  216.17442. 
324b:  
1
H NMR (700 MHz, CDCl3):  7.41-7.47 (m, 2H), 7.34-7.38 (m, 2H), 7.27-7.30 (m, 
1H), 5.75-5.77 (m, 1H), 5.62 (ddd, J = 10.0, 3.2, 1.9 Hz, 1H), 3.92 (d, J = 13.7 Hz, 1H), 
3.51 (d, J = 13.7 Hz, 1H), 3.18-3.20 (m, 1H), 2.59 (dd, J = 11.9, 6.3 Hz, 1H), 2.53 (dd, J = 
11.9, 4.9 Hz, 1H), 2.09 (bs, 1H), 1.36-1.46 (m, 2H), 1.19 (d, J = 6.6 Hz, 3H), 0.88 (t, J = 
7.4 Hz, 3H).  
13
C NMR (125 MHz, CDCl3):  132.0, 129.1, 128.8, 128.2, 128.2, 126.8, 
59.3, 55.2, 51.1, 37.0, 27.4, 19.0, 12.4. 
324c:  
1
H NMR (700 MHz, CDCl3):  7.27-7.44 (m, 5H), 5.67-5.70 (m, 1H), 5.55 (dt, J = 
9.9, 2.2 Hz, 1H), 4.08 (d, J = 13.7 Hz, 1H), 3.35 (d, J = 13.8 Hz, 1H), 3.04 (s, 1H), 2.90 
(dd, J = 11.2, 4.9 Hz, 1H), 2.20 (s, 1H), 1.94 (dd, J = 11.1, 9.5 Hz, 1H), 1.29 (d, J = 6.6 Hz, 
3H), 1.26-1.46 (m, 2H), 0.89 (t, J = 7.5 Hz, 3H). 
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1-benzyl-3-ethyl-1,2,3,6-tetrahydropyridine (325) 
The cuprate solution was prepared as follows: a suspension of CuCN (48.5 
mg, 0.542 mmol) in anhydrous THF (5 mL) chilled with a dry ice/acetone bath 
was added an ethylmagnesium chloride solution in ether (1.05 M, 0.500 mL, 0.675mmol).  
The suspension was allowed to warm to rt, becoming an opaque black suspension, then 
chilled with a cryostat bath (-15 °C). 
To a solution containing 236 (25.8 mg, 0.136 mmol) and proton sponge (37.1 mg, 0.173 
mmol) dissolved in anhydrous DCM (5 mL) under positive pressure of Argon was chilled 
with a cryostat bath (˗15 °C).  To this solution was added triflic anhydride (25 µL, 0.15 
mmol) via syringe causing the yellow solution to become orange.  5 minutes after the triflic 
anhydride addition the solution containing the aziridinium was cannulated to the cuprate 
solution.  The mixture was stirred for 15 minutes, then allowed to warm to ambient 
temperature.  Purification by flash chromatography (CHCl3) to yield 325 as a light yellow 
film (20 mg, 73%).  Rf = 0.05 (CHCl3).  IR (film)/cm
-1 
 3027, 2959, 2922, 2859, 2792, 
2748, 1664, 1493, 1454, 1362, 1152, 1126, 1028, 978, 909, 861, 728, 698.  
1
H NMR (300 
MHz, CDCl3):  7.24-7.38 (m, 5H), 5.63-5.75 (m, 2H), 3.62 (d, J = 13.1 Hz, 1H), 3.57 (d, J 
= 13.1 Hz, 1H), 3.07 (d, J = 16.7 Hz, 1H), 2.85 (d, J = 16.7 Hz, 1H), 2.77 (dd, J = 10.7, 5.0 
Hz, 1H), 2.21 (bs, 1H), 2.10 (dd, J = 10.8, 7.9 Hz, 1H), 1.28-1.44 (m, 2H), 0.90 (t, J = 7.4 
Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.4, 130.9, 129.9, 129.0, 127.8, 125.6, 63.7, 
56.3, 53.9, 38.6, 27.6, 12.3.   
 
326a and 326b 
The cuprate solution was prepared as follows: a 
suspension of CuCN (93.0 mg, 1.04 mmol) in 
anhydrous THF (3 mL) chilled with a dry ice/acetone 
bath was added an allylmagnesium chloride solution in ether (1.14 M, 2.00 mL, 2.28mmol).  
The suspension was allowed to warm to rt, becoming an opaque black suspension, then 
chilled with a cryostat bath (-15 °C). 
To a solution containing 244 (81.2 mg, 0.399 mmol) and proton sponge (104.6 mg, 0.488 
mmol) dissolved in anhydrous DCM (10 mL) under positive pressure of Argon was chilled 
with a cryostat bath (˗15 °C).  To this solution was added triflic anhydride (74 µL, 0.440 
mmol) via syringe causing the yellow solution to become orange.  5 minutes after the triflic 
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anhydride addition the solution containing the aziridinium was cannulated to the cuprate 
solution.  The mixture was stirred for 15 minutes, then allowed to warm to ambient 
temperature.  Purification by flash chromatography (CHCl3) to yield 326a and 326b, which 
were an inseparable mixture, as a light yellow oil (86 mg, 95%).  Rf = 0.05 (CHCl3).   
1
H 
NMR (400 MHz, CDCl3):  7.24-7.40 (m, 7.1H), 5.67-5.89 (m, 3.4H), 5.60 (ddd, J = 10.0, 
2.8, 1.7, 1H), 5.03 (dq, J = 17.3, 1.8 Hz, 0.57H), 4.89-4.99 (m, 3.03H), 3.91 (d, J = 13.6 
Hz, 1H), 3.67 (t, J = 6.6 Hz, 1H), 3.63 (t, J = 13.0 Hz, 0.54H), 3.43 (d, J = 13.6 Hz, 1H), 
3.04-3.13 (m, 1.32H), 2.78-2.94 (m, 0.81H), 2.57 (dd, J = 11.8, 5.6, 1H), 2.46 (dd, J = 11.8, 
4.6 Hz, 1H), 2.25-2.37 (m, 0.69H), 2.19 (s, 1H), 2.11 (t, J = 7.1 Hz, 2.91H), 1.93-2.03 (m, 
0.38H), 1.90 (s, 0.31H), 1.56-1.64 (m, 1H), 1.31-1.50 (m, 2.40H), 1.24 (d, J = 6.4 Hz, 
0.35H), 1.18 (d, J = 6.6 Hz, 3H), 0.99 (d, J = 6.6 Hz, 1.15H).  
 
 
(6R)-1-benzyl-6-methyl-3-phenyl-1,2,3,6-tetrahydropyridine (327) 
The cuprate solution was prepared as follows: a suspension of CuCN 
(100.3 mg, 1.12 mmol) in anhydrous DME (3 mL) chilled with a dry 
ice/acetone bath was added an phenylmagnesium bromide solution in 
ether (2.4 M, 0.470 mL, 1.13mmol).  The suspension was allowed to warm to rt, becoming 
an opaque black suspension, then chilled with a cryostat bath (-15 °C). 
To a solution containing 244 (86.1 mg, 0.424 mmol) and proton sponge (107.8 mg, 0.503 
mmol) dissolved in anhydrous DCM (8 mL) under positive pressure of Argon was chilled 
with a cryostat bath (˗15 °C).  To this solution was added triflic anhydride (79 µL, 0.470 
mmol) via syringe causing the yellow solution to become orange.  5 minutes after the triflic 
anhydride addition the solution containing the aziridinium was cannulated to the cuprate 
solution.  The mixture was stirred for 15 minutes, then allowed to warm to ambient 
temperature.  Purification by flash chromatography (CHCl3) to yield 327 and a minor 
unidentified isomer (5:1) as a light yellow oil (108 mg, 97%).  Rf = 0.05 (CHCl3). ).  IR 
(film)/cm
-1 
 3025, 2968, 2794, 1493, 1452, 1361, 1154, 1027, 910, 734.   
1
H NMR (400 
MHz, CDCl3):  7.20-7.33 (m, 10H), 5.83 (s, 2H), 3.89 (d, J  = 13.9 Hz, 1H), 3.58 (d, J = 
13.9 Hz, 1H), 3.48-3.54 (m, 1H), 3.20-3.29 (m, 1H, 2.76 (d, J = 6.0 Hz, 2H), 1.24 (d, J = 
N
Bn
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6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  175.2, 144.1, 139.8, 132.9, 128.8, 128.5, 
128.5, 128.4, 127.7, 127.0, 126.6, 58.4, 54.0, 53.7, 41.1, 18.2. 
 
 
(R)-1-benzyl-3-phenyl-1,2,3,6-tetrahydropyridine (328) 
The cuprate solution was prepared as follows: a suspension of CuCN (146.9 
mg, 1.64 mmol) in anhydrous THF (5 mL) chilled with a dry ice/acetone 
bath was added an phenylmagnesium bromide solution in ether (2.50 M, 
0.660 mL, 1.65mmol).  The suspension was allowed to warm to rt, becoming an opaque 
black suspension, then chilled with a cryostat bath (-15 °C). 
To a solution containing 236 (102.6 mg, 0.542 mmol) and proton sponge (140.4 mg, 0.655 
mmol) dissolved in anhydrous DCM (5 mL) under positive pressure of Argon was chilled 
with a cryostat bath (˗15 °C).  To this solution was added triflic anhydride (100 µL, 0.594 
mmol) via syringe causing the yellow solution to become orange.  5 minutes after the triflic 
anhydride addition the solution containing the aziridinium was cannulated to the cuprate 
solution.  The mixture was stirred for 15 minutes, then allowed to warm to ambient 
temperature.  Purification by flash chromatography (CHCl3) to yield 328 as a light yellow 
oil (130 mg, 96%).  The DEPT135 NMR clearly showed the product obtained to be the 
piperidine (43.7ppm peak assigned to the carbon not bound to a heteroatom in 
13
C NMR 
has one or three hydrogens on it due to phase).  The enantiomeric excess was determined 
by SFC analysis on a chiral stationary phase to be 64% ee (Chiralpak OD-H 25 cm, 2% i-
PrOH, 3mL/min, 35°C, 150bar, 210 nm, t
r 
(major) 21.8 min, t
r 
(minor) 26.5 min.  
Hydrogenation of 328 (21.6mg, 0.0866mmol) was done by dissolving 328 in methanol (5 
mL), and adding Pd/C (10% by wt Pd, 50% by wt water; 5mg) and H2 at ambient pressure 
and temperature (balloon) over 16 hours.  The optical rotation was taken of the 
hydrogenated compound, []20D = -10.6 (c = 0.0094 CHCl3), which showed the major 
enantiomer was R as shown above.  Rf = 0.08 (CHCl3). ).  
1
H NMR (400 MHz, CDCl3):  
7.21-7.34 (m, 10H), 5.80-5.91 (m, 2H), 3.57-3.66 (m, 3H), 3.18 (d, J = 16.4 Hz, 1H), 2.88-
3.03 (m, 2H), 2.36 (dd, J = 11.1, 8.2 Hz, 1H).  
13
C NMR (75 MHz, CDCl3):  144.6, 139.1, 
129.9, 129.5, 129.1, 129.1, 128.9, 127.8, 127.3, 127.1, 63.4, 59.1, 53.4, 43.7. 
N
Bn
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            Racemic 328               Enantio-enriched 328 
 
 
anti-N-((2R,3S)-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridin-3-yl)-
2,2,2-trifluoroacetamide (329) 
Following the general protocol with 244 and the sodium amide solution 
prepared by: NaH (2.6 equiv) was dissolved in anhydrous THF, the solution chilled with a 
cryostat bath (˗15 °C) under positive pressure of argon.  Then Trifluoroacetamide (3.4 
equiv) was added dropwise to the stirred solution (effervescence) followed by 15-Crown-5 
(2.5 equiv).  Purified by flash chromatography (CHCl3) to obtain 329 as a yellow oil (58%).  
Rf = 0.04 (chloroform).  IR (film)/cm
-1 
 3311, 3031, 2971, 2929, 2808, 1719, 1520, 1454, 
1374, 1361, 1271, 1201, 1159, 1003, 856.  
1
H NMR (300 MHz, CDCl3):  7.27-7.37 (m, 
5H), 6.87 (bs, 1H), 5.96 (ddd, J = 9.8, 4.2, 1.9 Hz, 1H), 5.76-5.79 (m, 1H), 4.18 (t, J = 7.0 
Hz, 1H), 3.69 (d, J = 13.0 Hz, 1H), 3.61 (d, J = 13.0 Hz, 1H), 3.22 (ddd, J = 17.9, 4.2, 1.9 
Hz, 1H), 3.02 (dd, J = 17.9, 1.9 Hz, 1H), 2.86 (q, J = 6.7 Hz, 1H), 1.00 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  138.5, 131.0, 128.9, 128.9, 127.8, 122.0, 58.5, 54.5, 49.6, 
47.7, 7.6.  HRMS Calcd for C15H18F3N2O [M + H]
+
:  299.13657; Found: 299.13697. 
 
anti-3-(-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridin-3-yl)oxazolidin-2-
one (330)  
Following the general protocol with 244 and the sodium 2-oxooxazolidin-3-
ide solution prepared by: 2-Oxazolidinone (3.0 equiv) was dissolved in 
anhydrous DME, the solution chilled with a cryostat bath (˗15 °C) and the NaHMDS (2.5 
equiv) and 15-Crown-5 (2.5 equiv) was added.  The sodium 2-oxooxazolidin-3-ide solution 
N
H
N CF3
O
Bn
N
Bn
N
O
O
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was added by cannula to the stirred aziridinium solution.  Purified by flash chromatography 
(CHCl3) to obtain 330 as white solid (86%).  Rf = 0.05 (chloroform).  mp = 122 °C.  IR 
(film)/cm
-1 
 2970, 2754, 1742, 1426, 1366, 1256, 1139, 1070, 1030, 910, 787, 739, 700.  
1
H 
NMR (300 MHz, CDCl3):  7.23-7.37 (m, 5H), 5.99 (d, J = 9.9 Hz, 1H), 5.54-5.59 (m, 1H), 
4.28 (t, J = 8.1 Hz, 2H), 4.14 (m, 1H), 3.94 (dt, J = 9.1, 7.9 Hz, 1H), 3.54-3.68 (m, 3H), 
3.04-3.12 (m, 2H), 2.88 (dq, J = 17.8, 2.3 Hz, 1H), 1.06 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 
MHz, CDCl3):  158.5, 139.0, 131.4, 129.1, 128.7, 127.5, 120.9, 62.8, 59.2, 57.1, 53.8, 
46.9, 43.6, 9.0.  HRMS Calcd for C16H21N2O2 [M + H]
+
:  273.15975; Found: 273.15976. 
 
 
2-((2R,3S)-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridin-3-
yl)isoindoline-1,3-dione (331) 
Following the general protocol with 244 and the sodium phthalimide 
solution prepared by: NaHMDS (2.4 equiv) was dissolved in anhydrous 
THF, the solution chilled with a cryostat bath (˗15 °C) under positive pressure of argon.  
Then phthalimide (2.5 equiv) was added in one portion to the stirred solution followed by 
15-Crown-5 (2.5 equiv).  Purified by flash chromatography (CHCl3), to obtain 331 as a 
white solid (70%, >99% ee).  The enantiomeric excess was determined by SFC analysis on 
a chiral stationary phase (Chiralpak AS-H 25 cm, 10% MeOH, 3mL/min, 35°C, 150bar, 
220 nm, t
r 
(minor) 4.6 min, t
r 
(major) 5.8 min.  mp = 72 °C.  Rf = 0.05 (chloroform).  []20D 
= +124 (c = 0.617, CHCl3).  IR (film)/cm
-1 
 3029, 2973, 2925, 2794, 1771, 1708, 1467, 
1382, 1329, 1120, 1019, 908, 718.  
1
H NMR (300 MHz, CDCl3):  7.89 (d, J = 3.1 Hz, 1H), 
7.87(d, J = 3.0 Hz, 1H), 7.77 (d, J = 3.1 Hz, 1H), 7.73 (d, J = 3.1 Hz, 1H), 7.21-7.37 (m, 
5H), 5.90 (ddd, J = 10.1, 3.2, 2.8 Hz, 1H), 5.62 (ddd, J = 10.1, 2.2, 2.1, 1H), 4.71-4.78 (m, 
1H), 3.99 (d, J = 13.2 Hz, 1H), 3.52 (d, J = 13.2 Hz, 1H), 3.40 (dq, J = 8.5, 6.5 Hz, 1H), 
3.11-3.14 (m, 2H), 1.19 (d, J = 6.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  168.3, 139.3, 
134.0, 131.9, 128.7, 128.2, 128.2, 126.9, 124.2, 123.2, 55.2, 55.1, 52.1, 50.5, 15.8.  HRMS 
Calcd for C21H21N2O2 [M + H]
+
:  333.15975; Found: 333.16003. 
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Racemic 331     Enantioenriched 331 
 
 
anti-(2R,3S)-3-azido-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridine (332) 
Following the general protocol with 244 and tetrabutylammonium azide (2.6 
equiv) added in one portion as a solid.  Purified by flash chromatography 
(CHCl3) to obtain 332 as a yellow oil (75%), note: the azide was unstable forming another 
isomer visible by 
1
H NMR over the course of days.  Rf = 0.26 (chloroform).  IR (film)/cm
-1 
 
3033, 2970, 2932, 2875, 2805, 2101, 1494, 1453, 1363, 1221, 1147, 1070, 1026, 1004, 928, 
876, 796, 751, 722, 697.  
1
H NMR (300 MHz, CDCl3):  7.26-7.42 (m, 5H), 6.11 (ddd, J = 
9.8, 4.2, 2.1 Hz, 1H), 5.72-5.77 (m, 1H), 3.70 (s, 2H), 3.11-3.22 (m, 3H), 2.91 (dq, J = 
18.0, 2.2 Hz, 1H), 0.99 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.4, 132.5, 
129.6, 129.2, 127.9, 120.4, 60.8, 59.6, 57.6, 47.8, 9.6.  HRMS Calcd for C13H16N4 [M + 
H]
+
:  229.14477; Found: 229.14384. 
 
 
anti-1-benzyl-2-methyl-N-phenyl-1,2,3,6-tetrahydropyridin-3-amine 
(333) 
Following the general protocol with 244 and aniline (1.2 equiv) added in 
one portion via syringe.  Purified by flash chromatography (CHCl3), to obtain 333 as a 
yellow oil (80%).  Rf = 0.14 (chloroform).  IR (film)/cm
-1 
 3377, 3027, 2964, 2924, 2754, 
1600, 1498, 1430, 1370, 1313, 1246, 1148, 996.  
1
H NMR (300 MHz, CDCl3):  7.17-7.30 
(m, 7H), 6.73 (t, J = 7.3 Hz, 1H), 6.67 (d, J = 7.7 Hz, 2H), 5.90-5.95 (m, 1H), 5.84 (ddd, J 
= 9.9, 3.9, 1.7 Hz, 1H), 4.26 (d, J = 8.3 Hz, 1H), 3.71 (bs, 1H), 3.66 (s, 2H), 3.07-3.16 (m, 
N
Bn
N3
N
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H
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2H), 2.94 (dq, J = 17.6, 2.0, 1H), 1.05 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  
148.2, 139.8, 130.1, 129.4, 129.0, 129.0, 127.8, 125.3, 118.4, 114.9, 59.7, 55.7, 54.4, 47.9, 
9.5.  HRMS Calcd for C19H23N2 [M + H]
+
:  279.18558; Found: 279.18572. 
 
 
anti-1-benzyl-N,2-dimethyl-N-phenyl-1,2,3,6-tetrahydropyridin-3-
amine (334) 
Following the general protocol with 244 and N-Methylaniline (1.2 equiv) 
added in one portion via syringe.  Purified by flash chromatography 
(CHCl3) to obtain 334 as a yellow oil (93%).  Rf = 0.50 (20% diethyl ether/chloroform).  IR 
(film)/cm
-1 
 3026, 2963, 2923, 2802, 1597, 1501, 1452, 1368, 1315, 1136, 1108, 990, 747, 
731.  
1
H NMR (300 MHz, CDCl3):  7.26-7.37 (m, 7H), 6.83 (d, J = 8.2 Hz, 2H), 6.76 (t, J 
= 7.2 Hz, 1H), 5.96-6.00 (m, 1H), 5.67-5.72 (m, 1H), 4.17 (bs, 1H), 3.74 (d, J = 13.2 Hz, 
1H), 3.62 (d, J = 13.2 Hz, 1H), 3.08-3.14 (m, 1H), 3.06 (s, 3H), 3.02-3.04 (m, 1H), 2.95 
(dq, J = 17.4, 2.4 Hz, 1H), 1.17 (d, J = 6.6 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  150.7, 
140.2, 130.1, 130.0, 129.5, 129.0, 127.7, 125.3, 116.8, 113.4, 60.0, 59.5, 57.9, 48.3, 34.7, 
12.2.  HRMS Calcd for C20H25N2 [M + H]
+
:  293.20123; Found: 293.20134. 
 
1,3-bis((2R,3S)-1-benzyl-2-methyl-1,2,3,6-tetrahydro-
pyridin-3-yl)-1H-imidazol-3-ium hydroxide (335) 
Following the general protocol with 244 and imidazole (1.2 
equiv) added in one portion via syringe. Purified by trituration 
with diethyl ether to obtain 337 as a yellow solid (60%).  The mono-alkylated product was 
present also but not isolated.   
1
H NMR (300 MHz, CDCl3):  9.13 (s, 1H), 7.60 (s, 2H), 
7.22-7.24 (m, 6H), 7.08-7.10 (m, 4H), 6.27 (dd, J = 9.8, 4.1 Hz, 2H), 5.87 (dd, J = 9.5, 5.6 
Hz, 2H), 4.87 (d, J = 5.2 Hz, 2H), 3.62 (d, J = 12.9 Hz, 2H), 3.58 (d, J = 13.0 Hz, 2H), 
3.19-3.28 (m, 2H), 2.95-3.11 (m, 4H), 1.18 (d, J = 6.7 Hz, 6H).   
 
 
(2R,3S)-1-benzyl-N-ethyl-2-methyl-1,2,3,6-tetrahydropyridin-3-amine 
(336) 
Following the general protocol with 244 and ethylamine (1.2 equiv) added 
N
Bn
N
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in one portion via syringe. Purified by flash chromatography (CHCl3) to obtain 337 as a 
yellow oil (89%).  Note: minor impurity of proton sponge present, unable to remove despite 
multiple column attempts.  Rf = 0.05 (chloroform).  IR (film)/cm
-1 
 3030, 2963, 2928, 2871, 
2822, 1577, 1494, 1453, 1369, 1134, 1068, 1028, 998, 909, 731.  
1
H NMR (300 MHz, 
CDCl3):  7.20-7.37 (m, 5H), 5.81-5.88 (m, 1H), 5.72 (ddd, J = 10.0, 4.1, 2.0 Hz, 1H), 3.67 
(d, J = 13.2 Hz, 1H), 3.61 (d, J = 13.1 Hz, 1H), 2.98-3.12 (m, 2H), 2.90 (dq, J = 17.2, 2.0 
Hz, 1H), 2.71-2.76 (m, 1H), 2.53 (q, J = 7.1 Hz, 2H), 1.08 (t, J = 7.1 Hz, 3H), 0.93 (d, J = 
6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.7, 129.1, 128.5, 127.3, 127.2, 126.6, 59.1, 
58.2, 52.9, 48.0, 41.3, 16.0, 8.7. 
 
anti-1-benzyl-N,N-diethyl-2-methyl-1,2,3,6-tetrahydropyridin-3-amine 
(337) 
Following the general protocol with 244 and Diethylamine (1.2 equiv) 
added in one portion via syringe. Purified by flash chromatography (CHCl3) 
to obtain 337 as a yellow oil (87%).  Rf = 0.05 (chloroform).  IR (film)/cm
-1 
 3028, 2965, 
2926, 2870, 2801, 1723, 1661, 1602, 1494, 1453, 1368, 1201, 1135, 1069, 1052, 1028, 996, 
909.  
1
H NMR (300 MHz, CDCl3):  7.24-7.40 (m, 5H), 5.81-5.87 (m, 1H), 5.70-5.74 (m, 
1H), 3.77 (d, J = 13.1 Hz, 1H), 3.55 (d, J = 13.1 Hz, 1H), 3.04 (bs, 1H), 2.84-2.96 (m, 3H), 
2.64-2.74 (m, 4H), 1.11 (d, J = 6.5 Hz, 3H), 1.07 (t, J = 7.2 Hz, 6H).  
13
C NMR (75 MHz, 
CDCl3):  140.2, 129.8, 129.0, 129.0, 127.7, 125.0, 62.0, 59.5, 55.4, 48.5, 45.7, 45.7, 30.5, 
15.1, 12.8.  HRMS Calcd for C17H27N2 [M + H]
+
:  259.21688; Found: 259.21690. 
 
anti-1-benzyl-2-methyl-1,2,3,6-tetrahydropyridin-3-yl acetate (338) 
Following the general protocol with 244 and tetrabutylammonium acetate 
(2.5 equiv) added in one portion as a solid.  Purified by flash 
chromatography (CHCl3) to obtain 338 as a yellow oil (65%).  Rf = 0.14 (chloroform).  IR 
(film)/cm
-1 
 3029, 2969, 2930, 1728, 1660, 1454, 1370, 1241, 1147, 1024.  
1
H NMR (400 
MHz, CDCl3):  7.40 (d, J = 6.6 Hz, 2H), 7.33 (t, J = 7.3 Hz, 2H), 7.26-7.28 (m, 1H), 6.05 
(ddd, J = 10.0, 3.6, 2.2 Hz, 1H), 5.78-5.82 (m, 1H), 4.96-4.97 (m, 1H), 3.80 (d, J = 13.4 Hz, 
1H), 3.64 (d, J = 13.4 Hz, 1H), 3.21 (d, J = 17.0 Hz, 1H), 3.00-3.08 (m, 2H), 2.10 (s, 3H), 
1.00 (d, J = 6.8 Hz, 3H).  
13
C NMR (100 MHz, CDCl3):  171.1, 139.0, 132.2, 129.0, 
N
Bn
N
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128.6, 127.4, 121.8, 72.1, 58.0, 54.4, 47.7, 21.7, 8.7.  HRMS Calcd for C15H20NO2 [M + 
H]
+
:  246.14886; Found: 246.14875. 
 
anti-1-benzyl-3-ethoxy-2-methyl-1,2,3,6-tetrahydropyridine (339)  
Following the general protocol with 244 and the ethanol (25 equiv) added in 
one portion via syringe.  Purified by flash chromatography (CHCl3), to 
obtain 339 as a yellow oil (73%).  Rf = 0.25 (chloroform).  IR (film)/cm
-1 
 3030, 2971, 
2927, 2870, 1494, 1453, 1371, 1304, 1148, 1092, 1028, 903, 734, 698..  
1
H NMR (300 
MHz, CDCl3):  7.41 (d, J = 7.2 Hz, 2H), 7.22-7.34 (m, 3H), 5.78-5.91 (m, 2H), 3.88 (d, J 
= 13.4 Hz, 1H), 3.42-3.59 (m, 4H), 3.03 (d, J = 8.9 Hz, 2H), 2.91-2.99 (m, 1H), 1.22 (t, J = 
7.0 Hz, 3H), 1.03 (d, J = 6.6 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  175.8, 130.1, 129.2, 
128.8, 128.1, 126.8, 123.9, 64.0, 57.6, 54.0, 48.5, 15.7, 10.5.  HRMS Calcd for C15H22NO 
[M + H]
+
:  232.16959; Found: 232.16939. 
 
anti-1-benzyl-2-methyl-3-phenoxy-1,2,3,6-tetrahydropyridine (340) 
Following the general protocol with 244 and the phenoxide solution 
prepared by dissolving sodium phenoxide (3.2 equiv) in anhydrous DME 
(5 mL), the solution chilled with a cryostat bath (˗15 °C) under positive pressure of argon.  
Then the phenoxide solution was added by cannula to the aziridinium solution.  Purified by 
flash chromatography (CHCl3) to obtain 340 as a yellow oil (85%).  Rf = 0.11 (chloroform).  
IR (film)/cm
-1 
 3028, 2968, 2924, 2797, 1663, 1596, 1585, 1492, 1453, 1372, 1300, 1236, 
1170, 1151, 1029, 909, 753, 734, 693.  
1
H NMR (300 MHz, CDCl3):  7.39 (d, J = 7.1 Hz, 
2H), 7.23-7.31 (m, 5H), 6.92-6.97 (m, 3H), 5.92-6.04 (m, 2H), 4.48 (s, 1H), 3.93 (d, J = 
13.4 Hz, 1H), 3.59 (d, J = 13.4 Hz, 1H), 3.08-3.19 (m, 3H), 1.15 (d, J = 6.7 Hz, 3H).  
13
C 
NMR (75 MHz, CDCl3):  158.0, 138.7, 130.5, 129.5, 128.7, 128.2, 126.9, 122.7, 120.7, 
115.8, 75.5, 57.6, 54.9, 48.4, 10.9.  HRMS Calcd for C19H22NO [M + H]
+
:  280.16959; 
Found: 280.16950. 
 
anti-1-benzyl-3-fluoro-2-methyl-1,2,3,6-tetrahydropyridine (341) 
Following the general protocol with 244 and TBAF (1.0M, 2.5 equiv) added 
dropwise to the stirred aziridinium solution.  Purified by flash chromatography 
(CHCl3) to obtain 341 as a yellow oil (57%).  Rf = 0.15 (chloroform).  IR (film)/cm
-1 
 3031, 
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2973, 2922, 2803, 1729, 1602, 1494, 1454, 1402, 1371, 1332, 1265, 1149, 1071, 1029, 983, 
965, 894, 775, 737, 698.  
1
H NMR (300 MHz, CDCl3):  7.25-7.42 (m, 5H), 6.03 (dq, J = 
10.0, 3.2 Hz, 1H), 5.85-5.92 (m, 1H), 4.67 (d, J= 49.2 Hz, 1H), 3.91 (d, J = 13.3 Hz, 1H), 
3.59 (d, J = 13.3 Hz, 1H), 3.03-3.15 (m, 3H), 1.09 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 MHz, 
CDCl3):  138.5, 132.3, 128.7, 128.2, 127.0, 122.0/121.8 (C-CF), 90.3/88.1 (C-F), 57.5, 
55.8/55.5 (C-CF), 48.2, 10.1.  HRMS Calcd for C13H17FN [M + H]
+
:  206.13395; Found: 
206.13376. 
 
anti-1-benzyl-3-(ethylthio)-2-methyl-1,2,3,6-tetrahydropyridine (342) 
Following the general protocol with 244 and Ethanethiol (10 equiv) added 
in one portion via syringe. Purified by flash chromatography (CHCl3) to 
obtain 342 as a yellow oil (56%).  Rf = 0.16 (chloroform).  IR (film)/cm
-1 
 3029, 2965, 
2924, 2869, 2802, 1659, 1494, 1452, 1367, 1261, 1203, 1135, 1067, 1028, 1013, 730.  
1
H 
NMR (300 MHz, CDCl3):  7.43 (d, J = 7.3 Hz, 2H), 7.22-7.35 (m, 3H), 5.75-5.77 (m, 2H), 
3.75 (d, J = 13.4 Hz, 1H), 3.61 (d, J = 13.4 Hz, 1H), 3.03-3.16 (m, 3H), 2.92-2.99 (m, 1H), 
2.50-2.70 (m, 2H), 1.24 (t, J = 7.5 Hz, 3H), 1.06 (d, J = 6.5 Hz, 3H).
  13
C NMR (75 MHz, 
CDCl3):  139.8, 129.6, 129.0, 127.7, 127.5, 125.3, 59.1, 57.0, 48.2, 47.8, 26.0, 15.9, 11.6.  
HRMS Calcd for C15H22NS [M + H]
+
:  248.14675; Found: 248.14663. 
 
anti-1-benzyl-2-methyl-3-(phenylthio)-1,2,3,6-tetrahydropyridine 
(343) 
Following the general protocol with 244 and the sodium thiophenoxide 
solution prepared by: NaH (2.7 equiv) was dissolved in anhydrous DME, the solution 
chilled with a cryostat bath (˗15 °C) under positive pressure of argon.  Then Thiophenol 
(4.0 equiv) was added dropwise to the stirred solution (effervescence).  Purified by flash 
chromatography (CHCl3) to obtain 343 as a yellow oil (70%).  Rf = 0.06 (chloroform).  IR 
(film)/cm
-1 
 3029, 2966, 2923, 2869, 2802, 2751, 1582, 1493, 1478, 1453, 1437, 1360, 
1203, 1135, 1066, 1025, 1015, 731.  
1
H NMR (300 MHz, CDCl3):  7.45 (d, J = 7.1 Hz, 
2H), 7.30-7.35 (m, 4H), 7.19-7.28 (m, 4H), 5.82-5.86 (m, 2H), 3.76 (d, J = 13.4 Hz, 1H), 
3.62 (d, J = 13.4 Hz, 1H), 3.50-3.54 (m, 1H), 3.17-3.25 (m, 1H), 3.14 (qd, J = 6.6, 2.2 Hz, 
1H), 2.97-3.05 (m, 1H), 1.03 (d, J = 6.7 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  139.6, 
N
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137.2, 132.2, 129.7, 129.6, 129.0, 128.6, 127.7, 127.4, 124.4, 59.0, 55.4, 51.9, 48.2, 11.0.  
HRMS Calcd for C19H22NS [M + H]
+
:  296.14675; Found: 296.14665. 
 
6.7 Divergent Substitution Using an Aziridinium 
  
N
OHBn
O
H
TBDPS
N
OHBn
OH
H
269 350  
(S)-1-((S)-1-benzyl-2,5-dihydro-1H-pyrrol-2-yl)-2-(tert-butyldiphenylsilyloxy)-ethanol 
(350) 
To a chilled (ice bath) solution of 269 (300 mg, 1.37 mmol) in anhydrous DCM (100 mL) 
was added imidazole (237 mg, 3.48 mmol), followed by dropwise addition of tert-
butylchlorodiphenylsilane (420 µL, 1.64 mmol).  After 2 hours the reaction mixture was 
diluted with ethyl acetate (200 mL) and washed with Sat. NaHCO3 (2x100 mL), brine (100 
mL) and dried (Na2SO4).  Purification by flash chromatography (0-30% ethyl 
acetate/hexane) to yield 350 as a colourless oil (527 mg, 84%).  Rf = 0.60 (30% ethyl 
acetate/hexane).  []20D = -64.8 (c = 0.925 CHCl3).  IR (film)/cm
-1 
 3070, 2929, 2857, 1472, 
1427, 1112, 911, 737, 701.  
1
H NMR (300 MHz, CDCl3):  7.66-7.70 (m, 4H), 7.36-7.47 
(m, 6H), 7.27-7.33 (5H), 5.81 (d, J = 6.2 Hz, 1H), 5.68 (dd, J = 6.1, 1.4 Hz, 1H), 4.07 (d, J 
= 13.2 Hz, 1H), 3.88-3.95 (m, 2H), 3.68-3.77 (m, 3H), 3.64 (d, J = 13.4 Hz, 1H), 3.22-3.31 
(m, 1H), 1.09 (s, 9H).  
13
C NMR (75 MHz, CDCl3):  140.2, 136.4, 136.4, 134.2, 134.2, 
130.6, 129.8, 129.4, 129.2, 128.6, 127.9, 129.5, 73.2, 71.7, 66.1, 61.1, 59.5, 27.7, 20.1.  
HRMS Calcd for C29H36NO2Si [M + H]
+
:  458.25098; Found:  458.25218. 
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(2S,3R)-1-benzyl-2-((tert-butyldiphenylsilyloxy)methyl)-3-phenoxy-1,2,3,6-
tetrahydropyridine (352) 
A flask containing Sodium phenoxide (290.0 mg, 1.70 mmol) in THF (5 mL) and a stir bar 
under positive pressure of Argon was chilled with a cryostat bath to -15
o
C and 15-Crown-5 
(280 µL, 1.41 mmol) was added to solubolize the compound.  A sealed (septum) flask 
containing 350 (260 mg, 0.568 mmol), proton sponge (147.4 mg, 0.688 mmol) and a stir 
bar was purged with Argon, and then anhydrous DCM (12 mL) was added via syringe.  The 
reaction vessel was chilled with a cryostat bath to -15
o
C white under positive pressure of 
Argon.  Triflic anhydride (105 µL, 0.624 mmol) was added to the stirred, clear colourless 
solution – within 1 minute the solution changed to an orange suspension.  5 minutes after 
the Tf2O addition the sodium phenoxide solution was added by cannula causing the mixture 
to become a yellow solution.  The mixture was stirred cold for 1 hour, then allowed to 
warm to rt during which time the colour did not change.  Purified by flash chromatography 
(5% diethyl ether/hexane) to obtain 352 as a yellow oil (264 mg, 87%).  Rf = 0.11 (5% 
diethyl ether/hexane).  []20D = -7.3 (c = 0.500 CHCl3).  IR (film)/cm
-1 
 3028, 2929, 2856, 
1596, 1586, 1492, 1471, 1427, 1390, 1361, 1290, 1229, 1105, 1028, 1005, 822, 752, 736, 
698.  
1
H NMR (300 MHz, CDCl3):  7.66 (d, J = 7.1Hz, 2H), 7.62 (d, J = 7.2 Hz, 2H), 
7.19-7.45 (m, 13H), 7.07 (d, J = 8.2 Hz, 2H), 6.94 (t, J = 7.3, 1H), 5.93-6.01 (m, 2H), 5.02 
(s, 1H), 3.99 (dd, J = 10.3, 4.3 Hz, 1H), 3.88 (d, J = 13.7 Hz, 1H), 3.29 (dd, J = 10.2, 8.0 
Hz, 1H), 3.72 (d, J = 13.7 Hz, 1H), 3.31-3.36 (m, 1H), 3.12 (d, J = 10.9 Hz, 1H), 3.02 (d, J 
= 10.9 Hz, 1H), 1.08 (s, 9H).  
13
C NMR (75 MHz, CDCl3):  158.7,136.5, 136.4, 131.7, 
130.6, 130.6, 130.3, 129.4, 129.0, 128.6, 128.6, 127.7, 123.4, 121.4, 116.7, 70.9, 61.6, 60.6, 
59.3, 27.7, 20.0.  HRMS Calcd for C35H40NO2Si [M + H]
+
:  534.28228; Found: 534.28461. 
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((2S,3R)-1-benzyl-3-phenoxy-1,2,3,6-tetrahydropyridin-2-yl)methanol (353) 
To a stirred solution of 352 (145 mg, 0.272 mmol) in anhydrous THF (2 mL) was added 
TBAF (1.0 M, 0.30 mL, 0.30 mmol), monitoring the reaction by TLC (10% acetone/DCM).  
After 30 minutes the solution was diluted with ethyl acetate (20 mL), washed with Sat. 
NaHCO3 (3x20 mL), brine (20 mL) and dried (Na2SO4).  Purification by flash 
chromatography (0-10% acetone/DCM) to obtain 353 as a white solid (74 mg, 92%).  Rf = 
0.29 (10% acetone/DCM).  mp = 67 °C.  []20D = -32 (c = 2.5 CHCl3).  IR (film)/cm
-1 
 
3412, 3030, 2927, 1596, 1493, 1454, 1401, 1290, 1232, 1172, 1076, 1028, 1002, 910, 753, 
736, 694.  
1
H NMR (300 MHz, CDCl3):  7.25-7.36 (m, 7H), 6.94-7.00 (m, 3H), 6.05 (d, J 
= 10.1 Hz, 1H), 5.95 (d, J = 10.3 Hz, 1H), 4.58 (s, 1H), 3.98 (q, J = 10.2 Hz, 2H), 3.80 (dd, 
J = 10.8, 5.6 Hz, 1H), 3.70 (dd, J = 10.8, 8.4 Hz, 1H), 3.25-3.32 (m, 2H), 3.12 (d, J = 18.4 
Hz, 1H), 2.11 (bs, 1H).  
13
C NMR (75 MHz, CDCl3):  158.4, 139.9, 130.5, 130.1, 129.6, 
129.2, 128.1, 124.3, 122.0, 116.4, 69.6, 62.3, 59.9, 58.6, 46.9.  HRMS Calcd for 
C19H22NO2 [M + H]
+
:  296.16451; Found:  296.16454. 
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(2S,3R)-1-benzyl-2-isobutyl-3-phenoxy-1,2,3,6-tetrahydropyridine  (355) 
The cuprate solution was prepared as follows: a suspension of CuCN (15.3 mg, 0.171 
mmol) in anhydrous THF (3 mL) chilled with a dry ice/acetone bath was added an 
isopropyl-magnesium chloride solution in THF (1.40M, 125 µL, 0.175 mmol).  The 
suspension was allowed to warm to rt, becoming an opaque black suspension, then chilled 
with a cryostat bath (-15 °C).  To a solution containing 353 (20 mg, 0.068 mmol) and 
proton sponge (20.4 mg, 0.0952 mmol) dissolved in anhydrous DCM (5 mL) under positive 
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pressure of Argon was chilled with a cryostat bath (˗15 °C).  To this solution was added 
triflic anhydride (14 µL, 0.083 mmol) via syringe causing the yellow solution to become 
orange.  5 minutes after the triflic anhydride addition the solution containing the 
aziridinium was cannulated to the cuprate solution.  The mixture was stirred for 15 minutes, 
then allowed to warm to ambient temperature.  Purification by flash chromatography (10% 
ethyl acetate/hexane) to yield 355  as a light yellow film (18 mg, 82%).  Rf = 0.55 (10% 
ethyl acetate/hexane).  IR (film)/cm
-1 
 2922, 2851, 1711, 1597, 1493, 1456, 1260, 1236, 
1076, 1027, 911, 798, 734.  
1
H NMR (300 MHz, CDCl3):  7.39 (d, J = 7.2 Hz, 2H), 7.18-
7.30 (m, 5H), 6.92-6.96 (m, 3H), 6.00 (bs, 2H), 4.48 (s, 1H), 3.86 (d, J = 13.7 Hz, 1H), 3.79 
(d, J = 13.7 Hz, 1H), 3.08-3.23 (m, 2H), 1.71-1.82 (m, 1H), 1.47-1.56 (m, 1H), 0.93 (d, J = 
6.5 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H).  
13
C NMR (75 MHz, CDCl3):  158.8, 140.5, 131.8, 
130.3, 129.5, 129.0, 127.6, 123.7, 121.6, 116.8, 73.6, 57.9, 57.9, 47.7, 35.9, 30.6, 26.1, 
23.7.  HRMS Calcd for C22H28NO [M + H]
+
:  322.21654; Found:  322.21687. 
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